Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3015322	s-alfa-1	g/l (g/l)	10254	22739	0.00%
3015322	s-alfa-1	— (—)	1802	2369	100.00%	Distribution not available
3015322	alfa1-glob	g/l (—)	683	2715	100.00%	Distribution not available
3015322	s-a1glob	g/l (—)	410	876	100.00%	Distribution not available
3015322	s-alfa-1-fraktio	g/l (—)	310	372	100.00%	Distribution not available
3015322	alfa-1	g/l (—)	113	347	100.00%	Distribution not available
3015322	alfa-1-glo	g/l (—)	84	95	100.00%	Distribution not available
3015322	s-alfa1-globuliini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue

1165

3502

3.56

320.90

1.8

2.3

3.25

3.06

g/l

5.90

910

2675

Acute renal failure

962

2559

4.10

320.49

2.9

2.1

3.39

3.05

g/l

15.38

780

1928

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2913

9415

2.23

315.65

3.1

2.0

3.26

2.98

g/l

32.05

2285

7292

Dialysis, with operation codes

669

1384

5.41

310.09

4.0

2.1

3.36

3.05

g/l

9.95

566

1075

Renal tubulo-interstitial diseases

3267

8702

3.01

307.65

2.5

2.2

3.20

3.01

g/l

18.44

2638

6629

Pneumonias (Asthma/COPD co-morbidities)

2987

9351

2.28

307.65

3.1

2.0

3.25

2.98

g/l

31.31

2345

7245

Autoimmune diseases excluding thyroid diseases, strict definition

3115

7604

2.34

307.65

2.0

2.4

3.14

3.03

g/l

6.18

2463

5864

General symptoms and signs

3259

6817

2.46

307.65

2.5

2.1

3.12

2.98

g/l

8.90

2551

5249

Multiple myeloma, excluding all cancers (controls excluding all cancers)

624

544

17.77

307.65

17.3

1.5

2.87

3.12

g/l

5.14

425

421

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2781

7595

2.36

307.65

3.1

1.9

3.25

2.99

g/l

26.24

2177

5898

Other soft tissue disorders, not elsewhere classified

2768

7458

2.36

307.65

2.3

3.05

3.07

g/l

0.30

2182

5808

Other and unspecified polyneuropathies, also in other diseases

1235

2513

5.66

307.65

2.0

2.3

2.79

3.11

g/l

21.62

931

1952

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4374

8350

3.98

307.65

2.5

2.1

3.14

3.02

g/l

10.16

3418

6436

Primary_lymphoid and hematopoietic malignant neoplasms

1520

3086

5.60

307.65

8.7

1.4

3.09

3.04

g/l

0.93

1150

2383

Metabolic disorders

2930

8042

2.33

307.65

2.6

2.1

3.08

3.04

g/l

1.13

2296

6218

L04AX Other immunosuppressants

1982

6939

2.99

307.65

5.1

1.7

3.22

3.02

g/l

12.45

1530

5426

Tramadol

2521

6444

2.60

307.65

2.3

1.9

3.13

3.01

g/l

5.58

2016

4931

Polyneuropathies and other disorders of the peripheral nervous system

1332

2877

5.26

307.65

2.3

2.80

3.11

g/l

23.26

1009

2235

Malaise and fatigue

1697

4899

3.01

307.65

2.1

3.20

3.01

g/l

10.09

1331

3712

Inflammatory bowel disease treatment related agents

3777

8489

2.61

307.65

2.0

2.3

3.19

2.98

g/l

22.47

2944

6561

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

369

303

20.65

307.65

21.4

1.6

2.92

3.24

g/l

4.15

261

234

Fever of other and unknown origin

1892

5718

3.20

307.65

3.8

2.1

3.38

2.99

g/l

34.59

1516

4366

Pneumonia, organism unspecified

2751

8872

2.31

307.65

3.0

2.0

3.26

2.99

g/l

29.26

2158

6864

Influenza and pneumonia

3079

9274

2.24

307.65

3.1

2.0

3.23

2.98

g/l

27.07

2402

7207

Bacterial infection, other or unspecified

2111

6427

3.13

307.65

3.4

2.0

3.49

2.97

g/l

62.96

1653

4880

Polyarthropathies

2538

5697

3.10

307.65

2.5

2.3

3.26

3.02

g/l

20.83

2019

4422

Renal failure

2380

5555

4.30

307.65

2.6

2.2

3.24

3.07

g/l

10.97

1966

4161

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

783

535

26.45

307.65

7.5

1.3

2.80

3.13

g/l

9.15

576

416

Primary_lymphoid and hematopoietic malignant neoplasms

1520

3135

5.51

307.65

8.7

1.4

3.09

3.08

g/l

0.13

1150

2419

Systemic connective tissue disorders

1548

4556

3.64

307.65

1.9

2.3

3.32

3.04

g/l

14.80

1221

3471

Second line medication for Crohn's disease

2007

7071

2.97

307.65

5.1

1.7

3.22

3.02

g/l

13.16

1552

5530

Multiple myeloma

369

303

20.65

307.65

21.4

1.6

2.92

3.24

g/l

4.15

261

234

ILD medications: prednisolone, methylprednisolone, prednisone

3815

7456

3.00

307.65

2.2

1.7

3.19

2.97

g/l

23.80

3013

5741

Heart failure, not strict

2703

7399

2.63

307.65

2.5

2.3

3.23

3.00

g/l

21.13

2148

5649

Condition for Implicit Sepsis (Organ dysfunction codes)

2702

8492

2.39

307.65

2.4

2.1

3.16

3.02

g/l

8.95

2097

6555

ILD medications: immunosuppressive drugs

2465

6324

3.95

307.65

4.4

1.7

3.21

2.96

g/l

23.62

1933

4890

Examination and observation for other reasons

1933

4253

2.86

307.65

2.3

2.1

3.11

g/l

0.05

1629

3455

All pneumoniae

3003

9370

2.27

307.65

3.1

2.0

3.25

2.98

g/l

31.35

2356

7267

Oral corticosteroids

3671

8424

2.73

307.65

2.1

2.4

3.20

2.98

g/l

23.09

2863

6510

First line medication for Crohn's disease

3675

7374

2.81

307.65

3.0

1.6

3.18

2.96

g/l

23.76

2879

5701

2781

7595

2.36

307.65

3.1

1.9

3.25

2.99

g/l

26.24

2177

5898

Other anaemias

2239

5438

4.35

307.65

2.6

2.2

3.16

3.09

g/l

1.73

1715

4141

Other bacterial diseases

3333

8823

2.71

307.65

2.9

2.0

3.35

2.95

g/l

67.55

2621

6791

Pain in limb

2458

7317

2.51

307.65

2.2

2.3

3.07

g/l

0.13

1954

5695

ILD medications

3994

7487

3.04

307.65

2.9

1.7

3.16

2.97

g/l

19.89

3135

5765

Bacterial Sepsis

1713

5580

2.88

307.65

2.9

2.1

3.35

3.04

g/l

24.68

1319

4253

Autoimmune diseases excluding thyroid diseases

3218

7853

2.34

307.65

1.9

2.4

3.14

3.03

g/l

6.69

2541

6052

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1256

991

20.85

307.65

11.1

1.3

2.83

3.05

g/l

7.25

890

764

Other systemic involvement of connective tissue (FG)

1140

2787

4.37

307.65

1.8

2.5

3.25

3.00

g/l

9.39

890

2111

Aplastic and other anaemias

2351

5774

4.21

307.65

2.6

2.2

3.16

3.09

g/l

1.85

1800

4392

Multiple myeloma and malignant plasma cell neoplasms

612

573

16.41

307.65

17.4

1.5

2.87

3.16

g/l

6.19

416

456

Other and unspecified anaemias

2225

5391

4.37

307.65

2.6

2.2

3.16

3.09

g/l

1.58

1704

4108

Chronic kidney disease

1729

3859

4.98

307.65

2.4

2.2

3.20

3.06

g/l

5.24

1440

2864

Multiple myeloma and malignant plasma cell neoplasms

612

542

17.38

307.65

17.4

1.5

2.87

3.12

g/l

5.11

416

420

Anaemias

988

690

10.15

307.65

2.5

1.2

3.18

2.85

g/l

9.84

776

542

Implicit Sepsis

2530

7962

2.57

307.65

2.5

2.2

3.20

3.02

g/l

12.10

1951

6127

Finngen Rheumatological endpoints

2731

6891

2.31

306.25

2.1

2.3

3.12

2.97

g/l

10.32

2161

5353

Glomerular diseases

870

2233

4.26

304.92

2.7

2.3

3.16

3.07

g/l

1.67

733

1741

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

553

999

6.52

301.86

3.5

2.3

3.38

3.13

g/l

3.93

384

781

Implicit bacterial Sepsis

1509

5070

2.88

287.66

2.8

2.1

3.35

3.04

g/l

20.24

1156

3871

Persons encountering health services for specific procedures and health care

3051

9137

2.12

282.29

2.7

2.1

3.13

3.03

g/l

5.57

2371

7102

Heart failure and antihypertensive medication

972

1718

3.96

278.92

2.1

2.5

3.31

2.99

g/l

12.41

773

1281

Infections, IBD-co-morbidities

558

700

6.12

273.69

4.1

2.1

3.14

3.04

g/l

0.93

414

559

Gout

1121

3331

3.27

264.09

3.2

2.4

3.26

3.05

g/l

8.62

902

2553

Codeine

2606

6622

2.21

260.93

2.1

1.9

3.05

3.01

g/l

0.98

2066

5083

Osteopathies and chondropathies

1780

7153

2.45

251.44

3.1

2.1

3.11

3.07

g/l

0.88

1311

5527

Other heart diseases

1226

2755

3.02

241.20

2.3

2.0

3.14

2.92

g/l

8.12

973

2149

Abnormal findings on examination of blood, without diagnosis

1625

6312

2.52

240.75

2.8

2.3

3.18

3.06

g/l

3.80

1228

4912

Disorders of lipoprotein metabolism and other lipidaemias

2492

7488

2.15

239.68

2.3

2.2

3.09

3.06

g/l

0.82

1947

5768

Hypertension, essential

2120

5358

2.32

237.90

2.2

3.10

2.97

g/l

5.53

1677

4125

Heart failure,strict

1810

5587

2.44

236.76

2.1

2.3

3.30

3.01

g/l

22.21

1450

4216

Glomerular disorders in diseases classified elsewhere

586

1362

4.78

235.55

2.7

2.3

3.21

3.09

g/l

1.93

485

1082

Nephropathy related operations

601

1446

4.60

230.84

4.1

2.3

3.41

3.06

g/l

11.58

505

1141

Reimbursement for rheumatic diseases

1795

7930

2.34

230.83

1.7

2.4

3.28

3.03

g/l

17.53

1425

6086

Oedema, not elsewhere classified

1031

3509

3.06

226.21

2.3

2.2

3.20

3.02

g/l

6.00

804

2661

Opioids

2605

6662

2.09

225.81

2.5

1.9

3.07

3.01

g/l

2.33

2076

5114

Autoimmune diseases related-to ILD

2379

10340

2.07

224.48

2.0

2.3

3.21

3.02

g/l

12.76

1875

7982

Gout, FINNGEN

1121

4082

2.91

221.50

3.2

2.3

3.26

3.04

g/l

9.90

902

3121

Codeine or tramadol medication

3162

9268

1.93

221.41

2.1

2.2

3.06

3.05

g/l

0.13

2507

7124

Unspecified kidney failure

510

1118

5.10

220.85

2.7

2.1

3.32

3.06

g/l

5.69

421

852

Certain infectious and parasitic diseases

2667

6597

2.06

219.99

2.6

1.9

3.15

2.93

g/l

18.95

2099

5080

Asthma, unspecified (mode), excluding more controls

1417

4434

2.58

217.56

2.1

1.9

3.12

2.96

g/l

7.42

1105

3457

Nutritional anaemias

1587

6671

2.41

215.85

2.0

2.3

3.23

3.08

g/l

5.96

1212

5107

Pain in joint

1646

4591

2.44

215.10

2.0

2.2

3.04

3.08

g/l

0.71

1298

3581

Hypertensive diseases (excluding secondary)

1297

2783

2.78

212.09

2.2

2.0

3.06

2.92

g/l

4.54

1042

2161

Iron deficiency anaemia

1364

5535

2.55

209.83

2.0

2.3

3.25

3.07

g/l

7.20

1036

4210

Other and unspecified iron deficiency

1117

4171

2.81

208.82

1.9

2.3

3.27

3.07

g/l

7.01

859

3178

Pure hypercholesterolaemia

2188

7116

2.12

206.44

2.3

2.2

3.09

3.07

g/l

0.44

1694

5467

Medical observation and evaluation for suspected diseases and conditions

1887

4305

2.30

202.26

2.4

2.1

3.03

3.12

g/l

2.79

1482

3491

Hypertensive diseases

2045

5407

2.19

201.57

2.2

3.09

2.97

g/l

5.40

1638

4162

Abnormalities of breathing

2333

6855

2.06

201.02

2.3

2.1

3.07

3.06

g/l

0.11

1834

5324

Hypertension

2041

5405

2.19

200.27

2.2

3.09

2.97

g/l

5.44

1634

4160

Asthma, excluding more controls

1944

4721

2.24

199.88

2.0

1.9

3.10

2.95

g/l

6.95

1513

3694

Cardiovascular diseases (excluding rheumatic etc)

1371

3104

2.60

198.92

2.2

2.0

3.09

2.91

g/l

6.87

1109

2428

Dental caries

849

2774

3.17

198.38

3.8

2.1

3.27

3.05

g/l

6.18

655

2186

Autoimmune diseases

2904

7877

1.92

196.53

2.0

2.4

3.07

3.03

g/l

1.01

2283

6071

Diseases of oesophagus, stomach and duodenum

2873

9388

1.90

195.97

2.1

2.3

3.04

3.06

g/l

0.41

2168

7345

Used for control exclusion in common control thyroid runs

2747

7275

1.95

194.73

2.1

2.4

3.06

3.03

g/l

0.76

2155

5619

Other arthritis (FG)

935

3294

2.96

194.35

2.2

2.5

3.33

2.97

g/l

18.03

740

2549

Other diseases of blood and blood-forming organs, wide

837

2794

3.19

193.86

3.2

2.2

3.18

3.07

g/l

2.05

665

2163

Care involving dialysis

415

855

5.46

193.83

2.5

2.1

3.31

3.02

g/l

5.59

349

702

Diseases of arteries, arterioles and capillaries (FINNGEN)

795

1690

3.44

192.62

2.2

3.32

2.94

g/l

15.30

653

1309

Septicaemia

1306

5238

2.49

191.98

3.1

2.1

3.36

2.97

g/l

27.01

1009

3980

Asthma, unspecified (mode)

1450

4916

2.40

191.73

2.1

1.9

3.13

2.97

g/l

6.87

1126

3834

Osteoporosis

972

3379

2.92

189.97

2.2

2.1

3.10

3.13

g/l

0.33

676

2581

GASTRO-related operations

1974

4608

2.19

189.17

2.3

1.9

3.12

2.95

g/l

8.21

1549

3577

Any gastric operation

1974

4608

2.19

189.17

2.3

1.9

3.12

2.95

g/l

8.21

1549

3577

Diverticular disease of intestine

2162

7159

2.06

188.88

2.5

2.3

3.10

3.06

g/l

0.89

1697

5538

Explicit Sepsis

1339

5456

2.44

188.46

3.1

2.1

3.36

3.04

g/l

19.41

1037

4152

Heart failure, strict

1923

6686

2.15

187.63

2.1

2.4

3.30

3.05

g/l

19.49

1536

5059

Other specific joint derangements/joint disorders

1831

5770

2.17

185.62

1.9

2.3

3.02

3.01

g/l

0.14

1428

4517

Asthma

2039

5245

2.13

185.34

2.1

1.9

3.10

2.97

g/l

5.89

1588

4108

Benign neoplasm of colon, rectum, anus and anal canal

1647

5373

2.26

183.75

2.3

1.4

3.13

3.03

g/l

2.75

1238

4161

Dyspnoea

2455

10013

1.92

182.01

2.4

2.2

3.12

3.05

g/l

2.91

1939

7703

Dentinal caries

763

2481

3.21

181.67

3.9

2.1

3.26

3.06

g/l

4.76

580

1962

All-cause Heart Failure

1869

6589

2.12

176.37

2.1

2.4

3.30

3.05

g/l

18.89

1490

4977

Exposure to unspecified factor

2519

10621

1.88

175.33

2.2

2.3

3.10

3.05

g/l

1.93

2019

8171

Polymyalgia rheumatica

603

1771

3.72

174.27

1.8

2.4

3.46

3.10

g/l

8.98

454

1350

Asthma (mode)

1975

5283

2.09

173.64

2.0

1.9

3.09

2.97

g/l

4.83

1536

4139

Transplanted organ and tissue status

437

1030

4.66

171.96

5.6

2.1

3.15

3.05

g/l

1.04

344

830

Other diseases of intestines

2652

8396

1.87

171.86

2.3

2.2

3.04

3.05

g/l

0.03

2033

6556

Other heart diseases, wide

2274

7341

1.96

171.82

2.4

2.2

3.11

2.99

g/l

6.15

1792

5691

Ulcer of lower limb, not elsewhere classified

612

1838

3.62

170.44

2.2

3.43

3.08

g/l

12.17

524

1411

Asthma (only as main-diagnosis), excluding more controls

1688

4721

2.17

166.42

2.0

1.9

3.10

2.95

g/l

6.52

1317

3694

Pain in throat and chest

2146

6758

1.98

166.32

2.3

2.1

3.03

3.06

g/l

0.85

1704

5245

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

375

533

5.49

165.36

2.4

2.1

3.29

3.06

g/l

3.01

306

418

Pain, not elsewhere classified

764

2643

3.00

164.00

2.5

2.1

3.02

2.98

g/l

0.42

618

2041

Benign neoplasm: Colon

1462

5152

2.25

163.25

2.3

1.4

3.13

3.04

g/l

2.73

1090

3992

Other specified/unspecified arthritis

829

3019

2.86

162.22

2.1

2.4

3.33

3.02

g/l

12.13

652

2326

Spondylopathies

2220

7100

1.94

161.97

2.5

2.1

3.03

3.09

g/l

1.57

1691

5560

Cardiovascular diseases

1171

2541

2.55

161.56

2.3

1.9

3.08

2.92

g/l

4.75

947

1995

Diabetic nephropathy, excluding more controls

555

1307

3.82

161.10

1.8

2.0

3.13

3.08

g/l

0.52

454

1007

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2886

9389

1.78

160.24

2.1

2.3

2.99

3.08

g/l

4.88

2357

7166

Low back pain

1885

7380

2.01

160.06

2.6

2.1

3.04

3.08

g/l

0.91

1453

5797

Other septicaemia

1134

4753

2.43

158.81

2.8

2.0

3.37

2.97

g/l

23.82

876

3612

Continuous positive airway pressure

654

1799

3.29

156.70

2.2

2.4

3.34

2.99

g/l

11.09

478

1439

Erysipelas

1564

6940

2.12

156.09

2.2

2.1

3.28

2.96

g/l

25.14

1246

5319

Rheumatoid arthritis

1009

3720

2.56

155.66

1.9

2.5

3.31

3.02

g/l

12.07

783

2841

Acute tubulo-interstitial nephritis

1626

7102

2.08

155.55

2.2

3.26

3.03

g/l

13.09

1270

5370

Cerebrovascular diseases (FINNGEN)

847

2179

2.87

155.47

2.4

2.1

3.15

2.93

g/l

6.35

669

1680

Symptoms and signs involving cognition, perception, emotional state and behaviour

2521

9934

1.81

154.16

2.0

2.3

3.01

3.07

g/l

1.78

1908

7736

Neurological diseases, wide definition

616

843

3.74

152.59

2.2

2.0

3.04

g/l

0.03

478

677

Persons encountering health services in other circumstances, wide

3102

9451

1.73

152.35

2.2

2.3

3.01

3.08

g/l

3.41

2497

7207

Complications of surgical and medical care, not elsewhere classified

2549

10386

1.79

151.21

2.3

3.15

3.04

g/l

5.44

1967

8044

Diseases of the skin and subcutaneous tissue

2591

7233

1.83

150.96

2.3

2.2

3.05

g/l

0.02

2037

5557

L04AA Selective immunosuppressants

711

2486

3.01

150.93

1.8

2.3

3.24

3.06

g/l

4.53

592

1936

Enlarged lymph nodes

516

1488

3.65

150.82

2.1

3.17

3.02

g/l

2.16

412

1163

Headache

1474

5901

2.13

149.28

2.1

2.0

2.95

2.98

g/l

0.45

1131

4540

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

551

1692

3.51

147.75

3.0

1.4

3.28

3.04

g/l

4.99

451

1286

Other disorders of skin and subcutaneous tissue

1908

9292

1.93

147.60

2.2

2.3

3.16

3.06

g/l

3.78

1502

7119

Gout, idiopatic and unspecified

897

3587

2.65

147.47

2.1

2.4

3.29

3.05

g/l

9.77

738

2763

Fall on same level

2846

9241

1.75

147.36

2.2

2.3

3.10

3.03

g/l

2.86

2190

7254

Asthma (only as main-diagnosis)

1741

5245

2.04

146.79

2.0

1.9

3.10

2.97

g/l

5.76

1355

4108

Symptoms and signs involving the skin and subcutaneous tissue

1812

9579

1.93

142.10

2.2

2.3

2.93

3.08

g/l

8.64

1448

7348

Dorsalgia

2466

7510

1.81

141.86

2.4

2.1

3.01

3.08

g/l

2.40

1923

5892

Covid-19 confirmed case

866

3471

2.60

140.12

2.8

2.2

3.26

3.06

g/l

5.57

666

2692

Disturbances of skin sensation

775

2950

2.73

139.09

1.9

2.2

2.81

3.07

g/l

13.78

635

2303

Coagulation defects, purpura and other haemorrhagic conditions

644

2237

3.04

138.58

2.5

2.3

3.15

3.08

g/l

1.05

513

1746

L04AD Calcineurin inhibitors

405

1061

4.11

137.59

2.6

2.5

3.24

3.06

g/l

2.81

351

836

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

810

1438

2.87

135.48

2.3

1.9

3.10

3.00

g/l

1.66

647

1145

Oxycodone

1046

4479

2.34

134.30

5.1

2.0

3.36

3.05

g/l

13.29

771

3405

COPD/asthma/ILD related infections

2621

7598

1.76

134.09

3.0

1.9

3.17

2.99

g/l

13.10

2055

5900

COPD/asthma related infections

2621

7598

1.76

134.09

3.0

1.9

3.17

2.99

g/l

13.10

2055

5900

Disorders of thyroid, IBD co-morbidities

403

720

4.20

133.06

2.0

2.1

3.09

3.04

g/l

0.36

316

576

Disorders resulting from impaired renal tubular function

219

357

7.23

132.92

2.3

2.5

3.26

3.14

g/l

0.78

192

290

Type 2 diabetes, wide definition

2220

8163

1.81

132.89

2.0

2.5

3.13

3.04

g/l

3.56

1738

6246

Malignant immunoproliferative diseases

121

19.70

132.55

10.5

1.3

3.03

3.14

g/l

0.39

Other pulmonary diagnosis

1982

5298

1.91

131.69

2.6

1.9

3.14

2.97

g/l

8.99

1557

4148

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

110

25.62

131.65

11.4

1.1

2.92

3.13

g/l

0.87

Diseases of arteries, arterioles and capillaries

1932

7902

1.87

131.22

2.0

2.4

3.27

3.05

g/l

14.00

1528

6027

Other disorders of fluid, electrolyte and acid-base balance

922

3776

2.45

130.68

2.6

2.1

3.22

3.11

g/l

2.29

702

2875

Small fibre neuropathy

194

288

8.26

129.68

2.5

2.6

2.88

3.18

g/l

2.76

142

227

Seropositive rheumatoid arthritis

758

2949

2.67

129.64

1.8

2.5

3.30

3.00

g/l

11.23

579

2242

Syncope and collapse

1169

4827

2.20

129.43

2.3

2.1

3.02

3.01

g/l

0.09

900

3649

Atrial fibrillation and flutter

824

2077

2.66

128.86

2.6

2.1

3.16

2.94

g/l

6.02

667

1599

Gout, strict definition

670

2485

2.88

128.71

2.0

2.4

3.33

3.06

g/l

8.70

551

1915

Gout, unspecified

732

2836

2.74

128.66

2.1

2.4

3.27

3.05

g/l

7.38

613

2181

Parasetamol

1857

4995

1.93

128.49

2.3

2.0

3.12

3.00

g/l

4.52

1440

3967

Viral Sepsis

635

2284

2.92

128.08

3.3

2.2

3.20

3.06

g/l

2.38

473

1766

Glomerulonephritis

407

1130

3.89

127.48

2.9

2.4

3.12

3.10

g/l

0.13

350

897

Implicit viral Sepsis

633

2279

2.92

127.45

3.3

2.2

3.20

3.07

g/l

2.36

471

1761

Symptoms and signs involving the nervous and musculoskeletal systems

1546

8108

1.96

126.35

2.0

2.3

2.87

3.10

g/l

17.55

1226

6212

Symptoms and signs concerning food and fluid intake

365

942

4.13

125.93

2.0

2.2

2.98

3.07

g/l

0.93

280

739

Excluding asthma or asthma-COPD overlap

1959

5298

1.88

125.66

2.5

1.9

3.15

2.97

g/l

9.46

1538

4148

Benign neoplasm of colon, rectum, anus and anal canal

1778

8790

1.88

125.46

2.3

2.4

3.11

3.08

g/l

0.69

1346

6751

Codes for special purposes

1131

5317

2.19

125.29

2.8

2.2

3.20

3.03

g/l

6.01

891

4142

Provisional assignment of new diseases of uncertain etiology

1129

5307

2.19

125.10

2.8

2.1

3.20

3.03

g/l

5.99

890

4135

Heart failure and bmi 25plus

1048

3208

2.34

124.78

2.1

2.5

3.34

3.08

g/l

12.15

831

2355

Asthma (diagnoses ohter than nonallergic)

2139

10561

1.76

123.90

2.0

2.3

3.10

3.05

g/l

1.83

1659

8159

Other dorsopathies, not elsewhere classified

2445

7517

1.74

123.76

2.3

2.1

3.00

3.08

g/l

2.94

1858

5898

Other necrotizing vasculopathies (FG)

277

594

5.16

123.09

1.4

2.9

3.73

2.97

g/l

15.69

221

461

Symptoms and signs involving the urinary system

2045

9011

1.79

122.21

2.1

2.3

3.09

3.07

g/l

0.51

1544

6985

Preparatory care for dialysis

247

489

5.86

122.03

2.0

2.9

3.25

3.09

g/l

1.34

223

389

COPD differential diagnosis

1940

5283

1.87

121.82

2.5

1.9

3.15

2.97

g/l

9.10

1525

4139

Lower back pain or/and sciatica

2532

10557

1.69

121.81

2.5

2.2

3.03

3.06

g/l

0.83

1969

8181

ILD differential diagnosis

1940

5283

1.87

121.80

2.5

1.9

3.15

2.97

g/l

9.10

1525

4139

Abnormalities of gait and mobility

479

1525

3.39

121.35

1.8

2.4

3.03

3.12

g/l

1.25

405

1182

Symptoms and signs involving the circulatory and respiratory systems

2366

6868

1.75

120.77

2.3

2.1

3.03

3.06

g/l

0.63

1865

5336

Care involving use of rehabilitation procedures

1614

8248

1.90

120.48

2.4

2.1

3.10

3.03

g/l

1.92

1229

6375

Pain (limb, back, neck, head abdominally)

1826

4910

1.89

119.29

2.3

2.2

3.05

3.07

g/l

0.41

1411

3808

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1765

9129

1.84

117.34

2.5

2.3

3.12

3.07

g/l

1.24

1367

6983

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

970

2670

2.35

117.24

2.4

2.1

3.07

2.92

g/l

3.67

758

2081

Any reimbursement code in KELA

1133

2557

2.25

117.20

2.4

1.5

3.13

2.83

g/l

15.36

903

1992

Non-follicular lymphoma, hilmo, excluding all cancers

396

1156

3.73

115.50

2.7

1.4

3.30

3.02

g/l

4.51

327

896

Chronic periodontitis

521

1784

3.09

115.45

3.3

2.1

3.26

3.06

g/l

3.63

422

1419

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2316

9365

1.71

115.30

2.8

2.1

3.08

3.05

g/l

0.77

1750

7368

Malignant immunoproliferative diseases

121

120

15.63

115.25

10.5

1.8

3.03

3.25

g/l

0.98

Other and unspecified dermatitis

1318

6775

2.00

114.50

2.1

2.3

3.01

3.08

g/l

1.45

1038

5188

Antihypertensive medication - note that there are other indications

1125

2827

2.21

114.03

2.0

2.2

3.05

2.95

g/l

2.04

897

2165

Diabetic nephropathy

558

1981

2.97

113.39

1.7

2.0

3.14

3.12

g/l

0.13

456

1539

Lymphoid leukaemia

266

597

4.97

112.20

2.7

1.4

3.03

3.06

g/l

0.18

221

471

Soft tissue disorders

2424

7517

1.70

112.01

2.3

3.01

3.07

g/l

1.61

1900

5852

Endocrine, nutritional and metabolic diseases

1768

4888

1.87

111.49

2.1

2.2

3.08

3.02

g/l

1.29

1394

3808

Hypertensive heart and/or renal disease

806

2628

2.47

111.46

2.0

2.4

3.23

3.03

g/l

5.81

665

1969

Other necrotizing vasculopathies

321

836

4.23

111.06

1.7

2.6

3.73

3.09

g/l

13.28

254

660

Cardiac arrhythmias

1357

4566

2.00

110.96

2.4

2.3

3.08

2.97

g/l

2.88

1080

3562

Disorders of mineral metabolism

327

860

4.12

110.91

3.8

2.2

3.08

g/l

0.00

241

680

Dermatitis and eczema

2606

10570

1.64

110.73

2.1

2.3

2.99

3.08

g/l

3.87

2051

8163

Non-ischemic cardiomyopathy

972

3677

2.26

110.53

2.3

3.24

3.04

g/l

6.82

766

2767

Diseases of pulp and periapical tissues

926

4232

2.25

110.48

3.7

2.0

3.15

3.06

g/l

1.62

692

3313

Diseases of the musculoskeletal system and connective tissue

1139

2647

2.19

110.41

2.4

2.1

3.09

3.01

g/l

1.72

906

2089

Osteoporosis with pathological fracture (FG)

285

683

4.58

110.09

1.8

2.5

3.06

3.03

g/l

0.18

206

507

Asthma-related infections

1449

7656

1.90

109.59

2.3

3.18

3.06

g/l

4.87

1135

5898

Asthma, hospital admission 2, infections

1449

7656

1.90

109.59

2.3

3.18

3.06

g/l

4.87

1135

5898

Rheumatoid arthritis, including avohilmo

1106

5443

2.10

109.36

1.9

2.4

3.29

3.07

g/l

8.80

856

4173

Depression medications

500

753

3.39

109.07

1.8

1.2

3.01

2.85

g/l

2.38

408

591

Constipation

2226

9588

1.69

107.93

2.7

2.2

3.04

3.07

g/l

0.71

1640

7469

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

185

317

6.98

107.36

2.1

1.4

2.98

3.12

g/l

1.00

158

247

Chronic lymphocytic leukaemia, helper endpoint

185

317

6.98

107.36

2.1

1.4

2.98

3.12

g/l

1.00

158

247

Neoplasms

1572

4481

1.91

107.22

2.8

1.2

3.08

3.01

g/l

1.87

1239

3551

Disorders of calcium metabolism

277

665

4.59

106.87

4.2

2.2

3.08

3.13

g/l

0.26

203

530

Dermatitis

1523

8389

1.86

106.68

2.2

2.3

3.02

3.08

g/l

1.59

1183

6454

Other CVD (FINNGEN)

386

875

3.68

106.29

2.9

2.3

3.08

2.96

g/l

1.33

286

664

Nephrotic syndrome

175

284

7.08

106.13

2.8

2.7

3.10

g/l

0.01

156

227

Other special examinations and investigations of persons without complaint or reported diagnosis

1592

4305

1.90

105.74

2.3

2.1

3.00

3.12

g/l

3.53

1165

3491

Chronic periapical parodontitis

623

2446

2.66

105.50

4.5

2.1

3.16

3.06

g/l

1.34

463

1924

Neurological diseases

1997

5786

1.76

104.33

2.1

2.4

2.99

3.14

g/l

7.99

1515

4607

Purpura and other haemorrhagic conditions

459

1553

3.13

104.01

2.5

2.3

3.10

g/l

0.01

361

1220

Non-follicular lymphoma

396

1245

3.45

102.77

2.7

2.5

3.30

3.08

g/l

3.05

327

992

Atrial fibrillation and flutter with reimbursement

697

1780

2.59

102.32

2.6

2.2

3.19

2.94

g/l

6.15

557

1379

Spinal stenosis

1425

6047

1.90

101.66

2.3

2.2

3.00

3.11

g/l

3.73

1061

4698

Asthma, hospital admissions 3, pneumonia

1007

4910

2.11

101.58

2.4

2.2

3.28

3.08

g/l

7.21

792

3726

Asthma-related pneumonia or sepsis

1007

4910

2.11

101.58

2.4

2.2

3.28

3.08

g/l

7.21

792

3726

Asthma-related pneumonia

1004

4901

2.11

100.99

2.3

2.2

3.28

3.08

g/l

7.20

789

3717

Bleeding

2128

9380

1.68

100.72

2.2

2.3

3.15

3.06

g/l

3.90

1666

7202

Follow-up examination after treatment for conditions other than malignant neoplasms

1087

3464

2.10

100.67

2.2

2.1

3.06

3.11

g/l

0.68

883

2814

Benign neoplasm: Colon

1490

8153

1.84

100.18

2.3

3.13

3.09

g/l

0.83

1114

6280

Lymphoid leukaemia

266

655

4.52

99.70

2.7

2.6

3.03

3.15

g/l

1.04

221

525

Valvular heart disease excluding rheumatic fever

1271

4857

1.96

99.29

2.3

3.21

3.01

g/l

8.19

976

3710

Persons encountering health services for examination and investigation

1578

4305

1.87

98.93

2.2

2.1

3.06

3.12

g/l

0.98

1209

3491

Chronic gastritis

863

4034

2.22

98.17

2.1

2.3

3.09

3.11

g/l

0.20

671

3133

Non-rheumatic valve diseases

1264

4844

1.95

97.62

2.3

3.20

3.01

g/l

7.91

970

3702

ILD medications: azathioprine

379

1182

3.33

97.59

1.8

1.6

3.26

2.98

g/l

4.82

297

924

Genitourinary diseases

1357

3539

1.95

97.28

2.2

2.1

3.09

3.05

g/l

0.66

1097

2745

Other disorders of white blood cells

248

589

4.65

97.18

2.0

2.6

3.14

3.11

g/l

0.12

200

470

Hypothyroidism (congenital or acquired)

422

725

3.40

97.08

2.3

1.2

2.96

2.85

g/l

1.18

330

570

Amyloidosis, other/unspecified

135

186

9.14

97.00

8.8

2.2

2.92

3.16

g/l

1.77

106

148

Arthropathies

2003

6003

1.72

96.79

2.1

2.3

3.06

3.01

g/l

1.10

1592

4684

Hypothyroidism and >3 levothyroxin purchases

419

724

3.38

95.79

2.4

1.2

2.96

2.85

g/l

1.19

329

570

Hypothyroidism, levothyroxine purchases

419

724

3.38

95.79

2.4

1.2

2.96

2.85

g/l

1.19

329

570

Extracorporeal dialysis

264

665

4.38

95.72

2.7

2.5

3.42

3.03

g/l

5.71

209

535

Chronic lymphocytic leukaemia

185

356

6.19

95.10

2.1

2.5

2.98

3.18

g/l

1.78

158

275

Diaphragmatic hernia

1045

5315

2.03

94.48

2.3

3.12

3.09

g/l

0.47

813

4081

Complications of procedures, not elsewhere classified

1932

10118

1.68

93.92

2.1

2.3

3.13

3.04

g/l

3.47

1499

7837

Intestinal infectious diseases

2171

10524

1.63

92.74

2.8

2.1

3.15

3.04

g/l

4.63

1685

8148

Diarrhoea and gastroenteritis of presumed infectious origin

1624

8586

1.75

92.52

2.7

2.1

3.14

3.05

g/l

3.29

1269

6646

Chronic lower respiratory diseases

2787

9812

1.56

91.72

2.0

2.3

3.13

3.03

g/l

5.70

2184

7587

Cardiomyopathy

552

2196

2.63

91.27

2.7

2.3

3.17

3.00

g/l

3.13

466

1672

Amyloidosis

143

225

7.67

90.40

8.5

2.2

2.93

3.21

g/l

2.34

113

183

Adjustment and management of implanted device

610

2567

2.49

89.68

2.5

2.1

3.20

3.07

g/l

2.53

535

1952

Haemorrhage from respiratory passages

946

4365

2.07

89.57

2.2

3.15

3.10

g/l

0.90

742

3329

Complications of medical and surgical care

1787

10251

1.69

89.42

2.4

2.3

3.15

3.05

g/l

4.09

1373

7921

Dizziness and giddiness

1831

8988

1.68

88.99

2.1

2.4

3.01

3.08

g/l

2.16

1399

6955

Hyperlipidaemia, other/unspecified

1072

5295

1.97

88.89

2.4

2.2

3.15

3.09

g/l

1.07

817

4058

Need for other prophylactic measures

232

561

4.53

88.60

2.4

2.6

3.14

g/l

0.00

185

450

Hypothyroidism, drug reimbursement

287

532

3.95

87.54

2.3

1.3

3.06

2.87

g/l

1.92

229

421

Fracture of lumbar spine and pelvis

664

2925

2.36

87.36

2.3

2.2

3.16

3.13

g/l

0.25

456

2235

Dorsopathies

2340

7525

1.61

87.34

2.3

2.1

3.00

3.08

g/l

2.98

1804

5903

Other disorders of urethra and urinary system

1651

7285

1.73

87.32

2.2

3.10

3.04

g/l

1.35

1277

5604

Certain disorders involving the immune mechanism

567

2333

2.54

87.23

2.8

2.2

3.01

3.07

g/l

0.72

450

1827

Gastrointestinal diseases

1253

3302

1.93

86.90

2.5

1.9

3.09

3.04

g/l

0.82

982

2633

Disorders of other endocrine glands

1052

5409

1.96

86.86

2.4

2.2

3.05

3.08

g/l

0.42

831

4160

Other antidepressants

2485

8316

1.58

86.67

2.1

2.3

3.03

3.07

g/l

0.98

1922

6451

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2050

7481

1.64

86.25

3.8

1.4

3.13

3.01

g/l

4.90

1612

5834

Malignant neoplasm, wide definition for exclusion

2050

7481

1.64

86.23

3.8

1.4

3.13

3.01

g/l

4.89

1612

5834

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2050

7481

1.64

86.22

3.8

1.4

3.13

3.01

g/l

4.89

1612

5834

Other intervertebral disc disorders

1955

7319

1.66

85.97

2.2

2.1

3.00

3.08

g/l

2.44

1469

5734

Sicca syndrome [Sjögren]

318

977

3.49

85.28

1.8

2.6

2.97

3.10

g/l

1.21

252

750

Spondylosis

1356

6576

1.81

85.16

2.1

2.2

2.99

3.09

g/l

3.11

1063

5146

Other joint disorders

1869

6000

1.68

83.92

2.0

2.3

3.03

3.01

g/l

0.21

1471

4681

Asthma, including avohilmo

2695

10375

1.53

83.10

2.0

2.3

3.10

3.05

g/l

1.80

2098

8032

Other diseases of urinary system

2387

8653

1.57

83.07

2.3

3.09

3.04

g/l

1.55

1868

6700

Bacterial pneumoniae

1064

4994

1.93

82.82

3.8

2.0

3.34

3.00

g/l

20.58

833

3830

1001

5192

1.95

82.47

2.3

2.2

3.14

3.04

g/l

2.53

790

4005

Disorders of parathyroid gland

642

2824

2.34

82.40

2.4

2.2

3.03

3.15

g/l

2.03

502

2140

Benign neoplasms

1558

5102

1.75

82.19

2.2

1.4

3.03

3.00

g/l

0.44

1213

4029

Bacterial pneumonia, not elsewhere classified

1024

4759

1.95

82.09

3.7

2.0

3.35

3.00

g/l

21.08

808

3646

Sulfasalazine

688

3146

2.25

82.03

1.7

2.4

3.28

2.97

g/l

11.60

541

2448

Injuries to the abdomen, lower back, lumbar spine and pelvis

992

5156

1.96

81.95

2.3

2.2

3.13

3.08

g/l

0.70

714

3979

Gingivitis and periodontal diseases

2166

7057

1.61

80.82

2.4

2.0

3.07

g/l

0.01

1702

5455

Use of hypnotics and sedatives

2501

9488

1.54

80.80

2.5

2.2

3.04

3.06

g/l

0.24

1932

7381

Parodontitis or operation codes

2164

10239

1.58

80.72

2.4

2.3

3.11

3.05

g/l

1.76

1697

7917

372

1285

3.02

80.72

2.3

3.21

3.08

g/l

1.52

318

990

Secondary hypertension

242

633

3.99

80.65

2.3

2.1

3.22

2.93

g/l

3.97

198

472

Parodontitis

2162

10239

1.58

80.62

2.4

2.3

3.11

3.05

g/l

1.76

1695

7918

Other and unspecified disorders of white blood cells

192

434

4.93

80.43

1.9

2.6

3.12

3.14

g/l

0.10

160

345

Diseases of the eye and adnexa

1733

5166

1.70

80.33

2.2

2.1

3.02

3.06

g/l

0.80

1355

4104

Azathioprine

379

1324

2.97

80.32

1.8

2.5

3.26

2.98

g/l

4.86

297

1038

Diseases of liver

895

4571

2.02

79.85

1.8

2.4

3.11

3.06

g/l

0.76

688

3575

Chronic periodontitis, including avohilmo

2151

10239

1.58

79.80

2.3

3.11

3.05

g/l

1.79

1685

7918

Nerve, nerve root and plexus disorders

2498

10363

1.53

79.68

2.2

2.3

2.99

3.07

g/l

3.47

1890

8064

2672

9378

1.52

79.63

3.0

2.0

3.11

3.04

g/l

2.70

2058

7270

Acquired haemolytic anaemia

142

251

6.61

79.51

3.7

2.2

3.02

3.18

g/l

0.94

108

199

Other disorders of kidney and ureter

431

1635

2.79

79.19

2.4

3.16

3.08

g/l

0.75

355

1275

Hypertensive Renal Disease

172

359

5.32

79.17

1.7

2.7

3.22

3.08

g/l

0.83

141

283

STROKE

1428

5746

1.76

78.96

2.5

2.4

3.12

3.03

g/l

2.70

1103

4396

Malignant neoplasm

2076

7802

1.60

78.71

4.1

1.4

3.12

3.02

g/l

3.50

1614

6094

Infections of the skin and subcutaneous tissue

1282

7319

1.78

78.34

2.4

2.2

3.17

3.03

g/l

4.37

1022

5707

Other and unspecified diseases of blood and blood-forming organs

145

265

6.34

78.28

5.4

2.6

3.15

g/l

0.01

124

216

Diseases of oral cavity, salivary glands and jaws

2173

7104

1.59

77.68

2.5

2.0

3.07

g/l

0.07

1672

5486

Benign neoplasms

2193

7863

1.58

77.16

2.3

2.2

3.04

3.06

g/l

0.42

1689

6183

SLE (Finngen)

154

299

5.68

76.83

1.8

2.3

3.26

3.11

g/l

0.82

128

239

Disorders of choroid and retina

2006

9331

1.59

76.74

2.3

3.10

3.07

g/l

0.46

1502

7215

Other/unspecified dorsalgia

894

4597

1.98

76.46

2.7

2.1

3.03

3.10

g/l

1.18

694

3582

Venous thromboembolism

1407

8110

1.72

75.99

2.6

2.2

3.18

3.08

g/l

3.12

1101

6197

Weight loss

334

1132

3.14

75.88

2.1

2.4

2.98

3.11

g/l

1.36

257

898

Gastro-oesophageal reflux disease

1596

8655

1.66

75.08

2.0

2.3

2.98

3.06

g/l

2.64

1158

6769

Abnormal findings on diagnostic imaging of lung

1283

7276

1.76

74.68

2.4

2.3

3.16

3.08

g/l

2.01

997

5577

Other external causes of accidental injury

1919

5996

1.62

74.44

2.2

2.3

3.08

3.04

g/l

0.90

1483

4687

Gonarthrosis [arthrosis of knee](FG)

1723

6225

1.65

74.23

2.0

2.5

3.09

2.98

g/l

4.10

1338

4805

Seronegative rheumatoid arthritis

341

1178

3.03

74.19

2.1

2.8

3.30

2.99

g/l

4.78

276

908

Glucagon-like peptide-1 (GLP-1) analogues

1493

7422

1.69

73.72

2.2

2.5

3.14

3.07

g/l

1.72

1172

5665

Disorders of eyelid, lacrimal system and orbit

1999

10125

1.57

73.70

2.4

2.3

2.98

3.08

g/l

3.84

1520

7829

Accidents

1913

5996

1.62

73.28

2.2

2.3

3.08

3.04

g/l

0.99

1483

4687

Haemolytic anaemias

161

340

5.28

73.26

3.5

2.2

3.00

3.17

g/l

1.24

125

269

Symptoms and signs involving the digestive system and abdomen

2369

7811

1.54

73.09

2.2

3.01

3.08

g/l

1.93

1825

6078

Seropositive rheumatoid arthritis, wide

758

3788

2.07

72.24

1.8

2.3

3.30

3.07

g/l

7.09

579

2906

Abnormal weight loss

314

1060

3.17

72.01

1.9

2.4

2.97

3.10

g/l

1.48

240

845

Statin medication

1502

5013

1.70

71.82

2.1

2.4

3.04

3.01

g/l

0.56

1219

3788

Injuries to the head

2438

10681

1.50

71.62

2.1

2.3

3.08

3.05

g/l

0.72

1874

8301

Kidney transplant status

193

478

4.38

71.28

1.7

2.5

3.34

2.99

g/l

4.07

170

385

Intracranial trauma

1147

4818

1.80

71.08

2.1

2.3

3.03

3.13

g/l

2.43

875

3837

Hypertensive Heart Disease

647

2473

2.21

70.82

2.0

2.4

3.25

3.03

g/l

5.58

530

1858

Other/unspecified seropositive rheumatoid arthritis

749

3754

2.06

70.82

1.9

2.3

3.30

3.07

g/l

7.14

574

2882

Thrombocytopenia, unspecified

260

793

3.53

70.77

2.1

2.6

3.07

3.11

g/l

0.23

199

631

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

739

3688

2.07

70.74

1.9

2.3

3.30

3.06

g/l

6.83

567

2835

Myalgia

540

2378

2.34

70.72

2.0

2.2

2.99

3.09

g/l

1.47

414

1852

Pruritus

335

1179

2.99

70.70

2.0

2.4

2.88

3.14

g/l

6.20

274

922

Diabetes mellitus

2307

9155

1.52

70.47

1.9

2.4

3.11

3.03

g/l

3.33

1794

7053

Falls/tendency to fall

2431

8118

1.52

70.39

2.2

2.3

3.06

3.03

g/l

0.79

1874

6392

Cough

947

4915

1.89

70.06

2.5

2.2

3.05

3.09

g/l

0.49

738

3769

Cerebrovascular diseases

1878

8647

1.58

70.05

2.3

2.4

3.14

3.07

g/l

2.17

1437

6676

Diabetes, varying definitions

2298

9138

1.52

69.96

1.9

2.4

3.12

3.03

g/l

3.41

1789

7038

Benign neoplasm: Colon, unspecified

671

3233

2.14

69.81

2.3

1.4

3.13

3.04

g/l

1.38

473

2498

Coxarthrosis [arthrosis of hip](FG)

1288

5448

1.74

69.73

2.1

2.6

3.08

2.99

g/l

2.39

974

4169

Diseases of the respiratory system

1496

4463

1.70

69.53

2.6

1.9

3.15

2.98

g/l

7.19

1184

3477

Isolated proteinuria

138

268

5.77

69.21

3.2

2.6

2.97

3.15

g/l

1.03

119

207

Cystitis

1921

7550

1.58

68.83

2.2

2.3

3.08

3.04

g/l

0.91

1492

5815

Parodontitis and operation codes

1998

10189

1.55

68.57

2.3

3.09

3.06

g/l

0.59

1569

7886

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2203

8945

1.52

67.77

1.9

2.4

3.11

3.04

g/l

2.51

1718

6886

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

21.70

67.49

13.6

1.4

2.95

3.25

g/l

1.03

Giant cell arteritis

190

489

4.33

67.39

1.5

2.7

3.88

3.11

g/l

10.07

148

379

Bacterial pneumonia (organism specified)

1134

5960

1.77

67.27

4.0

2.0

3.35

3.05

g/l

17.40

891

4559

Other diseases of pleura

1209

6296

1.74

67.20

2.4

2.3

3.29

3.07

g/l

10.90

946

4818

Systemic lupus erythematosus

154

336

5.04

67.16

1.8

2.1

3.26

3.10

g/l

0.90

128

265

Explicit bacterial Sepsis

314

1103

2.99

66.48

4.1

2.2

3.37

3.04

g/l

5.70

246

876

DVT of lower extremities and pulmonary embolism

1096

6297

1.78

66.47

2.7

2.3

3.17

3.09

g/l

1.77

858

4811

Other arrhythmias

1394

6474

1.67

66.32

2.1

2.3

3.02

3.00

g/l

0.38

1064

4987

Viral pneumonia

353

1320

2.79

66.23

3.3

2.0

3.21

3.00

g/l

3.31

280

1013

Streptococcal septicaemia

271

883

3.25

65.78

4.0

2.2

3.36

2.96

g/l

6.93

211

697

Episodal and paroxysmal disorders

2468

8607

1.48

65.16

1.9

2.3

2.98

3.09

g/l

6.00

1880

6739

Direct fill therapy

366

1405

2.71

65.14

4.9

2.2

3.24

3.09

g/l

1.68

270

1122

Disorders of lens

1685

6735

1.61

65.13

2.6

2.3

3.12

3.06

g/l

1.45

1279

5312

Chronic rhinitis, nasopharyngitis and pharyngitis

743

3818

1.99

64.92

2.1

2.2

3.02

3.05

g/l

0.38

587

3001

Hypo-osmolality and hyponatraemia

485

2122

2.37

64.63

2.8

2.1

3.18

3.13

g/l

0.38

373

1604

Other diseases of blood and blood-forming organs

246

767

3.44

64.63

4.3

2.6

3.11

3.09

g/l

0.11

198

615

Peripheral artery disease

1212

5778

1.73

64.53

2.0

2.4

3.34

3.06

g/l

15.44

959

4402

Other disorders involving the immune mechanism, not elsewhere classified

137

281

5.41

64.43

2.1

2.6

3.11

3.09

g/l

0.09

113

227

Asthma, hospital admissions , main diagnosis only

1809

10586

1.55

64.39

2.0

2.3

3.10

3.05

g/l

1.24

1405

8181

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

166

399

4.62

64.37

2.3

1.4

3.23

3.10

g/l

0.62

126

309

Other functional intestinal disorders

1024

5544

1.79

64.24

2.6

2.2

3.01

3.08

g/l

1.19

753

4262

Unspecified haematuria

1079

5322

1.78

64.10

2.2

2.4

3.14

3.07

g/l

1.34

834

4122

Type 2 diabetes

2237

8964

1.50

63.71

1.9

2.4

3.12

3.04

g/l

3.47

1745

6898

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2232

9843

1.50

63.65

2.4

2.2

3.10

3.05

g/l

1.18

1718

7654

Factors influencing health status and contact with health services

742

1818

2.08

63.54

2.4

1.8

3.10

g/l

0.06

585

1486

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

147

326

5.10

63.46

2.4

1.4

3.24

3.14

g/l

0.39

109

250

Idiopathic gout

317

1155

2.93

63.38

2.0

2.3

3.29

3.06

g/l

3.03

251

908

Abdominal and pelvic pain

2303

7811

1.50

63.26

2.3

2.2

3.00

3.08

g/l

2.48

1790

6078

Mixed connective tissue disease

231

702

3.52

63.20

1.7

2.6

3.16

3.11

g/l

0.29

198

549

Speech therapy

719

3697

2.00

63.20

2.4

2.3

3.13

3.08

g/l

0.69

647

2826

Paroxysmal tachycardia

468

1699

2.38

62.63

1.9

2.1

3.09

2.95

g/l

1.91

372

1314

Other specified/unspecified systemic involvement of connective tissue

209

600

3.73

62.45

1.8

2.7

3.13

3.09

g/l

0.17

183

465

Other cataract

1137

5156

1.75

62.45

2.6

2.4

3.05

3.07

g/l

0.32

883

4073

Hernia

2118

9680

1.50

62.39

2.4

2.2

3.06

3.07

g/l

0.26

1637

7461

Vasculitis limited to skin, not elsewhere classified

130

265

5.55

61.97

2.3

2.5

3.17

3.16

g/l

0.04

112

213

Sleep disorders (combined)

2224

9937

1.48

61.43

1.9

2.3

2.99

3.07

g/l

3.47

1696

7757

Sciatica+with lumbago

1113

6229

1.73

61.28

2.1

3.01

3.07

g/l

1.18

886

4906

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1433

8997

1.61

61.20

2.3

3.17

3.05

g/l

3.82

1109

6944

All influenza

599

2915

2.11

61.10

4.4

1.9

3.12

2.99

g/l

2.44

443

2266

Exposure to other specified factors

1546

9272

1.58

61.08

2.1

2.3

3.11

3.04

g/l

1.53

1212

7237

Obesity related asthma

787

4211

1.92

61.06

1.9

2.4

3.06

3.03

g/l

0.39

596

3296

Dialysis

153

358

4.65

61.01

2.2

2.1

3.40

3.04

g/l

3.18

131

282

Other arthrosis

1209

5160

1.71

60.74

2.0

2.4

3.04

3.02

g/l

0.38

938

4001

Benzodiazepine use

2225

10848

1.48

60.73

2.1

2.3

3.05

3.06

g/l

0.12

1689

8441

Injuries to the hip and thigh

1157

6326

1.71

60.60

2.1

2.3

3.17

3.09

g/l

1.51

810

4883

Polyuria

617

3055

2.09

60.53

2.0

2.4

3.03

3.07

g/l

0.46

502

2389

Diabetes, insulin treatment (Kela reimbursement)

2297

9646

1.47

60.42

2.0

2.4

3.11

3.05

g/l

2.04

1797

7437

Arthrosis

1611

5607

1.60

60.38

2.1

2.4

3.06

3.02

g/l

0.77

1252

4354

Insulin medication

1408

7538

1.62

60.34

2.0

2.4

3.15

3.06

g/l

2.16

1099

5790

Pulmonary heart disease, diseases of pulmonary circulation

849

4677

1.87

60.27

2.5

2.3

3.20

3.08

g/l

2.66

677

3578

SLE, ICD10

148

343

4.75

59.98

1.8

1.9

3.24

3.10

g/l

0.73

122

272

SLE, strict definition

148

343

4.75

59.98

1.8

1.9

3.24

3.10

g/l

0.73

122

272

Shoulder lesions

1757

7002

1.56

59.84

2.2

2.3

3.05

3.07

g/l

0.34

1346

5448

Hyperparathyroidism

536

2500

2.20

59.77

2.5

2.2

3.04

3.16

g/l

2.09

420

1887

Fibromyalgia

229

713

3.36

59.57

2.2

2.1

2.96

3.07

g/l

0.94

180

564

Diabetes medication

2275

9502

1.47

59.41

1.9

2.4

3.11

3.04

g/l

2.34

1758

7326

Other nutritional deficiencies

1324

8053

1.63

59.17

1.9

2.3

3.15

3.02

g/l

4.63

1030

6321

Bronchitis

2342

10660

1.46

58.84

3.1

2.0

3.12

3.05

g/l

3.12

1810

8256

Other bacterial intestinal infections

489

2240

2.26

58.73

3.6

2.1

3.21

3.10

g/l

1.11

348

1728

Unspecified privation

318

1203

2.77

58.58

2.0

2.3

3.35

3.10

g/l

3.37

271

952

Immunodeficiencies

177

475

4.02

58.55

4.5

2.4

3.00

3.06

g/l

0.34

132

385

Viral hepatitis, IBD co-morbidity

114

214

5.52

58.03

1.9

1.7

3.05

2.97

g/l

0.31

177

Any event in cancer register

2009

8019

1.50

58.03

3.7

1.6

3.10

3.01

g/l

3.05

1567

6259

Chronic periodontitis, complicated

307

1151

2.82

57.93

3.7

2.4

3.28

3.06

g/l

2.87

254

911

Other autoimmune haemolytic anaemias

129

8.20

57.17

3.0

2.2

2.79

3.20

g/l

3.19

101

COPD (mode)

773

3293

1.91

57.11

1.8

1.9

3.35

2.98

g/l

18.96

617

2521

Fracture of rib(s), sternum and thoracic spine

762

4131

1.90

57.01

2.6

2.3

3.10

3.08

g/l

0.19

571

3204

Visual disturbances and blindness

1161

7090

1.67

56.57

2.3

3.03

3.08

g/l

1.00

876

5483

Injuries to the thorax

1066

6394

1.70

55.75

2.3

3.11

3.07

g/l

0.62

804

4957

Immunodeficiency with predominantly antibody defects

118

242

5.42

55.60

5.2

2.1

2.99

3.08

g/l

0.42

203

Presence of cardiac and vascular implants and grafts

1224

5704

1.66

55.57

1.8

2.3

3.18

3.10

g/l

1.84

898

4453

Other symptoms and signs involving cognitive functions and awareness

1090

6167

1.69

55.36

2.0

2.4

3.05

3.11

g/l

0.92

797

4765

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

122

259

5.20

55.10

1.9

2.7

3.15

3.06

g/l

0.37

101

207

Dysphagia

626

3221

2.00

54.90

2.3

3.01

3.11

g/l

1.55

465

2496

General examination and investigation of persons without complaint and reported diagnosis

1313

4297

1.64

54.89

2.3

2.1

2.84

3.11

g/l

14.02

889

3485

Visual disturbances

1071

6458

1.69

54.89

2.2

2.3

3.02

3.08

g/l

1.00

820

5007

Temporal arteritis

163

437

4.14

54.65

1.5

2.9

3.88

3.13

g/l

8.47

130

335

Other acute lower respiratory infections

1182

6969

1.64

54.41

3.3

2.1

3.20

3.06

g/l

4.73

947

5330

Other and unspecified vasculitis limited to skin

117

244

5.42

54.36

2.5

2.6

3.21

3.18

g/l

0.09

100

196

Coxarthrosis

1187

4919

1.66

54.04

2.1

2.5

3.07

3.03

g/l

0.66

899

3798

Depression or dysthymia

1637

5980

1.55

54.00

2.1

2.3

3.02

3.08

g/l

1.66

1244

4703

Pulmonary embolism

767

4238

1.86

54.00

2.5

2.3

3.19

3.09

g/l

1.91

610

3239

Abnormal findings on examination of urine, without diagnosis

167

458

3.94

53.67

3.6

2.7

3.01

3.12

g/l

0.69

139

367

Pulmonary heart disease

767

4247

1.86

53.63

2.5

2.3

3.19

3.09

g/l

1.84

610

3245

Mood disorders, excluding more controls

2070

8676

1.47

53.49

2.0

2.3

3.01

3.07

g/l

1.65

1603

6793

Systemic lupus erythematosus, unspecified

128

292

4.83

52.98

1.8

2.0

3.29

3.09

g/l

0.99

105

234

Other gastritis (incl. Duodenitis)

598

3069

2.01

52.93

2.3

3.18

3.09

g/l

1.13

456

2407

Acute bronchitis

951

5494

1.73

52.84

3.2

2.1

3.20

3.07

g/l

3.74

779

4184

Senile cataract

1553

6285

1.56

52.82

2.7

2.4

3.12

3.06

g/l

1.18

1172

4966

Other retinal disorders

1526

8050

1.55

52.82

2.2

2.3

3.09

g/l

0.02

1129

6196

Hernia of abdominal wall, postoperative

402

1775

2.33

52.52

2.0

3.07

2.99

g/l

0.77

317

1394

Insulin, intermediate and long-acting

1288

8052

1.60

52.43

2.0

2.3

3.11

3.07

g/l

0.82

1004

6199

Bacterial intestinal infections, IBD co-morbidities

490

2350

2.16

52.43

3.7

2.2

3.19

3.11

g/l

0.80

354

1815

Asthma/COPD (KELA code 203)

2011

9796

1.46

52.37

2.0

2.3

3.12

3.03

g/l

3.16

1539

7576

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

162

6.66

51.89

2.7

1.4

3.14

3.13

g/l

0.02

122

External causes of morbidity and mortality

1475

4728

1.58

51.71

2.3

2.2

3.10

3.04

g/l

1.20

1141

3719

Dental caries 1

1874

6474

1.50

51.54

2.2

2.3

3.08

3.09

g/l

0.04

1442

5009

Dental caries, including avohilmo

1872

6470

1.50

51.42

2.2

2.3

3.08

3.09

g/l

0.05

1440

5005

ILD, hospital admission 2, with pulmonary infections

293

1139

2.71

51.36

2.4

1.9

3.32

3.02

g/l

4.97

239

878

Osteonecrosis

200

634

3.38

51.26

7.6

2.1

3.18

3.07

g/l

0.60

153

508

Atherosclerosis, excluding cerebral and coronary sclerosis

1111

5462

1.66

51.25

2.0

2.4

3.37

3.07

g/l

15.75

890

4152

IgA nephropathy (IgA glomerulonephritis)

107

217

5.49

51.12

1.7

2.6

3.18

3.10

g/l

0.29

171

Persons with potential health hazards related to communicable diseases

652

3439

1.91

51.05

2.2

2.0

3.03

3.02

g/l

0.13

438

2788

Disorders of gallbladder, biliary tract and pancreas

2219

10090

1.43

51.04

2.3

3.09

3.06

g/l

0.79

1711

7825

Diseases of the digestive system

1091

6720

1.65

51.00

2.2

3.17

3.09

g/l

1.76

848

5149

Other (seronegative) rheumatoid arthritis, wide

514

2540

2.09

50.81

2.0

2.3

3.34

3.09

g/l

4.75

398

1954

Dental pulpitis 2

1699

5781

1.52

50.73

2.2

3.10

3.09

g/l

0.10

1309

4462

Non-allergic asthma (mode), excluding more controls

428

1947

2.23

50.63

1.9

1.8

3.18

2.95

g/l

4.94

338

1491

Benign neoplasm: Colon, unspecified

671

3637

1.90

50.60

2.3

3.13

3.09

g/l

0.55

473

2814

Other disorders of lacrimal gland

783

4444

1.80

50.24

2.7

2.3

2.94

3.10

g/l

3.91

586

3435

Diseases of pulp and periapical tissues, including avohilmo

2406

8902

1.42

50.19

2.3

2.2

3.06

g/l

0.05

1880

6878

Other disorders of veins

902

5328

1.73

49.98

2.2

3.11

3.05

g/l

0.78

725

4116

Obesity

1229

7759

1.59

49.86

1.9

2.3

3.15

3.02

g/l

4.13

966

6078

Giant cell arteritis with polymyalgia rheumatica

163

466

3.87

49.82

1.5

2.7

3.88

3.16

g/l

8.00

130

361

Obesity and other hyperalimentation

1235

7805

1.59

49.72

1.8

2.3

3.15

3.02

g/l

4.23

969

6113

Abnormalities of heart beat

760

4244

1.81

49.64

2.2

2.1

2.95

3.08

g/l

3.31

570

3247

Hyperkalaemia

188

585

3.44

49.63

2.6

2.2

3.37

3.13

g/l

1.80

144

466

Cardiomyopathy, other and unspecified

246

890

2.91

49.62

2.3

2.2

3.13

3.02

g/l

1.00

212

682

Gonarthrosis

1453

5411

1.56

49.52

2.0

2.4

3.07

3.02

g/l

0.94

1137

4192

Deposits [accretions] on teeth

193

584

3.35

49.46

6.0

1.9

3.05

3.04

g/l

0.03

153

474

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1306

8466

1.57

49.38

2.2

2.3

3.17

3.06

g/l

3.07

1007

6521

Vocal cord dysfunction

279

988

2.69

49.22

2.6

2.5

3.02

2.95

g/l

0.53

208

808

Dental pulpitis 4

2402

8917

1.41

49.15

2.3

2.2

3.06

g/l

0.07

1877

6894

Persons encountering health services for specific procedures, not carried out

207

683

3.17

49.05

2.2

2.0

3.09

3.00

g/l

0.77

188

559

Dental pulpitis 1

2401

8922

1.41

48.92

2.3

2.2

3.06

g/l

0.04

1877

6897

Dental caries 1 and operation codes

2025

7206

1.46

48.84

2.3

2.2

3.09

g/l

0.01

1554

5599

Irritable bowel syndrome

577

3000

1.96

48.79

2.2

2.87

3.07

g/l

5.20

426

2349

Methotrexate

353

1530

2.38

48.34

1.8

2.5

3.22

3.00

g/l

3.08

282

1175

Diabetic retinopathy, excluding more controls

597

1709

2.02

48.31

1.8

2.0

3.13

3.08

g/l

0.48

463

1313

Prurigo nodularis

112

249

5.02

48.09

1.6

3.2

2.93

3.15

g/l

1.43

195

Dental pulpitis 2, only avohilmo

1724

5948

1.50

48.09

2.2

2.3

3.08

3.09

g/l

0.16

1322

4586

Lumbar disc prolapse

1335

6898

1.56

48.01

2.3

2.2

2.99

3.08

g/l

2.37

1015

5432

Hard cardiovascular diseases

1844

8183

1.47

47.59

2.4

3.15

3.05

g/l

3.51

1432

6307

Endocarditis

130

325

4.32

47.56

1.7

2.3

3.75

3.12

g/l

6.34

106

259

Cutaneous abscess, furuncle and carbuncle

565

2947

1.96

47.48

2.1

2.2

3.15

3.04

g/l

1.55

451

2327

Nausea and vomiting

599

3130

1.92

47.37

2.8

2.3

3.11

3.12

g/l

0.08

462

2401

Insulin, combination of fast acting with intermediate-acting or long-acting

1408

8614

1.53

47.27

2.0

2.3

3.15

3.07

g/l

1.85

1099

6638

Anxiety disorders, excluding more controls

1697

7672

1.48

47.00

2.2

2.3

2.96

3.06

g/l

4.34

1334

6019

Any mental disorder

2483

8997

1.39

46.91

2.1

2.3

3.04

3.07

g/l

0.77

1888

7036

Seropositive rheumatoid arthritis, strict definition

412

1933

2.21

46.86

1.7

2.3

3.33

3.07

g/l

5.07

325

1512

Other diseases of pericardium

150

425

3.78

45.85

1.7

2.4

3.58

3.08

g/l

4.26

112

331

Coxibs

661

1873

1.91

45.61

2.1

2.3

3.09

3.12

g/l

0.23

534

1433

Conduction disorders

708

3309

1.82

45.56

2.2

3.16

3.02

g/l

3.13

543

2492

Chronic nephritic syndrome

147

414

3.83

45.48

2.5

2.7

3.25

3.07

g/l

1.14

129

333

Concussion

906

4718

1.68

45.44

2.0

2.3

2.99

3.13

g/l

3.73

692

3757

Mood disorders

2144

10086

1.41

45.40

2.0

2.3

3.01

3.07

g/l

1.91

1664

7839

Mood [affective] disorders

2137

10065

1.41

45.32

2.0

2.3

3.01

3.06

g/l

1.94

1658

7822

Polyarthrosis

494

2396

2.03

45.30

2.3

2.5

3.22

3.07

g/l

2.04

350

1822

Postmenopausal osteoporosis with pathological fracture

217

777

3.00

45.24

1.9

2.3

2.99

3.19

g/l

2.15

155

607

Soft tissue disorders related to use, overuse and pressure

605

3284

1.88

45.02

2.2

2.3

3.06

3.09

g/l

0.36

467

2577

Viral infections characterized by skin and mucous membrane lesions

873

5256

1.69

44.92

3.4

2.2

3.06

3.05

g/l

0.13

666

4099

Subjective visual disturbances

566

3013

1.93

44.90

2.2

2.98

3.09

g/l

1.95

446

2340

Agranulocytosis

304

1281

2.48

44.80

3.4

2.3

3.21

3.10

g/l

0.93

243

1012

Cardiomyopathies, Primary/intrinsic

336

1482

2.35

44.47

1.9

2.3

3.21

2.99

g/l

3.02

284

1132

Other disorders of teeth and supporting structures

496

2535

2.01

44.39

3.4

2.1

3.11

3.07

g/l

0.38

361

1982

Anxiety (asthma-related co-morbidities)

1066

5280

1.61

44.33

1.8

2.3

2.94

3.03

g/l

2.18

857

4150

Other diseases of intestine

332

1460

2.36

44.30

2.5

2.3

3.09

g/l

0.02

269

1145

Secondary and unspecified malignant neoplasm of lymph nodes

259

1023

2.67

44.11

1.8

2.5

3.38

3.09

g/l

3.42

214

819

Undetermined asthma, excluding more controls

283

1158

2.51

43.95

2.1

1.7

3.12

2.97

g/l

1.83

214

899

Obesity, other/unspecified

667

3754

1.81

43.88

1.6

2.3

3.15

3.02

g/l

2.95

534

2951

Psychiatric diseases

2400

8748

1.39

43.82

2.1

2.3

3.03

3.07

g/l

0.76

1834

6856

Other anxiety disorders

774

4005

1.74

43.75

1.8

2.2

2.96

3.03

g/l

1.14

631

3169

Other CVD

520

2723

1.97

43.68

2.6

2.3

3.09

3.12

g/l

0.20

382

2065

Dental caries 1, only avohilmo

1890

6764

1.44

43.58

2.2

2.3

3.07

3.10

g/l

0.45

1456

5228

Sleep apnoea

2010

9743

1.41

43.55

2.0

2.4

2.99

3.07

g/l

2.70

1530

7618

Dental caries 3

1913

6862

1.44

43.42

2.2

2.3

3.08

3.09

g/l

0.12

1473

5325

Non-allergic asthma (mode)

428

2069

2.10

43.37

1.9

1.8

3.18

2.96

g/l

4.50

338

1597

Biological medication for rheuma

332

1468

2.32

43.37

1.5

2.4

3.32

3.07

g/l

3.26

262

1158

Retention of urine

836

4230

1.71

43.29

1.9

2.4

3.16

3.07

g/l

1.56

647

3299

Early onset COPD, excluding more controls

463

2328

2.04

43.28

2.0

1.9

3.32

2.94

g/l

11.38

364

1829

Symptoms and signs involving speech and voice

760

4468

1.74

43.17

2.4

2.2

3.00

3.08

g/l

1.52

599

3431

Enterocolitis due to Clostridium difficile

309

1335

2.41

43.08

4.2

2.2

3.30

3.11

g/l

2.00

226

1042

Convulsions, not elsewhere classified

431

2085

2.08

42.99

1.7

2.1

3.22

2.98

g/l

4.21

340

1629

Other dialysis

119

302

4.31

42.92

2.4

2.7

3.33

3.14

g/l

0.99

103

238

Conjunctivitis

1431

8448

1.49

42.89

2.2

2.97

3.06

g/l

3.07

1151

6527

Type 1 diabetes

537

2846

1.92

42.73

1.8

2.3

3.12

3.04

g/l

0.86

424

2235

Urticaria and erythema

722

4189

1.75

42.72

2.4

2.2

2.99

3.05

g/l

0.86

572

3257

Cardiomyopathy (excluding other)

343

1553

2.29

42.65

1.9

2.2

3.20

2.99

g/l

2.94

290

1178

All anxiety disorders

1077

5519

1.59

42.50

1.8

2.2

2.94

3.04

g/l

2.58

865

4335

Depression

1930

9469

1.42

42.47

2.0

2.3

3.00

3.06

g/l

2.16

1492

7375

Other (not insulin) diabetes medications

2118

9214

1.40

42.41

1.9

2.4

3.11

3.04

g/l

2.24

1646

7091

Secondary right heart disease

158

489

3.49

42.39

2.0

2.4

3.10

3.18

g/l

0.51

137

392

Sleep apnoea, including avohilmo

2096

9835

1.40

42.04

1.9

2.4

3.00

3.07

g/l

2.76

1592

7683

ILD, hospital admissions 3, with pneumonia sepsis

252

1009

2.63

41.75

2.3

2.0

3.35

3.02

g/l

5.21

207

781

Amputation

297

1280

2.43

41.72

1.7

2.3

3.43

3.09

g/l

6.80

246

993

Other headache syndromes

847

5163

1.67

41.59

1.8

2.4

2.92

3.08

g/l

5.72

654

4047

Type 2 diabetes, definitions combined

2050

8812

1.40

41.40

1.9

2.4

3.11

3.04

g/l

2.63

1586

6780

Benign neoplasm of other and ill-defined parts of digestive system

433

2169

2.06

41.32

2.1

1.5

3.11

3.06

g/l

0.54

323

1654

Other diseases of anus and rectum

671

3852

1.78

41.29

2.3

3.11

3.10

g/l

0.07

491

2988

Dental caries 3 and operation codes

2047

7532

1.41

41.16

2.3

2.2

3.08

g/l

0.00

1574

5859

Other diseases of liver

424

2111

2.07

41.08

2.1

2.3

3.03

3.07

g/l

0.44

332

1658

Acetic acid derivatives and related substances

654

1868

1.85

41.03

2.1

2.3

3.08

3.11

g/l

0.35

530

1431

Other respiratory diseases principally affecting the interstitium

486

2548

1.97

40.80

2.4

2.3

3.30

3.08

g/l

5.38

389

1965

Type 2 diabetes, strict (exclude DM1)

2055

8871

1.40

40.59

1.9

2.4

3.11

3.04

g/l

2.51

1591

6826

Hypotension

452

2319

2.02

40.45

2.7

2.3

3.08

3.11

g/l

0.28

327

1768

Fracture of shoulder and upper arm

796

4815

1.68

40.42

2.6

2.3

3.14

3.08

g/l

0.73

596

3728

Noninfective enteritis and colitis

948

5986

1.61

40.12

2.4

2.2

3.13

3.05

g/l

1.45

727

4662

Adverse effects, not elsewhere classified

409

2027

2.07

39.92

2.1

2.2

3.00

3.07

g/l

0.90

348

1596

Fracture of femur

668

3527

1.77

39.85

2.3

2.2

3.24

3.13

g/l

1.47

437

2691

Disorders of conjunctiva

1600

9397

1.44

39.76

2.2

2.96

3.06

g/l

3.97

1274

7251

Other and unspecified immunodeficiencies with predominantly antibody defects

112

6.87

39.67

5.5

2.3

3.06

3.08

g/l

0.06

Disorders of lacrimal system

912

5745

1.62

39.42

2.7

2.2

2.94

3.10

g/l

4.61

677

4414

Neurotic, stress-related and somatoform disorders

1726

8698

1.42

39.39

2.2

2.3

2.96

3.06

g/l

4.13

1361

6768

Injury, poisoning and certain other consequences of external causes

1161

3755

1.57

39.39

2.3

3.11

3.05

g/l

0.91

898

2957

Fibrosis and cirrhosis of liver

226

884

2.70

39.37

1.6

2.7

3.10

g/l

0.03

176

706

Insulin, fast-acting

793

4825

1.67

39.33

1.9

2.2

3.09

3.07

g/l

0.27

624

3736

In situ neoplasms

761

4366

1.69

39.33

2.3

1.4

3.14

3.05

g/l

1.35

605

3337

Volume depletion

247

1005

2.56

39.29

1.8

2.1

3.29

3.14

g/l

1.17

177

775

Sequelae of external causes of morbidity and mortality

597

3371

1.82

39.28

2.4

2.3

3.22

3.08

g/l

2.43

481

2612

Injuries to the shoulder and upper arm

1770

10628

1.41

39.19

2.5

2.2

3.07

g/l

0.06

1355

8237

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

148

462

3.45

39.12

2.9

1.4

3.33

3.11

g/l

1.46

117

364

Abnormal involuntary movements

332

1540

2.23

38.92

2.2

2.3

2.91

3.15

g/l

4.71

265

1204

Arthropathies in other diseases classified elsewhere

121

332

3.90

38.84

2.3

2.5

3.09

3.03

g/l

0.29

255

Iron deficiency anaemia secondary to blood loss (chronic)

403

2013

2.06

38.78

2.1

2.3

3.15

3.10

g/l

0.49

283

1552

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1003

6360

1.57

38.69

2.0

2.1

2.98

3.06

g/l

1.60

812

4926

Rotator cuff syndrome

1333

6731

1.49

38.55

2.2

2.4

3.06

3.07

g/l

0.18

1025

5234

Anxiety disorders

1743

8807

1.42

38.50

2.2

2.3

2.96

3.06

g/l

4.18

1373

6854

Chronic sinusitis

884

5551

1.62

38.47

2.4

2.3

2.98

3.05

g/l

1.54

704

4333

Undetermined asthma

283

1231

2.36

38.42

2.1

1.7

3.12

2.97

g/l

1.70

214

952

Isolated proteinuria with specified morphological lesion

106

7.01

38.35

4.5

2.7

2.96

3.16

g/l

0.77

Other diseases of the digestive system

773

4713

1.67

38.33

2.2

2.3

3.24

3.10

g/l

3.11

603

3609

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

155

505

3.30

38.21

2.0

1.4

3.66

3.10

g/l

5.67

128

399

Diffuse large B-cell lymphoma, helper endpoint

155

505

3.30

38.21

2.0

1.4

3.66

3.10

g/l

5.67

128

399

Need for immunization against other single viral diseases

174

5.27

38.18

2.9

2.1

3.08

3.10

g/l

0.04

139

Spondylopathies in diseases classified elsewhere

124

6.49

38.14

18.6

1.3

3.13

3.17

g/l

0.07

GI-bleeding

774

4734

1.67

37.89

2.2

3.24

3.10

g/l

3.00

611

3620

Other diseases of upper respiratory tract

2426

9453

1.35

37.89

2.2

2.3

3.03

3.08

g/l

1.55

1868

7326

Other medical care

892

5506

1.61

37.86

3.8

2.1

3.38

3.07

g/l

12.80

696

4222

Allergic conjunctivitis

1037

6670

1.55

37.72

1.9

2.2

2.99

3.05

g/l

1.09

838

5167

Parodontitis or/and operation codes

1334

5383

1.49

37.41

2.3

2.4

3.07

3.01

g/l

1.18

1054

4082

Cardiomyopathy in other diseases

10.49

37.33

9.4

2.1

2.92

3.21

g/l

0.97

Other and unspecified coagulation defects

143

448

3.37

37.29

2.7

2.4

3.23

3.11

g/l

0.65

120

350

Other coagulation defects

192

709

2.83

37.26

2.5

3.28

3.14

g/l

1.02

161

560

Other neurological diseases

1625

9306

1.42

37.14

2.3

3.00

3.09

g/l

3.00

1210

7172

Anaemia in chronic diseases classified elsewhere

241

4.47

36.99

2.0

2.6

3.02

3.11

g/l

0.29

192

Idiopathic thrombocytopenic purpura

111

298

4.03

36.95

2.5

2.88

3.17

g/l

2.24

232

Dental operations

1561

5586

1.45

36.87

2.4

2.1

3.09

3.10

g/l

0.18

1204

4377

AV-block

443

2103

1.97

36.71

2.2

2.1

3.18

3.02

g/l

2.45

332

1562

Type 2 diabetes, definitions combined, including avohilmo

2023

8785

1.38

36.58

1.9

2.4

3.12

3.04

g/l

2.85

1572

6763

Benign neoplasm: Sigmoid colon

439

2307

1.96

36.55

2.3

1.4

3.13

3.03

g/l

1.05

344

1770

Asthma and allergy, excluding more controls

211

808

2.63

36.50

1.9

1.6

2.98

2.93

g/l

0.31

160

631

Artrosis, including avohilmo

1828

7222

1.40

36.48

2.0

2.4

3.02

3.06

g/l

0.82

1420

5650

Pericarditis

115

318

3.85

36.45

1.9

2.3

3.62

3.09

g/l

4.85

252

Other abnormal findings of blood chemistry

138

430

3.42

36.45

3.4

2.3

2.90

3.10

g/l

1.42

122

344

Amputation of toe

220

883

2.63

36.43

1.7

2.6

3.45

3.11

g/l

4.85

184

706

Disorder of lipoprotein metabolism, unspecified

355

1735

2.12

36.41

1.7

2.2

3.23

3.09

g/l

1.73

287

1326

ILD, hospital admissions

410

2114

2.01

36.34

2.4

2.3

3.28

3.07

g/l

3.94

331

1638

Other pulmonary heart/vessel disease

161

552

3.12

36.28

2.0

2.5

3.10

3.19

g/l

0.58

137

449

Zoster [herpes zoster]

446

2368

1.94

35.99

3.8

2.2

3.11

g/l

0.03

318

1829

Non-Hodgkin lymphoma, all

149

494

3.25

35.74

4.1

2.6

3.33

3.15

g/l

1.21

120

396

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1232

5709

1.50

35.70

2.7

1.5

3.04

3.05

g/l

0.15

955

4405

Other interstitial pulmonary diseases

413

2148

1.99

35.68

2.4

2.3

3.29

3.08

g/l

4.15

334

1660

Other and unspecified types of non-Hodgkin lymphoma, hilmo

148

489

3.25

35.64

2.9

2.6

3.33

3.14

g/l

1.22

117

388

Rash and other nonspecific skin eruption

256

1109

2.40

35.50

2.0

2.4

3.00

3.14

g/l

1.61

213

870

Interstitial lung disease endpoints

413

2152

1.99

35.49

2.4

2.3

3.29

3.08

g/l

4.10

334

1666

Interstitial lung disease

413

2152

1.99

35.49

2.4

2.3

3.29

3.08

g/l

4.10

334

1666

Voice disturbances

593

3441

1.76

35.47

2.6

2.3

2.99

3.07

g/l

1.36

476

2653

Pleural effusion

419

2195

1.97

35.36

2.7

2.2

3.41

3.04

g/l

9.75

345

1680

Biguanides

2058

9393

1.36

35.33

1.9

2.4

3.11

3.05

g/l

2.20

1618

7231

Peripheral artery operations in Hilmo

353

1744

2.09

35.14

1.9

2.3

3.35

3.06

g/l

6.01

294

1337

Fungal Sepsis

124

371

3.58

35.04

2.9

2.5

3.41

3.08

g/l

2.30

299

Diseases of the myoneural junction and muscle

313

1481

2.19

35.03

1.6

2.3

3.18

3.11

g/l

0.61

236

1160

Lichen simplex chronicus and prurigo

186

702

2.78

34.78

2.0

2.8

2.98

3.12

g/l

0.99

152

553

Other symptoms and signs involving the nervous and musculoskeletal systems

844

5375

1.59

34.76

2.0

2.3

2.75

3.08

g/l

17.38

642

4165

Pacemaker

831

5135

1.61

34.76

2.1

2.3

3.18

3.10

g/l

1.30

615

3893

Dental caries 3, only avohilmo

1912

7138

1.38

34.69

2.2

2.3

3.07

3.10

g/l

0.34

1474

5534

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

373

1891

2.04

34.65

1.5

2.3

3.14

3.07

g/l

0.65

297

1488

Hepatomegaly and splenomegaly, not elsewhere classified

7.63

34.60

1.9

1.8

3.16

3.20

g/l

0.10

Allergic asthma (mode), excluding more controls

384

1916

1.99

34.53

1.9

1.7

2.99

2.91

g/l

0.87

294

1517

Insulin, fast-acting or short human

796

5008

1.61

34.53

1.9

2.2

3.09

3.07

g/l

0.23

626

3883

Calcific aortic valvular stenosis, operated

758

4631

1.64

34.33

2.3

3.32

3.10

g/l

6.59

576

3516

Calcific aortic valvular stenosis

758

4631

1.64

34.33

2.3

3.32

3.10

g/l

6.59

576

3516

Other noninfective gastroenteritis and colitis

519

2922

1.81

34.29

2.7

2.2

3.13

3.09

g/l

0.41

409

2258

COPD

1072

5924

1.52

34.23

1.9

2.4

3.30

3.05

g/l

12.95

854

4528

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.36

34.20

3.7

1.4

3.50

3.18

g/l

0.97

Operations 2 for CAVS

757

4630

1.64

34.13

2.3

3.32

3.10

g/l

6.56

575

3515

Calcific aortic valvular stenosis, diagnosis (helper)

757

4630

1.64

34.13

2.3

3.32

3.10

g/l

6.56

575

3515

Dental operations, only avohilmo

1647

6026

1.41

34.11

2.3

3.09

3.10

g/l

0.19

1278

4699

Selective serotonin reuptake inhibitors

2122

8316

1.35

34.10

2.2

2.3

3.04

3.07

g/l

0.73

1679

6451

Drug-induced osteoporosis with pathological fracture

185

5.02

34.09

1.6

2.3

3.22

3.25

g/l

0.05

146

Non-invasive ventilation

415

2045

1.94

33.96

3.2

2.3

3.32

3.01

g/l

4.16

153

1633

Other and unspecified effects of external causes

510

2865

1.81

33.92

2.0

2.2

2.99

3.06

g/l

0.82

430

2241

Acute sinusitis

956

5849

1.54

33.90

3.2

2.0

3.03

3.04

g/l

0.08

733

4619

Calcific aortic valvular stenosis, including rheumatic fever

759

4651

1.63

33.83

2.3

3.32

3.10

g/l

6.56

577

3530

Asthma and allergy

211

840

2.53

33.72

1.9

1.6

2.98

2.94

g/l

0.27

160

650

Obesity due to excess calories

860

5542

1.57

33.60

1.9

2.4

3.12

3.01

g/l

2.44

666

4365

Type 1 diabetes, wide definition, subgroup 1

413

2179

1.93

33.51

1.8

2.3

3.07

3.04

g/l

0.23

319

1718

Deforming dorsopathies

558

3232

1.76

33.42

2.3

2.2

3.03

3.10

g/l

0.97

412

2531

Special screening examination for other diseases and disorders

190

735

2.66

33.39

2.7

2.2

2.62

3.16

g/l

9.95

173

598

Acute upper respiratory infections of multiple and unspecified sites

1421

7532

1.43

33.20

3.1

2.1

3.08

3.06

g/l

0.35

1088

5892

Dental pulpitis 4, only avohilmo

2348

9300

1.33

33.16

2.0

2.3

3.04

3.07

g/l

0.68

1856

7166

Atopic dermatitis

916

5094

1.55

33.02

1.8

2.2

3.01

3.03

g/l

0.23

739

3983

Other symptoms and signs involving the urinary system

272

1247

2.26

33.02

2.1

2.5

3.10

3.04

g/l

0.28

155

975

Cellulitis

475

2643

1.84

32.86

2.7

2.2

3.18

3.06

g/l

1.53

389

2064

Stroke, excluding SAH

1418

7484

1.43

32.75

2.4

2.3

3.17

3.10

g/l

1.78

1089

5751

Benign neoplasm: Transverse colon

269

1235

2.27

32.69

2.4

1.4

3.16

3.02

g/l

1.28

196

939

Somatoform disorder

347

1746

2.04

32.63

2.3

2.97

3.10

g/l

1.66

263

1377

Migraine

796

4288

1.60

32.59

1.9

2.3

2.92

3.06

g/l

4.35

633

3406

Other reaction to severe stress, and adjustment disorders

605

3603

1.70

32.55

2.5

2.1

2.95

3.03

g/l

1.49

495

2836

Stroke, including SAH

1471

7794

1.42

32.42

2.4

3.16

3.09

g/l

1.85

1130

5998

Overexertion and strenuous or repetitive movements

237

1033

2.37

32.36

2.4

3.19

3.07

g/l

1.01

198

827

Diffuse large B-cell lymphoma

155

556

2.99

32.33

2.0

2.8

3.66

3.14

g/l

4.98

128

442

Unspecified fall

1009

6737

1.51

32.21

2.2

2.3

3.17

3.07

g/l

2.23

764

5206

Chronic ulcer of skin, not elsewhere classified

199

808

2.58

32.11

2.3

2.4

3.15

3.11

g/l

0.22

155

640

Ischaemic Stroke, excluding all haemorrhages

1346

7196

1.43

32.00

2.3

3.16

3.10

g/l

1.42

1033

5525

ILD, hospital admissions 1, main diag only

365

1893

2.00

31.92

2.4

2.3

3.28

3.07

g/l

3.40

292

1475

Special screening examination for infectious and parasitic diseases

367

1386

2.00

31.91

2.4

2.1

2.96

3.03

g/l

0.78

307

1166

Other abnormalities of plasma proteins

149

5.29

31.89

5.0

3.0

3.33

3.13

g/l

0.64

118

Nonalcoholic fatty liver disease

223

955

2.42

31.78

2.1

2.5

2.95

3.07

g/l

1.14

179

755

Hypokalaemia

277

1301

2.20

31.56

2.8

2.1

3.20

3.12

g/l

0.66

206

1000

Diabetic neuropathy

303

1470

2.14

31.50

2.0

2.1

3.06

3.12

g/l

0.44

238

1132

Injuries to the knee and lower leg

2412

10624

1.31

31.31

2.0

2.3

3.05

3.06

g/l

0.05

1864

8239

Tumor necrosis factor alpha inhibitors

272

1269

2.20

31.29

1.4

2.4

3.31

3.07

g/l

2.71

214

1008

Trochanteric bursitis

315

1557

2.08

31.29

2.3

3.03

3.14

g/l

1.03

241

1210

Reactive arthropathies, FINNGEN

160

588

2.82

31.26

2.3

2.7

3.15

2.96

g/l

1.44

129

454

Cytomegalovirus infection, IBD co-morbidity

200

4.47

31.24

7.2

2.4

3.15

3.16

g/l

0.04

160

Other diseases of hard tissues of teeth

1219

6326

1.45

31.22

3.0

2.0

2.93

3.06

g/l

4.35

914

4937

Other/unspecified cytomegaloviral diseases

167

4.87

31.20

7.8

2.4

3.13

3.06

g/l

0.23

134

Other inflammation of eyelid

311

1536

2.09

31.03

2.8

2.4

2.89

3.12

g/l

4.16

229

1201

Dental pulpitis 1, only avohilmo

2339

9352

1.32

30.96

2.0

2.3

3.04

3.07

g/l

0.76

1845

7202

Osteopathy in diseases classified elsewhere

8.18

30.94

16.0

2.5

3.25

3.11

g/l

0.51

Functional dyspepsia

548

3234

1.73

30.80

2.5

2.3

2.98

3.08

g/l

1.51

409

2532

Rheumatism, unspecified

316

1572

2.06

30.79

2.1

2.4

3.03

3.14

g/l

0.96

243

1222

Allergic asthma (mode)

384

1994

1.92

30.78

1.9

1.7

2.99

2.93

g/l

0.58

294

1576

Implicit fungal Sepsis

113

347

3.49

30.72

3.0

2.4

3.37

3.11

g/l

1.50

280

Superficial injury of head

474

2690

1.80

30.62

1.9

2.2

3.18

3.09

g/l

1.08

384

2068

Urticaria

540

3177

1.73

30.57

2.3

2.1

2.98

3.06

g/l

1.15

430

2474

Open wound of head

1069

7242

1.47

30.52

2.1

2.3

3.13

3.07

g/l

1.10

834

5602

Personality disorders, excluding more controls

416

2268

1.86

30.49

1.7

2.2

2.97

3.02

g/l

0.56

338

1806

Migraine with aura

388

2071

1.90

30.41

1.6

2.3

2.89

3.07

g/l

3.28

321

1658

Motor neuron disease

150

5.01

30.36

1.3

1.9

2.70

3.21

g/l

4.02

125

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1118

5276

1.47

30.30

2.7

1.5

3.04

3.06

g/l

0.21

874

4061

Spondylopathies (FG)

257

1188

2.21

30.22

1.7

2.6

3.16

2.97

g/l

1.96

196

925

Benign neoplasm: Ascending colon

322

1630

2.04

30.15

2.2

1.4

3.21

3.06

g/l

1.66

239

1238

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

100

6.46

30.14

3.7

2.0

3.50

3.20

g/l

0.93

Spondyloarthritis

382

2039

1.91

30.14

2.2

2.3

3.34

3.05

g/l

5.04

298

1584

Cytomegaloviral disease

210

4.29

30.09

7.2

2.4

3.13

3.15

g/l

0.04

170

Ischaemic heart disease, wide definition

1735

8055

1.36

29.84

2.4

3.11

3.05

g/l

1.26

1366

6180

Eosinophilic disease (BM)

110

5.76

29.82

2.3

1.5

3.27

3.11

g/l

0.42

Myeloproliferative diseases

237

1075

2.30

29.76

2.9

2.5

3.18

3.09

g/l

0.67

175

850

Ischemic heart diseases

1746

8129

1.36

29.60

2.3

2.4

3.09

3.06

g/l

0.50

1377

6234

DVT of lower extremities

454

2577

1.81

29.55

3.0

2.2

3.14

3.09

g/l

0.37

346

2003

Substance abuse, excluding more controls

1095

6639

1.46

29.53

1.6

2.4

3.13

3.06

g/l

1.59

848

5241

Viral pneumonia (unknown virus, not influenza)

162

619

2.72

29.46

2.1

2.5

3.23

3.09

g/l

0.94

138

494

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1079

5118

1.48

29.44

2.6

1.4

3.09

3.06

g/l

0.35

832

3940

Complications of internal orthopaedic prosthetic devices, implants and grafts

545

3262

1.71

29.35

2.0

2.3

3.22

3.08

g/l

2.03

398

2474

Cirrhosis of liver, NAS

153

573

2.83

29.30

1.7

2.7

3.11

3.12

g/l

0.04

121

460

Motor neuron disease (with DMD)

155

4.83

29.14

1.3

1.9

2.70

3.22

g/l

4.14

129

Diseases of spleen

157

4.83

28.83

2.2

3.26

3.14

g/l

0.30

123

Benign neoplasm of other and ill-defined parts of digestive system

433

2449

1.82

28.66

2.1

2.3

3.11

3.09

g/l

0.21

323

1895

Later onset COPD, excluding more controls

506

2305

1.75

28.60

1.6

1.9

3.33

3.00

g/l

10.90

410

1726

Abnormal findings on diagnostic imaging of other body structures

309

1572

2.03

28.48

3.0

2.4

3.07

3.11

g/l

0.27

231

1226

Phlebitis and thrombophlebitis (not including DVT)

499

2939

1.73

28.43

2.8

2.2

3.08

3.07

g/l

0.03

389

2283

Type 1 diabetes, wide definition

427

2402

1.81

28.28

1.7

2.2

3.07

3.05

g/l

0.16

330

1890

Open wound of lower leg

323

1670

1.98

28.26

2.0

2.2

3.26

3.11

g/l

1.88

261

1315

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

213

942

2.34

28.23

3.7

2.4

3.09

3.08

g/l

0.07

164

742

Osteomyelitis

173

699

2.59

28.22

2.0

2.2

3.37

3.09

g/l

2.44

143

568

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1087

5193

1.46

28.18

2.6

1.4

3.09

3.06

g/l

0.37

837

3994

Injuries to the elbow and forearm

1339

8766

1.39

28.18

2.0

2.3

3.10

3.06

g/l

0.82

1008

6788

Disorders of skin appendages

859

5758

1.51

27.93

2.2

3.05

3.04

g/l

0.14

671

4521

Other chronic obstructive pulmonary disease

1009

5791

1.47

27.87

1.8

2.4

3.32

3.05

g/l

13.33

803

4423

Recurrent or chronic depression

713

3283

1.59

27.78

1.8

2.2

2.97

3.05

g/l

1.37

570

2621

Disorders of continuity of bone

208

916

2.34

27.77

4.0

2.1

3.05

3.10

g/l

0.28

159

739

Osteonecrosis due to drugs

135

5.25

27.67

15.1

1.8

3.10

3.20

g/l

0.23

104

Acute upper respiratory infections

2139

10345

1.30

27.64

2.9

2.1

3.06

g/l

0.15

1638

8035

Hypertrophic cardiomyopathy

128

453

3.00

27.33

2.7

2.8

3.22

3.11

g/l

0.61

114

366

Failure and rejection of transplanted organs and tissues

112

5.55

27.31

6.7

2.5

3.25

3.12

g/l

0.37

Phobic anxiety disorders

195

837

2.37

27.30

2.0

2.1

3.02

3.07

g/l

0.25

163

671

Pain in thoracic spine

299

1522

2.01

27.27

3.0

2.1

2.94

3.13

g/l

2.38

226

1205

Heart failure and coronary heart disease

843

4202

1.53

27.11

1.9

2.4

3.38

3.09

g/l

10.86

656

3182

Other diseases of arteries and capillaries

228

1061

2.23

26.76

2.0

2.4

3.22

3.09

g/l

0.88

174

831

Marginal zone B-cell lymphoma

6.12

26.41

2.0

1.9

3.02

3.08

g/l

0.13

Reactive arthropathies

193

841

2.36

26.40

2.2

2.5

3.10

3.05

g/l

0.32

153

658

Other disorders of eye and adnexa

288

1466

2.01

26.37

2.0

2.3

3.02

3.10

g/l

0.75

241

1144

Myeloproliferative diseases (CML excluded)

213

974

2.28

26.30

3.1

2.6

3.17

3.09

g/l

0.55

160

769

Systemic sclerosis (FG)

199

4.09

26.21

1.9

2.7

3.09

2.97

g/l

0.57

151

L01XX Other antineoplastic agents

174

733

2.51

26.18

3.8

2.7

3.11

3.15

g/l

0.18

130

584

Papulosquamous disorders

807

5426

1.51

26.14

2.2

2.4

3.07

g/l

0.00

625

4244

Abnormal serum enzyme levels

687

4412

1.57

26.12

2.1

2.3

3.14

3.05

g/l

1.66

533

3453

Dermatopolymyositis

124

5.12

26.12

3.0

2.1

3.10

3.09

g/l

0.04

100

Mycoses

543

3342

1.65

26.12

2.8

2.3

3.09

3.07

g/l

0.23

403

2603

Benign neoplasm of other and unspecified endocrine glands

280

1419

2.03

26.07

2.4

1.4

3.01

3.04

g/l

0.17

215

1093

Psoriatic and enteropathic arthropathies

225

1049

2.20

26.05

1.7

2.6

3.19

2.95

g/l

2.07

173

819

Charcot foot

166

4.48

25.99

2.5

2.9

3.19

3.12

g/l

0.19

131

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

291

3.48

25.93

4.3

1.4

3.10

3.07

g/l

0.11

225

Cardiodefibrillation

871

5956

1.49

25.92

2.2

2.3

3.28

3.08

g/l

6.76

711

4561

Dermatopolymyositis (FG)

125

5.10

25.90

3.0

2.7

3.10

2.99

g/l

0.40

101

1150

7574

1.41

25.85

1.6

2.4

3.12

3.04

g/l

1.70

914

5935

Coronary atherosclerosis

1548

7451

1.36

25.84

2.2

2.4

3.15

3.06

g/l

2.31

1226

5721

Alcohol use disorder, Swedish definition

1107

7327

1.42

25.82

1.7

2.4

3.10

3.05

g/l

0.91

877

5735

Diseases of external ear

683

4446

1.56

25.81

2.1

2.3

3.09

3.07

g/l

0.19

466

3485

Other chronic obstructive pulmonary disease, including avohilmo

1216

7318

1.40

25.80

1.8

2.4

3.27

3.06

g/l

10.61

957

5618

Other disorders of skin and subcutaneous tissue, not elsewhere classified

331

1781

1.91

25.77

2.3

2.1

3.09

3.11

g/l

0.13

236

1377

Cerebral palsy and other paralytic syndromes

257

1268

2.08

25.76

1.9

2.3

3.03

3.09

g/l

0.49

205

1004

Hypothyroidism, strict autoimmune

1361

6590

1.38

25.76

2.0

2.4

2.99

3.03

g/l

0.85

1054

5062

Sequelae with surgical and medical care as external cause

457

2708

1.73

25.63

2.1

2.3

3.21

3.10

g/l

1.47

354

2094

Other peripheral vascular diseases

200

899

2.31

25.60

1.7

2.4

2.96

3.06

g/l

0.60

160

716

Myositis

240

3.74

25.55

1.5

2.1

2.99

3.10

g/l

0.46

185

Cholelithiasis, broad definition with cholecystitis

1812

9503

1.32

25.51

2.3

3.08

3.06

g/l

0.33

1375

7339

Other and unspecified acquired haemolytic anaemias

5.93

25.49

3.0

1.6

3.24

3.14

g/l

0.24

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

649

4189

1.57

25.46

2.4

2.2

3.05

3.07

g/l

0.13

497

3245

Hypoparathyroidism

118

417

3.02

25.34

1.6

2.4

3.03

3.19

g/l

1.02

338

Carcinoma in situ of skin of scalp and neck

273

3.62

25.31

1.8

1.4

3.12

3.22

g/l

0.35

212

Essential (haemorrhagic) thrombocythaemia

117

412

3.02

25.24

2.5

1.4

3.07

g/l

0.01

321

Stomatitis and related lesions

178

766

2.39

25.09

3.3

1.9

3.05

g/l

0.01

125

611

Injuries to the ankle and foot

1181

7785

1.39

25.05

2.1

2.2

3.03

g/l

0.02

951

6116

Diseases of salivary glands

387

2199

1.79

25.04

2.5

2.1

3.08

3.07

g/l

0.08

280

1698

Cervical disc disorders

744

4965

1.52

24.99

2.3

2.2

2.94

3.08

g/l

3.32

545

3908

Secondary uncertain malignant neoplasm

315

1688

1.92

24.97

2.0

2.4

3.42

3.07

g/l

5.18

254

1311

Other pleural conditions

269

1369

2.03

24.93

2.8

2.3

3.38

3.06

g/l

5.63

215

1058

L04AC Interleukin inhibitors

116

407

2.97

24.91

1.4

2.0

3.27

3.07

g/l

0.95

324

Heart failure and hypertrophic cardiomyopathy

195

4.14

24.83

2.9

2.4

3.32

3.15

g/l

0.69

149

Superficial injury of lower leg

462

2765

1.70

24.72

1.9

2.2

3.08

3.07

g/l

0.04

352

2144

Gonarthrosis,primary

1974

9638

1.30

24.70

2.0

2.4

3.10

3.06

g/l

1.03

1517

7450

Meniscus derangement

1096

5339

1.42

24.63

2.2

2.4

3.02

g/l

0.03

846

4145

1191

7755

1.39

24.62

1.6

2.4

3.11

3.04

g/l

1.40

946

6079

Other disorders of bone

374

2116

1.80

24.53

3.6

2.0

3.04

3.05

g/l

0.02

282

1680

Other general symptoms and signs

104

341

3.12

24.53

1.4

2.6

2.93

3.13

g/l

1.15

272

Other and unspecified aplastic anaemias

104

5.48

24.42

1.5

2.1

3.17

3.08

g/l

0.20

In situ neoplasms

761

5134

1.51

24.35

2.3

3.14

3.09

g/l

0.66

605

3881

Benign neoplasm: Transverse colon

269

1383

2.02

24.33

2.4

2.5

3.16

3.09

g/l

0.52

196

1084

Migraine without aura

286

1490

1.95

24.25

2.0

2.2

2.97

3.06

g/l

0.90

225

1202

Pyogenic arthritis

161

675

2.47

24.18

2.9

2.4

3.19

3.01

g/l

1.18

126

513

Oxicams

522

1796

1.68

24.17

2.3

3.00

3.12

g/l

1.58

397

1369

Adalimumab

171

735

2.39

24.15

1.4

2.3

3.22

3.06

g/l

1.05

131

586

Oter anti-inflammatory and antirheumatic agents, non-steroids

519

1738

1.68

24.15

2.4

3.09

3.13

g/l

0.32

411

1319

Disorders of muscles

216

1025

2.16

24.02

1.6

2.2

3.01

3.13

g/l

0.98

172

808

Disorders of sclera, cornea, iris and ciliary body

1046

7495

1.41

24.01

2.2

2.3

3.06

g/l

0.03

810

5816

Sequelae of cerebrovascular disease

811

4862

1.49

24.01

2.0

2.3

3.14

3.10

g/l

0.61

592

3731

Behavioural syndromes associated with physiological disturbances and physical factors

511

3156

1.64

24.00

1.9

2.1

3.00

3.05

g/l

0.55

396

2481

Peripheral arterial reconstruction

425

2519

1.73

23.95

1.8

2.3

3.38

3.08

g/l

7.61

344

1920

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

300

3.29

23.88

1.5

2.1

3.07

3.14

g/l

0.29

244

Injuries to unspecified part of trunk, limb or body region

223

1077

2.13

23.77

1.7

2.5

3.39

3.08

g/l

3.81

171

854

All influenza (not pneumonia)

293

1553

1.92

23.76

4.4

1.9

3.06

2.99

g/l

0.65

218

1220

Psoriasis

574

3673

1.59

23.49

1.8

2.3

3.14

3.05

g/l

1.18

448

2871

Temporomandibular joint disorders

262

1341

1.99

23.47

2.5

2.1

3.01

3.09

g/l

0.60

200

1048

Other enthesopathies

561

3569

1.59

23.45

1.9

2.3

2.95

3.07

g/l

2.28

433

2787

Gastroduodenal ulcer

590

3797

1.58

23.33

2.0

2.4

3.19

3.10

g/l

1.23

465

2950

Valvular operations

325

1795

1.85

23.31

1.6

2.2

3.35

3.02

g/l

6.25

254

1352

Nonorganic sleeping disorders, excluding more controls

309

1676

1.87

23.27

1.6

2.3

2.95

3.08

g/l

1.57

244

1327

Infection of intervertebral disc (pyogenic)

142

4.65

23.19

2.2

3.88

3.19

g/l

3.32

114

Metatarsalgia

203

956

2.18

23.07

2.3

2.88

3.12

g/l

3.34

167

750

Cholelithiasis

1736

9403

1.31

22.98

2.3

3.07

3.06

g/l

0.15

1318

7260

Benign neoplasm: Sigmoid colon

439

2654

1.70

22.97

2.3

2.4

3.13

3.09

g/l

0.34

344

2056

Paralytic ileus and intestinal obstruction

525

3307

1.61

22.96

2.6

2.3

3.22

3.10

g/l

1.74

388

2565

Carcinoma in situ of skin of other and unspecified parts of face

208

996

2.18

22.93

2.1

1.5

3.10

3.12

g/l

0.12

177

745

Bipolar affective disorders

308

1676

1.87

22.93

1.8

2.3

3.04

3.03

g/l

0.07

243

1324

Erosion of teeth

5.57

22.83

4.2

2.4

3.17

2.92

g/l

0.68

Benign neoplasm: Stomach

230

1144

2.08

22.75

2.4

1.4

3.16

3.06

g/l

0.80

170

878

Budesonide

244

1236

2.01

22.65

2.0

2.5

3.12

2.98

g/l

1.15

190

960

Benign neoplasm: Rectum, anus and anal canal

430

2596

1.69

22.52

2.2

1.4

3.14

3.04

g/l

1.09

342

1994

Gastric ulcer

413

2470

1.71

22.40

2.0

2.3

3.15

3.11

g/l

0.30

323

1913

Mixed and other personality disorders

150

630

2.44

22.34

1.6

2.0

2.98

3.05

g/l

0.44

131

499

Pneumonia derived septicemia

329

3.11

22.32

5.5

2.6

3.09

3.15

g/l

0.24

261

Sequelae of other external causes

137

556

2.57

22.22

2.9

2.6

3.21

3.13

g/l

0.36

124

441

Paracetamol of NSAID medication

317

845

1.91

22.16

2.5

2.0

3.12

3.09

g/l

0.22

249

662

Encephalitis

263

3.38

22.15

2.0

2.6

3.04

3.09

g/l

0.17

211

Elevated blood glucose level

185

855

2.23

22.15

2.0

2.3

3.12

3.08

g/l

0.21

141

683

Other enthesopathy of foot (+metatarsalgia)

210

1019

2.11

22.07

2.2

2.3

2.88

3.12

g/l

3.23

173

802

Dentofacial anomalies [including malocclusion]

434

2601

1.67

22.06

2.4

2.0

3.02

3.03

g/l

0.11

345

2044

Filling of root of tooth

290

3.25

21.98

5.4

2.7

3.11

3.07

g/l

0.15

235

Other encephalitis

250

3.44

21.89

2.0

2.6

3.07

3.10

g/l

0.09

200

Diabetic retinopathy

730

3114

1.51

21.78

1.8

2.0

3.13

g/l

0.04

564

2444

Carcinoma in situ of skin of scalp and neck

300

3.28

21.76

1.8

2.6

3.12

3.19

g/l

0.23

235

Other and unspecified drugs and medicaments

193

914

2.18

21.76

3.5

2.4

3.08

3.12

g/l

0.20

145

717

Missing teeth due to accident, extraction or parodontitis

260

1370

1.95

21.71

3.9

2.0

3.19

3.10

g/l

0.70

188

1079

Sub-endpoint used in defining T1D endpoints

568

3626

1.56

21.70

1.7

2.1

3.11

3.07

g/l

0.30

445

2818

Other symptoms and signs involving the circulatory and respiratory systems

146

616

2.45

21.64

2.0

2.4

3.10

3.12

g/l

0.06

480

Rare circulating lymphoid malignancy

325

3.10

21.63

4.3

2.9

3.10

3.17

g/l

0.22

256

Benign neoplasm: Caecum

246

1277

1.99

21.63

2.6

1.4

3.05

g/l

0.00

191

978

Degeneration of macula and posterior pole

1070

6443

1.39

21.62

2.2

2.4

3.11

3.10

g/l

0.05

785

4912

Other embolism and thrombosis

290

1585

1.88

21.59

2.9

2.3

3.26

3.09

g/l

1.78

231

1239

Disorders of adult personality and behaviour

441

2711

1.65

21.24

1.7

2.1

2.97

3.03

g/l

0.58

357

2149

Kela reimbursement Agammaglobulinemia (D80-84)

6.16

21.16

3.4

2.5

2.93

3.15

g/l

0.55

Substance abuse

1095

7710

1.37

21.09

1.6

2.4

3.13

3.04

g/l

2.18

848

6051

Progressive vascular leukoencephalopathy

109

409

2.84

21.04

2.3

2.5

3.07

3.23

g/l

1.01

316

Benign neoplasm: Ascending colon

322

1836

1.81

21.01

2.2

2.4

3.21

3.08

g/l

1.35

239

1421

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

323

1841

1.80

20.94

2.0

1.4

3.29

3.04

g/l

3.43

259

1421

Polyarthritis, unspecified

352

2.95

20.91

2.7

2.2

3.41

3.04

g/l

2.50

267

Pneumococcal septicemia

315

3.08

20.86

5.4

2.7

3.07

3.15

g/l

0.28

248

Radiculopathy

361

2124

1.73

20.82

2.5

2.3

2.93

3.14

g/l

4.31

288

1658

Fracture of foot, except ankle

426

2613

1.65

20.81

2.4

2.2

3.01

3.07

g/l

0.51

334

2067

Other overlap syndromes

167

3.99

20.68

1.8

2.5

3.15

g/l

0.01

135

Myeloid leukaemia

260

3.32

20.62

1.9

1.4

3.21

3.09

g/l

0.43

202

Generalized anxiety disorder

221

1119

2.00

20.49

1.7

2.4

2.82

3.09

g/l

4.90

172

884

Other specified and unspecified disorders of eye and adnexa

108

407

2.78

20.48

2.3

2.4

3.05

3.11

g/l

0.22

324

Mental and behavioural disorders due to psychoactive substance use

1122

7867

1.36

20.43

1.6

2.3

3.14

3.04

g/l

2.56

870

6166

Discitis, unspecified

160

4.07

20.39

3.8

2.0

3.67

3.16

g/l

2.25

125

Recurring oral aphthae, including avohilmo

282

1556

1.85

20.36

2.7

2.3

3.00

3.12

g/l

0.96

202

1230

Disorders of the thyroid gland

1882

9736

1.27

20.30

2.1

2.3

3.00

3.07

g/l

2.09

1457

7523

Opening and dilatation of root channel of tooth

136

573

2.45

20.26

4.3

2.2

3.02

3.09

g/l

0.36

454

Basal cell carcinoma, including avohilmo

1287

7677

1.34

20.26

2.6

2.3

3.10

g/l

0.05

978

5853

Other viral diseases

464

2915

1.61

20.24

3.6

2.1

3.16

3.03

g/l

1.66

378

2297

Migraine with aura and triptan purchases

220

1118

2.00

20.21

1.5

1.9

2.86

3.05

g/l

2.33

182

863

Decubitus ulcer and pressure area

149

657

2.36

20.17

1.8

2.4

3.49

3.17

g/l

2.67

106

513

Other/unspecified reactive arthropathies

150

662

2.34

20.15

2.4

3.15

3.07

g/l

0.35

122

525

Myelodysplastic syndrome

5.23

20.14

2.2

1.8

3.06

3.25

g/l

0.50

Basal cell carcinoma

1259

7585

1.34

20.11

2.6

2.3

3.10

g/l

0.10

958

5786

Intracranial injury

1083

7758

1.36

20.09

2.1

2.2

3.05

3.07

g/l

0.24

818

6006

Other metabolic disorders

242

1277

1.93

20.03

3.4

2.1

3.01

3.08

g/l

0.50

203

1004

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.14

20.03

5.6

2.1

3.21

3.00

g/l

0.76

Cramp and spasm

114

447

2.66

19.92

2.6

2.5

2.87

3.05

g/l

1.30

363

Memory loss

241

1281

1.95

19.83

2.1

2.4

3.09

3.13

g/l

0.24

191

1021

Superficial injury of hip and thigh

307

1751

1.79

19.79

1.9

2.3

3.19

3.12

g/l

0.60

224

1358

Disorders of synovium and tendon

938

6128

1.39

19.78

1.9

2.3

2.97

3.06

g/l

2.01

694

4788

Other extrapyramidal and movement disorders in other diseases

479

3067

1.59

19.77

2.1

2.3

2.94

3.10

g/l

2.73

376

2367

Benign neoplasm: Rectum

376

2271

1.69

19.77

2.2

1.4

3.15

3.04

g/l

1.17

302

1733

Persistent mood disorders

372

2238

1.69

19.68

2.0

2.2

2.98

3.09

g/l

1.55

304

1747

Non-selective monoamine reuptake inhibitors

784

5370

1.43

19.67

2.2

2.4

3.04

3.08

g/l

0.65

618

4116

Fissure and fistula of anal and rectal regions

464

2948

1.60

19.66

2.2

2.3

3.01

3.07

g/l

0.47

354

2333

Amiodarone users

253

1371

1.91

19.59

2.1

2.4

3.25

3.09

g/l

1.61

204

1079

Pneumocystosis

176

3.86

19.36

7.5

2.6

3.43

3.16

g/l

1.13

137

Acute myeloid leukaemia and myelodysplastic syndromes

195

3.66

19.30

1.9

2.4

3.16

3.26

g/l

0.25

156

Pneumonia due to other infectious organisms, not elsewhere classified

291

3.07

19.28

6.4

1.9

3.44

3.05

g/l

2.16

223

Benign neoplasm of other and unspecified endocrine glands

280

1570

1.83

19.26

2.4

3.01

3.08

g/l

0.46

215

1244

Noninfectious colitis NAS

272

1513

1.84

19.12

2.5

2.3

3.13

3.10

g/l

0.23

218

1187

Fenamates

316

1212

1.79

19.11

2.0

2.3

3.11

g/l

0.01

261

922

Systemic sclerosis

246

3.29

19.10

1.9

2.2

3.09

3.06

g/l

0.11

196

5-aminosalicylic acid

340

2012

1.71

19.07

1.9

2.4

3.11

2.97

g/l

1.69

266

1575

Spondylolisthesis/Spondylolysis

356

2140

1.69

18.96

2.6

2.2

3.03

3.13

g/l

1.00

264

1684

Eosinophilia

159

3.95

18.96

2.3

1.8

3.27

3.19

g/l

0.20

128

Heartburn

215

1113

1.98

18.94

2.1

2.4

2.93

3.14

g/l

2.31

159

886

Hypersplenism

8.49

18.92

1.7

1.3

2.83

2.88

g/l

0.08

Postprocedural endocrine and metabolic disorders, not elsewhere classified

225

1182

1.94

18.92

3.3

2.2

3.04

3.10

g/l

0.39

187

927

Protozoal diseases

290

3.08

18.91

6.4

2.6

3.40

3.14

g/l

1.38

232

Use of pramipexole

479

3103

1.57

18.83

1.9

2.3

2.98

3.11

g/l

1.88

361

2384

Retinal detachments and breaks

755

5349

1.43

18.82

2.5

2.4

3.10

3.08

g/l

0.14

575

4145

Haemorrhage, not elsewhere classified

350

2.84

18.82

2.5

2.8

3.27

3.20

g/l

0.26

275

Donors of organs and tissues

5.00

18.81

8.7

1.9

2.19

2.94

g/l

2.01

Invasive ventilation

177

861

2.13

18.73

2.5

2.4

3.65

3.07

g/l

9.63

147

678

Other hammer toe(s) (acquired)

363

2061

1.68

18.67

1.8

2.5

3.21

3.08

g/l

1.44

269

1560

Personality disorders

416

2606

1.62

18.64

1.7

2.1

2.97

3.02

g/l

0.54

338

2064

Psoriatic arthropathies

194

974

2.04

18.63

1.7

2.4

3.25

3.01

g/l

1.86

147

764

Other complications of surgical and medical care, not elsewhere classified

204

1047

2.00

18.48

2.6

2.3

3.12

3.09

g/l

0.15

153

822

Cervicalgia

389

2408

1.64

18.43

2.2

3.01

3.12

g/l

1.47

302

1877

Other infectious diseases

188

944

2.05

18.22

2.7

2.4

3.51

3.10

g/l

4.82

149

752

Persons encountering health services in other circumstances

642

4432

1.46

18.19

2.3

2.2

2.95

3.07

g/l

2.07

478

3396

COPD, early/later onset

1020

6419

1.36

18.19

1.8

2.4

3.31

3.06

g/l

12.26

811

4918

Collagenous colitis

201

1034

2.00

18.17

3.1

2.4

3.20

3.10

g/l

0.61

155

811

Panic disorder

210

1091

1.95

18.14

1.6

2.3

2.88

3.10

g/l

3.29

170

859

Etanercept

129

559

2.38

18.09

1.6

2.4

3.37

3.07

g/l

1.97

105

438

Myocardial infarction

1137

6166

1.34

18.07

2.2

2.4

3.22

3.07

g/l

4.73

893

4713

Injury of unspecified body region

170

825

2.13

18.07

1.6

2.5

3.37

3.12

g/l

2.04

128

661

Enthesopathies of lower limb, excluding foot

390

2430

1.63

17.97

2.3

2.2

2.98

3.08

g/l

1.19

313

1928

Substance use, excluding alcohol

332

1988

1.69

17.90

1.5

2.3

3.14

3.06

g/l

0.79

252

1579

Extrapyramidal and movement disorders

768

5507

1.41

17.88

2.0

2.4

2.97

3.10

g/l

3.15

591

4227

COPD, hospital admissions

1009

6379

1.36

17.77

1.8

2.4

3.31

3.06

g/l

11.67

799

4889

Amputation of foot

296

3.00

17.73

1.4

2.6

3.41

3.16

g/l

1.44

227

Vitreous haemorrhage

225

1212

1.91

17.71

2.0

2.5

3.08

3.10

g/l

0.13

181

952

Open wound of ankle and foot

201

1042

1.97

17.67

2.2

2.3

3.19

3.10

g/l

0.57

167

828

Myeloid leukaemia

285

3.02

17.66

1.9

2.7

3.21

3.14

g/l

0.21

223

Bronchiectasis

205

1075

1.97

17.63

2.6

3.16

3.07

g/l

0.72

168

822

Sequelae of injuries of lower limb

192

981

2.01

17.62

2.2

2.5

3.02

3.06

g/l

0.23

154

780

Sleep disorders

362

2227

1.65

17.58

1.5

2.3

3.00

3.07

g/l

0.78

281

1764

923

6429

1.37

17.55

2.8

2.3

3.06

3.12

g/l

0.87

700

4882

Idiopathic urticaria

162

3.72

17.53

1.2

2.0

2.89

3.11

g/l

0.99

135

111

454

2.48

17.50

1.4

1.7

2.94

2.98

g/l

0.13

101

351

Other and unspecified myopathies

200

1042

1.98

17.47

1.6

2.4

3.22

3.10

g/l

0.90

146

823

Carcinoma in situ of skin of other and unspecified parts of face

208

1101

1.96

17.46

2.1

2.4

3.10

3.16

g/l

0.35

177

850

Restless leg syndrome

260

1472

1.81

17.38

2.1

2.4

2.96

3.10

g/l

1.23

201

1158

Scoliosis

155

735

2.16

17.38

2.2

3.05

3.16

g/l

0.74

120

580

Insomnia

272

1557

1.78

17.33

1.6

2.3

2.95

3.11

g/l

1.94

216

1233

Hallux valgus (acquired)

625

3114

1.47

17.29

2.1

2.5

3.18

3.02

g/l

2.93

464

2373

Other or unspecified ileus, impaction or obstruction

372

2317

1.63

17.25

2.4

2.2

3.20

3.11

g/l

0.93

277

1805

Transient ischemic attack

1138

7196

1.32

17.23

2.2

2.3

3.04

3.10

g/l

1.01

859

5513

KRA_PSY_EATING, excluding more controls

323

2.75

17.14

1.4

1.7

2.90

3.00

g/l

0.45

263

Actinic keratosis

859

5999

1.38

17.10

2.9

2.2

3.07

3.12

g/l

0.90

650

4557

Malignant neoplasm of skin

1368

8045

1.29

17.09

2.5

2.3

3.07

3.10

g/l

0.44

1040

6161

COPD related to multimorbidity

878

5446

1.38

16.98

1.8

2.4

3.30

3.06

g/l

10.00

690

4177

Viral pneumonia (known virus, not influenza)

232

3.20

16.95

6.0

2.6

3.12

3.19

g/l

0.21

183

Other interventions on the root canals of the tooth

147

3.83

16.94

5.4

1.7

3.14

3.00

g/l

0.55

116

Suppurative and necrotic conditions of lower respiratory tract

137

629

2.26

16.92

2.6

3.53

3.10

g/l

3.74

104

499

Wegener granulomatosis

129

4.07

16.91

1.2

2.5

3.34

3.12

g/l

0.65

100

Benign neoplasm: Caecum

246

1385

1.83

16.90

2.6

2.4

3.05

3.09

g/l

0.31

191

1093

Nonischemic cardiomyopathy

137

629

2.26

16.88

1.7

2.3

3.09

g/l

0.01

115

503

Lupus erythematosus

254

3.09

16.86

2.1

2.2

2.84

3.14

g/l

1.91

201

Diplopia

273

1582

1.76

16.81

2.0

2.2

3.05

3.10

g/l

0.32

199

1241

Acute pancreatitis

406

2600

1.59

16.81

1.8

2.3

3.22

3.08

g/l

1.61

319

2019

Ankylosing spondylitis

173

867

2.04

16.76

1.5

2.1

3.17

3.13

g/l

0.18

135

705

Other respiratory disorders and diseases

447

2930

1.55

16.72

2.2

2.3

3.29

3.07

g/l

3.97

337

2261

Other diseases of the respiratory system

447

2930

1.55

16.72

2.2

2.3

3.29

3.07

g/l

3.97

337

2261

Agoraphobia

152

3.66

16.67

1.8

1.7

2.97

3.08

g/l

0.34

128

Erosion of teeth, including avohilmo

303

1742

1.70

16.63

2.5

2.0

3.01

3.00

g/l

0.06

239

1329

Alcoholic liver disease

220

1202

1.88

16.60

1.3

2.5

3.15

3.04

g/l

0.89

171

945

Vasomotor and allergic rhinitis

593

4047

1.46

16.57

2.1

2.2

2.93

3.03

g/l

1.68

451

3188

Nonorganic sleeping disorders

309

1856

1.69

16.52

1.6

2.3

2.95

3.08

g/l

1.67

244

1472

Inflammatory bowel disease

552

3779

1.48

16.52

2.1

2.2

3.13

3.04

g/l

1.14

417

2986

Carpal tunnel syndrome

1162

8081

1.31

16.48

2.3

2.98

3.07

g/l

2.51

899

6285

Coxarthrosis, primary

1290

8747

1.29

16.46

2.1

2.4

3.10

3.09

g/l

0.06

969

6709

Psoriasis vulgaris

366

2302

1.62

16.37

1.7

2.3

3.19

3.07

g/l

1.28

281

1817

Other disorders of eyelid

936

6783

1.35

16.34

2.1

2.3

3.04

3.11

g/l

1.43

720

5190

Skin changes due to chronic exposure to nonionizing radiation

874

6143

1.36

16.33

2.8

2.3

3.06

3.12

g/l

0.96

662

4660

Other degenerative diseases of the nervous system

531

2723

1.50

16.27

1.9

2.3

3.04

3.18

g/l

1.97

370

2137

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

944

6940

1.34

16.25

2.3

2.95

3.06

g/l

2.81

725

5432

Localized swelling, mass and lump of skin and subcutaneous tissue

581

4033

1.46

16.23

2.2

2.3

3.00

3.09

g/l

1.15

464

3104

Major coronary heart disease event

1542

8189

1.27

16.20

2.2

2.4

3.16

3.07

g/l

2.68

1208

6301

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

391

2497

1.58

16.18

1.9

2.2

3.05

3.03

g/l

0.14

294

1990

Disorders of vitreous body and globe

1029

7643

1.33

16.17

2.4

2.99

3.09

g/l

2.34

799

5869

Fracture of forearm

1007

7149

1.33

16.15

2.0

2.3

3.13

3.07

g/l

0.95

744

5502

Migraine without aura and triptan purchases

212

1149

1.87

16.14

1.6

2.0

2.95

3.04

g/l

0.70

170

895

Drug-induced polyneuropathy

5.13

16.13

13.6

1.3

2.88

3.19

g/l

1.35

Alcohol induced polyneuropathy

4.57

16.05

1.3

2.0

2.98

3.18

g/l

0.45

Exclusions for E4_PCOS_BROAD

296

1772

1.70

16.04

3.0

2.2

3.00

3.09

g/l

0.78

230

1401

Major coronary heart disease event excluding revascularizations

1430

7804

1.28

16.02

2.2

2.4

3.19

3.07

g/l

4.26

1113

6003

Other viral hepatitis

110

469

2.40

16.00

2.2

1.9

3.10

3.03

g/l

0.34

371

Other specified/unspecified inflammatory spondylopathies

379

2.58

15.99

1.7

2.0

3.08

3.11

g/l

0.09

299

Special screening examination for neoplasms

104

434

2.48

15.97

3.4

2.3

3.25

3.18

g/l

0.28

359

Lesion of lateral popliteal nerve

113

490

2.39

15.96

2.4

2.87

3.09

g/l

1.36

389

Bullous disorders

144

691

2.16

15.93

2.1

2.5

2.94

3.18

g/l

2.40

121

544

Pain and other conditions associated with female genital organs and menstrual cycle

283

1605

1.71

15.88

2.0

2.89

3.08

g/l

2.70

218

1264

Chronic pancreatitis

263

1536

1.75

15.81

1.9

2.4

3.18

3.08

g/l

0.74

214

1204

Allergic purpura

257

2.96

15.78

1.8

2.5

3.22

3.15

g/l

0.25

202

Vitamin B12 deficiency anaemia

244

1396

1.79

15.77

2.0

2.4

3.17

3.09

g/l

0.64

191

1087

Disorders of vitreous body

1000

7454

1.33

15.75

2.4

2.98

3.08

g/l

2.43

779

5737

Other and unspecified injuries of head

131

607

2.22

15.75

1.6

2.4

3.03

3.12

g/l

0.55

102

482

Thyrotoxicosis

464

3102

1.52

15.74

1.8

2.3

3.14

3.08

g/l

0.57

362

2396

Atopic dermatitis, strict definition with reimbursement

395

2465

1.57

15.73

1.8

2.1

3.01

3.03

g/l

0.20

316

1953

Fall on and from stairs and steps

481

3241

1.51

15.72

2.2

2.3

3.11

3.10

g/l

0.10

363

2517

Other disorders of glucose regulation and pancreatic internal secretion

169

862

2.01

15.66

2.0

2.3

3.10

3.13

g/l

0.16

129

684

Guillain-Barre syndrome

151

3.69

15.62

2.4

2.5

3.00

3.23

g/l

0.86

120

Other specified/unspecified necrotizing vasculopathies

137

3.86

15.62

1.4

3.1

3.43

3.03

g/l

1.87

107

Systemic sclerosis, icd10

271

2.93

15.62

1.9

2.0

3.09

3.06

g/l

0.10

217

Benign neoplasm: Stomach

230

1300

1.82

15.60

2.4

3.16

3.09

g/l

0.45

170

1020

Thoracic aortic aneurysm

305

1862

1.68

15.57

2.2

2.4

3.18

3.02

g/l

2.25

238

1452

Hypermobility syndrome

325

2.68

15.56

2.1

1.8

2.94

3.10

g/l

0.84

265

Neuromuscular dysfunction of bladder

195

1047

1.91

15.55

2.1

2.5

3.17

3.04

g/l

0.89

148

821

Sarcoidosis

275

1634

1.72

15.50

1.9

2.3

2.98

3.08

g/l

0.92

218

1294

Fracture of lower leg, including ankle

1021

7779

1.32

15.48

2.0

2.3

3.05

3.06

g/l

0.18

781

6009

Benign neoplasm: Adrenal gland

165

841

2.03

15.45

2.1

1.4

3.19

3.00

g/l

1.34

126

662

Other/unspecified rheumatoid arthritis

283

1698

1.71

15.43

1.9

2.3

3.28

3.13

g/l

1.25

205

1299

Thyroiditis, ILD-related definition

203

1105

1.87

15.39

2.4

2.96

3.08

g/l

0.86

168

859

Faecal incontinence

204

1116

1.88

15.37

1.6

2.3

3.00

3.18

g/l

1.30

156

872

Primary biliary cholangitis (PBC)

203

3.23

15.33

1.5

2.0

3.15

3.10

g/l

0.16

168

Pyothorax

107

463

2.41

15.28

2.9

2.5

3.47

3.12

g/l

2.06

363

Other diseases of lip and oral mucosa

309

1900

1.65

15.21

2.6

2.1

3.02

3.09

g/l

0.52

243

1472

Aortic aneurysm

500

3363

1.48

15.15

2.1

2.4

3.25

3.03

g/l

5.12

385

2604

Unknown and unspecified causes of morbidity

136

649

2.14

15.08

2.4

2.3

2.38

3.08

g/l

12.20

510

Systemic atrophies primarily affecting the central nervous system

109

479

2.38

15.05

1.4

2.7

2.71

3.11

g/l

4.51

379

Candidiasis

255

1496

1.74

15.04

3.2

2.3

3.14

3.09

g/l

0.36

184

1174

Hypertension, Pulmonary Arterial

4.77

14.94

2.7

1.9

3.17

3.02

g/l

0.46

Conjunctivitis (acute, non atopic)

457

3068

1.50

14.90

2.8

2.1

2.93

3.08

g/l

2.41

366

2376

Demyelinating diseases of the central nervous system

150

746

2.05

14.90

1.5

2.1

2.88

3.10

g/l

1.66

117

582

Juvenile arthritis (FINNGEN)

242

2.92

14.87

1.8

2.0

3.07

3.03

g/l

0.11

186

Mucosal proctocolitis

218

1226

1.81

14.85

2.2

2.4

3.19

3.08

g/l

0.85

182

976

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1198

7410

1.29

14.82

2.6

2.3

3.08

3.11

g/l

0.39

914

5662

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

257

1520

1.73

14.81

2.1

1.4

3.33

3.03

g/l

3.86

199

1152

Myocardial infarction, strict

1043

5861

1.31

14.60

2.0

2.4

3.22

3.08

g/l

4.06

817

4470

Gout due to impairment of renal function

121

4.03

14.53

2.9

1.8

3.19

3.15

g/l

0.09

Excessive attrition of teeth

622

2377

1.43

14.51

2.3

2.0

2.89

3.02

g/l

2.56

468

1791

Myocardial infarction, without ST-elevation

881

6155

1.34

14.44

2.1

2.3

3.22

3.09

g/l

2.84

678

4699

Viral hepatitis

129

615

2.15

14.38

2.1

2.0

3.10

3.07

g/l

0.13

108

489

Thyrotoxicosis, other and/or unspecified

355

2288

1.57

14.33

1.9

2.3

3.09

3.08

g/l

0.06

282

1788

Other disorders of peripheral nervous system

5.47

14.28

3.7

1.7

2.75

3.26

g/l

2.10

Spirochaetal infections, other/unspecified

183

993

1.90

14.21

2.3

2.6

3.07

3.10

g/l

0.18

134

791

Open wound of forearm

173

920

1.92

14.20

2.1

2.4

3.17

3.14

g/l

0.13

141

737

Inflammatory diseases of the central nervous system

164

858

1.96

14.16

2.7

2.4

3.01

3.11

g/l

0.60

121

679

Acute pancreatitis (for exclusion)

406

2708

1.52

14.06

1.8

2.3

3.22

3.08

g/l

1.73

319

2111

Early onset COPD

463

3172

1.48

14.04

2.0

2.4

3.32

3.03

g/l

7.41

364

2474

Familial hypercholesterolemia

327

2082

1.60

14.02

2.4

2.2

3.03

3.11

g/l

0.57

238

1592

Hyperplasia of prostate

788

3324

1.37

14.02

2.5

3.01

3.08

g/l

1.12

594

2661

Other lack of coordination

157

3.46

14.01

1.6

2.6

2.76

3.18

g/l

2.70

122

Herpesviral [herpes simplex] infections

214

1220

1.79

14.01

3.3

2.4

3.07

3.10

g/l

0.20

174

963

Vascular disorders of the intestines

154

794

2.00

13.96

2.5

2.3

3.27

3.15

g/l

0.74

120

619

Internal derangement of knee

629

4535

1.40

13.95

1.9

2.4

3.08

3.02

g/l

0.79

480

3555

Intestinal stricture

613

4426

1.40

13.84

2.6

2.3

3.18

3.09

g/l

1.23

451

3422

Unspecified acute lower respiratory infection

274

1675

1.66

13.84

3.2

2.1

3.27

3.09

g/l

1.90

199

1308

Benign neoplasm of mouth and pharynx

216

1241

1.78

13.81

3.0

1.5

3.08

3.05

g/l

0.17

159

950

Abnormal results of function studies

169

902

1.92

13.77

2.4

2.6

2.95

3.08

g/l

1.10

125

725

Melanocytic naevi

448

3057

1.48

13.73

2.3

1.4

2.99

3.01

g/l

0.21

366

2397

Ulcerative colitis

428

2896

1.50

13.72

2.3

2.2

3.12

3.05

g/l

0.75

326

2275

Crystal arthropathies, rheuma endpoint

191

3.18

13.65

1.7

3.1

3.49

3.03

g/l

1.60

144

Diagnoses used for exclusion with ILD

517

3636

1.44

13.60

2.2

3.11

3.08

g/l

0.26

391

2815

Ascites

162

858

1.94

13.59

1.6

2.4

3.07

3.12

g/l

0.27

128

685

Recurring oral aphthae

103

461

2.31

13.58

3.7

2.6

2.95

3.09

g/l

0.69

373

Congenital malformations, deformations and chromosomal abnormalities

913

6707

1.31

13.54

1.9

2.2

3.01

3.03

g/l

0.22

716

5269

Iridocyclitis

422

2858

1.50

13.53

2.3

2.2

3.11

3.08

g/l

0.26

332

2219

COPD-related respiratory insufficiency

274

1694

1.66

13.41

1.9

2.4

3.45

3.06

g/l

7.04

199

1286

Carcinoma in situ of skin

178

978

1.88

13.36

2.0

1.5

3.16

3.10

g/l

0.33

147

745

Propionic acid derivatives

542

1895

1.45

13.31

2.4

2.3

3.12

3.11

g/l

0.03

425

1449

Anti-inflammatory and antirheumatic products, non-steroids

542

1895

1.45

13.31

2.6

2.3

3.13

3.11

g/l

0.12

430

1449

Fitting and adjustment of other devices

706

4875

1.36

13.27

2.4

2.1

2.72

3.08

g/l

12.43

465

3725

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

201

1146

1.80

13.26

2.8

2.5

3.17

3.09

g/l

0.56

158

914

Keratitis

613

4456

1.39

13.24

2.1

2.2

3.04

3.05

g/l

0.13

470

3475

Mental and behavioural disorders due to alcohol

931

6997

1.31

13.22

1.6

2.4

3.12

3.04

g/l

1.50

732

5506

Other shoulder lesions

166

892

1.90

13.20

1.6

2.2

3.00

3.09

g/l

0.51

131

703

Ptosis of eyelid

241

1449

1.70

13.16

2.6

2.5

2.98

3.11

g/l

1.37

203

1134

Fibroblastic disorders

455

3145

1.47

13.15

2.4

2.3

2.97

3.09

g/l

1.89

348

2445

Other and unspecified visual disturbances

187

1048

1.83

13.06

2.6

2.3

3.05

3.13

g/l

0.57

156

825

Other and unspecified urticaria

322

2075

1.57

13.03

2.5

2.2

3.00

3.09

g/l

0.84

256

1622

Benign neoplasm: Rectum, anus and anal canal

430

2951

1.48

13.02

2.2

2.3

3.14

3.07

g/l

0.61

342

2275

Folate deficiency anaemia

4.28

12.97

2.3

1.8

3.24

3.19

g/l

0.09

Allergic rhinitis

420

2833

1.48

12.95

2.2

2.1

2.90

3.03

g/l

1.93

324

2239

Chronic tubulo-interstitial nephritis

401

2.38

12.93

2.2

3.19

3.11

g/l

0.30

318

Other specified/unspecified bacterial intestinal infections

145

753

1.98

12.93

3.0

2.5

3.07

3.10

g/l

0.08

101

598

Other local infections of skin and subcutaneous tissue

193

1095

1.80

12.92

3.0

2.4

3.16

3.10

g/l

0.33

151

873

Other benign neoplasms of skin

656

4748

1.37

12.89

3.0

1.4

2.97

3.06

g/l

1.30

491

3656

Mental and behavioural disorders due to alcohol, excluding acute intoxication

819

6243

1.32

12.80

1.6

2.3

3.10

3.04

g/l

0.97

641

4916

Sequelae of injuries, of poisoning and of other consequences of external causes

418

2858

1.48

12.78

2.5

2.3

3.05

3.06

g/l

0.07

314

2261

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

223

1324

1.72

12.76

1.9

1.4

3.38

3.03

g/l

4.25

171

1020

Nummular dermatitis

170

933

1.87

12.76

2.3

2.6

2.97

3.10

g/l

0.84

123

741

Other and unspecified local infections of skin and subcutaneous tissue

182

1019

1.83

12.75

3.1

2.4

3.17

3.09

g/l

0.51

145

815

Traumatic subdural haemorrhage

259

1569

1.65

12.74

2.4

2.3

3.15

3.21

g/l

0.43

188

1219

Fracture of skull and facial bones

367

2446

1.52

12.73

2.4

2.2

3.10

3.05

g/l

0.39

284

1925

Insulin, fast-acting (human)

237

1426

1.69

12.73

1.7

2.1

3.04

3.09

g/l

0.35

184

1144

Nonhereditary hypogammaglobulinemia

103

3.99

12.73

4.0

1.6

2.91

3.14

g/l

0.49

Other inflammatory liver diseases

139

715

2.00

12.72

1.7

2.7

3.33

3.08

g/l

1.53

102

567

Other skin changes

335

2196

1.55

12.68

3.0

2.3

3.02

3.14

g/l

0.98

244

1705

Alcohol-induced chronic pancreatitis

139

717

1.99

12.64

1.8

2.4

3.20

3.04

g/l

0.83

108

578

Diabetic retinopathy, strict definition

349

2023

1.54

12.60

1.7

2.0

3.08

3.11

g/l

0.26

254

1585

Temporomandibular joint disorders, including avohilmo

596

4340

1.38

12.57

2.2

2.92

3.03

g/l

1.96

461

3406

Carcinoma in situ of skin of upper limb, including shoulder

252

2.78

12.49

2.5

1.4

3.28

3.21

g/l

0.22

192

Acute posthaemorrhagic anaemia

346

2.46

12.44

3.4

2.6

3.38

3.21

g/l

0.69

274

Otitis externa

384

2597

1.50

12.43

2.1

2.3

3.03

3.08

g/l

0.45

269

2049

Artificial joint operation, meniscal resection

1841

10218

1.21

12.41

2.2

2.3

3.12

3.06

g/l

1.26

1407

7903

Other disorders of the musculoskeletal system and connective tissue

294

1883

1.59

12.37

2.1

2.4

3.10

g/l

0.02

225

1489

Ocular pain

146

770

1.94

12.37

1.7

2.4

2.96

3.10

g/l

1.10

123

604

Mental and behavioural disorders due to sedatives or hypnotics

119

585

2.08

12.31

1.4

2.2

2.99

3.05

g/l

0.31

464

Cyst of kidney

159

867

1.89

12.29

2.7

2.6

3.08

3.12

g/l

0.23

125

693

Diseases of the ear and mastoid process

2222

9503

1.19

12.28

2.2

2.97

3.08

g/l

5.33

1665

7530

COPD, hospital admissions 3, with asthma pneumonia sepsis

589

3658

1.39

12.26

1.9

2.4

3.37

3.07

g/l

10.59

466

2789

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

257

1542

1.63

12.23

1.8

2.3

3.11

3.09

g/l

0.14

209

1231

Chronic viral hepatitis

372

2.37

12.22

1.8

1.7

3.05

3.02

g/l

0.11

297

Congenital malformations of the urinary system

106

501

2.17

12.19

2.0

2.4

3.24

3.10

g/l

0.79

405

Other crystal arthropathies

204

2.97

12.19

1.7

2.3

3.49

3.10

g/l

1.23

152

Total colectomy

399

2.33

12.18

2.6

2.4

3.05

3.08

g/l

0.08

321

Total colectomy operation

399

2.33

12.18

2.6

2.4

3.05

3.08

g/l

0.08

321

Other immunodeficiencies

3.98

12.13

4.5

2.0

2.92

2.99

g/l

0.17

COPD, hospital admission 2, with asthma infections

684

4369

1.35

12.10

1.9

2.4

3.35

3.07

g/l

10.90

537

3349

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

172

3.13

12.06

7.3

1.3

3.13

3.14

g/l

0.02

133

Pemphigoid

316

2.53

12.04

1.6

2.6

2.92

3.25

g/l

2.46

242

Allergic urticaria

141

742

1.94

12.01

2.1

2.4

3.05

3.12

g/l

0.32

107

590

Emotionally unstable personality disorder

155

839

1.87

12.01

1.6

1.8

2.88

3.05

g/l

1.43

126

670

Hypothyroidism, other/unspecified

1669

9132

1.21

12.00

2.1

2.3

2.99

3.07

g/l

2.16

1291

7061

Respiratory insufficiency

163

898

1.85

12.00

1.7

1.6

3.27

2.98

g/l

3.05

120

688

Poisoning by drugs, medicaments and biological substances

350

2339

1.51

11.97

2.0

2.2

3.08

3.04

g/l

0.38

279

1860

Personal history of other diseases and conditions

152

816

1.88

11.93

4.2

2.0

2.99

3.11

g/l

0.87

108

651

Other diseases of pancreas

164

911

1.85

11.91

2.3

2.4

3.15

3.12

g/l

0.14

128

721

Dementia in Alzheimer disease

157

2370

0.56

11.86

1.5

2.3

3.01

3.18

g/l

0.90

1808

Benign neoplasm: Rectosigmoid junction

450

2.24

11.85

2.1

1.4

2.91

3.09

g/l

1.12

353

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

773

5189

1.32

11.84

2.7

1.4

3.44

3.05

g/l

14.19

602

3999

Atopic dermatitis, strict definition

369

2446

1.49

11.82

1.9

2.1

3.02

g/l

0.02

299

1939

Gingival hyperplasia

287

2.56

11.82

2.4

2.0

3.41

3.08

g/l

1.57

228

Hydronephrosis

208

1237

1.71

11.80

1.8

2.1

3.25

3.06

g/l

1.56

167

958

Social phobias

447

2.20

11.78

1.4

1.9

2.94

3.11

g/l

0.92

366

Lung transplant status

4.80

11.78

1.3

2.0

3.35

3.09

g/l

0.62

Lung transplantation

4.80

11.77

1.3

2.0

3.35

3.09

g/l

0.62

Other and unspecified paralytic syndromes

128

3.49

11.77

3.1

2.5

2.85

3.19

g/l

1.48

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

448

2.20

11.76

1.5

1.9

2.99

3.09

g/l

0.57

362

Biomechanical lesions, not elsewhere classified

109

530

2.13

11.76

2.4

2.5

2.92

3.12

g/l

1.67

420

Inflammatory diseases of female pelvic organs

953

5625

1.28

11.75

1.7

2.3

3.04

3.06

g/l

0.23

711

4350

Colonic or urogenital fistula

500

3590

1.41

11.75

2.3

3.06

3.07

g/l

0.04

384

2810

Lesion of ulnar nerve

264

1669

1.61

11.74

2.1

2.2

3.06

3.07

g/l

0.05

205

1333

Polymyositis

4.38

11.72

2.0

2.3

3.20

3.13

g/l

0.12

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

254

1595

1.62

11.67

2.5

1.4

3.14

3.07

g/l

0.49

200

1190

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

289

2.53

11.59

1.5

1.7

3.01

2.97

g/l

0.11

231

Cystic kidney disease

296

2.52

11.59

1.8

2.4

3.35

3.11

g/l

1.16

238

Cervicobrachial syndrome

364

2471

1.49

11.57

2.2

2.92

3.08

g/l

2.83

286

1933

Artificial opening status

123

629

2.02

11.56

2.5

2.3

3.32

3.16

g/l

0.91

104

506

Benign neoplasm: Adrenal gland

165

928

1.83

11.55

2.1

2.7

3.19

3.07

g/l

0.71

126

739

Hypothyreosis and Thyroxine purchase for inclusion criteria

1732

9549

1.20

11.49

2.1

2.3

3.00

3.07

g/l

1.97

1340

7385

Artificial joint re-operation

164

923

1.83

11.49

2.1

2.6

3.31

3.13

g/l

1.19

135

725

Transport accidents

702

4712

1.33

11.42

1.8

2.2

3.01

3.03

g/l

0.34

535

3703

Ankylosing spondylitis, ICD10

162

907

1.82

11.39

1.6

2.4

3.19

3.06

g/l

0.83

126

724

Benign neoplasm: Rectum

376

2585

1.48

11.38

2.2

2.4

3.15

3.07

g/l

0.75

302

1989

Abnormal spermatozoa

1729

0.46

11.35

1.9

2.5

2.67

3.04

g/l

2.51

1355

Microscopic polyangiitis

4.64

11.35

1.5

2.0

3.84

3.26

g/l

1.49

Other specified/unspecified soft tissue disorders

105

510

2.12

11.32

2.4

2.1

3.08

3.17

g/l

0.35

395

Poisoning by medicine

315

2085

1.53

11.32

2.1

2.2

3.05

g/l

0.00

255

1656

Oesophageal varices

439

2.22

11.29

1.6

2.4

3.19

3.07

g/l

0.60

347

Selective deficiency of immunoglobulin G [IgG] subclasses

4.76

11.29

2.8

1.2

2.72

3.21

g/l

1.29

Other and unspecified mood [affective] disorders

450

2.17

11.23

1.5

2.1

3.03

3.08

g/l

0.25

354

Hypoglycaemia, other or unspecified

128

669

1.96

11.20

1.7

2.4

3.08

3.13

g/l

0.20

102

533

Symptoms and signs involving emotional state

212

2.78

11.19

1.7

2.0

3.14

3.09

g/l

0.13

170

Macular pucker

327

2197

1.52

11.18

1.9

2.4

3.17

3.08

g/l

0.87

244

1695

Exclusions for E4_PCOS_CONSORTIUM

1175

5929

1.25

11.16

2.2

3.07

3.05

g/l

0.15

889

4605

Neuralgia and neuritis, unspecified

101

486

2.13

11.16

2.8

2.2

2.97

3.13

g/l

0.77

385

Specific personality disorders

329

2204

1.51

11.15

1.7

2.1

2.97

3.02

g/l

0.47

261

1741

Epilepsy

533

3888

1.38

11.15

2.0

2.4

3.15

3.10

g/l

0.44

389

3047

Paraplegia, diplegia of upper limbs

214

2.79

11.10

1.8

2.6

3.33

3.06

g/l

1.10

167

Speech disturbances, not elsewhere classified

181

1057

1.75

11.08

1.9

2.4

3.02

3.13

g/l

0.82

133

842

Cholera

102

496

2.13

11.05

3.7

2.4

3.21

3.17

g/l

0.14

388

Diseases of male genital organs

972

3860

1.28

11.03

2.1

2.3

2.99

3.08

g/l

1.77

761

3091

Other bursopathies

250

1586

1.60

11.00

2.4

2.2

3.16

3.11

g/l

0.27

195

1239

Cardiomyopathy, Hypertrophic obstructive

176

2.99

10.99

1.6

2.7

3.15

3.08

g/l

0.18

139

Unspecified nephritic syndrome

239

2.68

10.94

2.1

2.6

3.27

3.15

g/l

0.40

188

Other diseases of stomach and duodenum

139

754

1.89

10.93

2.2

2.8

3.20

3.12

g/l

0.36

111

609

Other viral diseases, not elsewhere classified

282

1833

1.55

10.92

3.4

2.2

3.20

3.08

g/l

1.01

232

1444

Synovial cyst of popliteal space [Baker]

150

833

1.84

10.90

2.7

2.2

3.13

3.14

g/l

0.07

119

649

Barrett oesophagus

110

553

2.06

10.89

2.2

2.8

3.16

3.07

g/l

0.30

451

Cervicocranial syndrome

188

1115

1.71

10.80

2.0

2.2

3.05

3.15

g/l

0.70

144

878

Infections with a predominantly sexual mode of transmission

397

2773

1.44

10.79

2.0

2.99

3.00

g/l

0.01

310

2208

Other disorders of gingiva or/and edentulous alveolar ridge

466

2.14

10.78

2.4

2.0

3.33

3.02

g/l

1.85

378

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

136

3.30

10.74

1.5

1.3

3.29

3.16

g/l

0.28

106

Hernia of abdominal wall

852

6700

1.28

10.71

2.2

2.3

3.06

g/l

0.03

678

5184

Presence of other functional implants

1167

6703

1.24

10.68

2.3

3.07

3.09

g/l

0.37

859

5230

Other forms of systemic lupus erythematosus

4.37

10.67

2.0

2.6

2.98

3.19

g/l

0.59

Alcohol-induced acute pancreatitis

359

2.31

10.61

2.1

2.6

3.09

3.06

g/l

0.09

292

Other localized connective tissue disorders

197

2.83

10.56

2.8

2.1

3.11

3.12

g/l

0.02

161

Ventral hernia

455

3279

1.40

10.55

2.4

2.2

3.06

3.08

g/l

0.12

350

2527

Delirium, not induced by alcohol and other psychoactive substances

235

1485

1.61

10.53

2.1

2.3

3.44

3.13

g/l

3.62

171

1161

Traumatic subarachnoid haemorrhage

303

2.42

10.53

2.7

2.0

3.24

3.23

g/l

0.01

244

Anterior Iridocyclitis

365

2530

1.46

10.52

2.4

2.3

3.09

3.08

g/l

0.03

286

1981

Problems related to lifestyle

159

906

1.78

10.51

1.5

2.4

3.07

3.08

g/l

0.03

122

709

Disorders of vestibular function (Vertigo)

893

7036

1.27

10.45

2.0

2.3

3.00

3.09

g/l

1.92

651

5409

Left bundle-branch block

144

802

1.84

10.39

1.7

2.3

3.07

3.04

g/l

0.11

105

609

Hyperhidrosis

186

2.82

10.39

2.6

2.75

3.11

g/l

2.29

147

Asthma and opportunity respiratory infection

114

592

1.99

10.35

2.5

2.7

3.28

3.14

g/l

0.80

461

Speech and linguistic disorders, excluding more controls

362

2.21

10.33

1.7

2.0

3.10

3.20

g/l

0.35

282

Dislocation, sprain and strain of joint and ligaments of hip

396

2.23

10.32

1.5

2.3

3.17

3.15

g/l

0.05

320

Intestinal adhesions without obstruction

168

983

1.75

10.24

3.0

2.2

3.18

3.11

g/l

0.40

128

770

Carbimazole or st.post thyroidectomy, condition for graves disease

346

2387

1.47

10.23

2.4

2.3

3.09

3.07

g/l

0.11

269

1854

Ovarian cyst

586

2519

1.36

10.21

1.9

2.1

3.05

3.14

g/l

1.09

442

1971

Panniculitis, unspecified

3.79

10.17

2.9

1.9

3.18

2.99

g/l

0.49

Retinal vascular occlusion

257

1675

1.57

10.16

2.5

2.4

3.20

3.09

g/l

0.91

195

1283

Angina pectoris

1251

6937

1.23

10.15

2.3

2.4

3.13

3.07

g/l

1.13

962

5314

Anogenital herpesviral [herpes simplex] infection

403

2.17

10.13

2.1

1.7

2.94

3.08

g/l

0.68

324

Carcinoma in situ of skin of upper limb, including shoulder

280

2.49

10.13

2.5

3.0

3.28

3.23

g/l

0.17

211

Olecranon bursitis

124

665

1.91

10.12

2.4

2.1

3.09

3.10

g/l

0.06

525

Postviral fatigue syndrome

5.73

10.06

1.1

2.1

2.83

2.84

g/l

0.01

Mixed hyperlipidaemia

453

2.12

10.05

1.3

2.2

3.17

3.08

g/l

0.36

372

Background retinopathy and retinal vascular changes

220

2.67

10.03

1.8

2.9

3.04

3.20

g/l

0.48

176

Carcinoma in situ of skin of lower limb, including hip

215

2.71

10.00

3.1

1.4

3.00

3.13

g/l

0.55

165

Alcohol use disorder, ICD-based

740

5768

1.29

10.00

1.7

2.3

3.11

3.04

g/l

1.15

583

4531

Juvenile rheumatoid arthirtis

125

3.21

9.98

1.3

1.9

2.95

2.92

g/l

0.05

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

490

3595

1.37

9.97

2.0

2.2

3.01

3.02

g/l

0.03

395

2857

Late syphilis

137

3.19

9.96

2.8

2.0

3.02

3.15

g/l

0.38

107

Haemorrhoids and perianal venous thrombosis

533

3973

1.35

9.93

2.1

2.3

3.02

3.10

g/l

1.00

384

3075

Other spirochaetal diseases

465

3400

1.38

9.90

2.6

2.3

3.00

3.06

g/l

0.78

355

2642

Primary gonarthrosis, bilateral

1038

7363

1.24

9.90

1.9

2.4

3.12

3.07

g/l

0.72

793

5644

Acute and subacute iridocyclitis

339

2346

1.46

9.89

2.4

2.2

3.10

3.07

g/l

0.17

266

1836

Retinal vascular disorders

259

1702

1.55

9.86

2.5

2.4

3.20

3.09

g/l

0.93

197

1303

Dental caries 2 and operation codes

1191

7765

1.22

9.84

2.6

2.2

2.96

3.04

g/l

2.11

940

6077

Dermatitis due to substances taken internally

103

524

2.01

9.82

3.6

2.7

3.21

3.17

g/l

0.12

415

Colectomy operation

343

2386

1.46

9.82

2.6

2.3

3.17

3.09

g/l

0.78

270

1838

Polycystic ovarian syndrome, consortium definition

1119

5484

1.24

9.80

2.0

2.2

3.04

3.07

g/l

0.47

783

4289

Diseases of inner ear

1035

8233

1.24

9.78

1.9

2.3

2.99

3.09

g/l

2.32

755

6343

Causalgia

122

3.25

9.77

1.2

2.2

2.89

3.06

g/l

0.49

101

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

144

3.10

9.76

2.6

1.4

2.99

3.09

g/l

0.24

109

Follicular lymphoma

493

2.06

9.75

1.4

3.27

3.09

g/l

0.91

390

Benign neoplasm: Pancreas

278

2.45

9.74

2.5

1.4

2.92

3.06

g/l

0.52

213

Multifocal fibrosclerosis

4.25

9.73

1.4

2.5

3.37

3.14

g/l

0.41

Dental caries 2

1218

7880

1.22

9.73

2.6

2.2

2.96

3.04

g/l

1.90

963

6176

Pollen allergy

209

1292

1.61

9.72

2.3

2.0

2.98

3.06

g/l

0.59

159

1037

Other abnormal immunological findings in serum

149

3.01

9.71

2.7

2.5

2.92

3.13

g/l

0.67

117

Leukaemia of unspecified cell type

3.95

9.69

2.3

1.2

3.50

3.16

g/l

0.94

Impacted cerumen

199

1237

1.64

9.67

2.2

2.4

3.05

3.11

g/l

0.29

113

989

Benign neoplasm of mouth and pharynx

216

1369

1.61

9.65

3.0

2.4

3.08

3.09

g/l

0.03

159

1090

Deviated nasal septum

599

4561

1.32

9.64

2.7

2.4

2.93

3.07

g/l

3.46

467

3620

Dissociative [conversion] disorders

259

2.45

9.62

1.2

2.0

2.94

3.12

g/l

0.97

210

Acute pharyngitis

189

1148

1.65

9.61

2.6

2.1

3.04

3.02

g/l

0.08

150

930

Other infective otitis externa

117

627

1.91

9.59

2.3

2.5

2.92

3.08

g/l

1.26

494

Lyme disease

459

3369

1.38

9.57

2.6

2.3

3.00

3.06

g/l

0.73

350

2619

Covid-19 suspected case

293

1982

1.49

9.56

2.7

2.2

3.06

g/l

0.03

249

1568

Other prurigo

104

3.48

9.54

1.2

3.1

2.71

3.22

g/l

1.45

Injuries to the neck

350

2453

1.44

9.52

2.7

2.1

2.97

3.05

g/l

0.88

266

1930

Other and unspecified erythematous conditions

318

2.32

9.51

2.6

2.3

2.89

3.15

g/l

1.58

250

Oral leukoplakia and related diseases, including avohilmo

178

1081

1.68

9.49

2.1

2.5

3.05

3.08

g/l

0.17

135

849

Polyarteritis nodosa and related conditions

109

3.37

9.49

3.0

2.3

3.08

3.12

g/l

0.07

Mental disorders, not otherwise specified

126

692

1.85

9.48

1.7

2.1

2.97

3.08

g/l

0.73

104

553

Tubulo-interstitial nephritis, not specified as acute or chronic

131

730

1.83

9.46

2.7

2.1

3.04

3.09

g/l

0.19

576

Dermatographic urticaria

110

580

1.93

9.43

1.8

2.3

2.88

3.11

g/l

2.45

465

MS-disease / Multiple Sclerosis

112

594

1.92

9.42

1.6

2.1

2.79

3.11

g/l

2.61

472

Intestinal malabsorption

444

2.08

9.40

2.0

2.6

3.11

3.06

g/l

0.16

357

Acute nephritic syndrome

210

2.63

9.32

2.2

2.7

3.13

3.07

g/l

0.16

167

Cholecystectomy

1330

9826

1.20

9.31

2.3

3.06

3.07

g/l

0.05

1020

7544

Eating disorder

429

2.07

9.31

1.4

1.6

2.90

3.06

g/l

0.85

354

Ulcerative ileocolitis

333

2.25

9.29

2.9

2.2

2.95

3.10

g/l

0.77

264

Pain associated with micturition

208

1318

1.60

9.29

2.4

2.3

2.76

3.10

g/l

5.94

149

1025

Adrenocortical insufficiency

347

2.23

9.28

2.8

2.5

3.03

3.14

g/l

0.32

282

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

111

3.35

9.28

7.6

1.4

3.12

3.00

g/l

0.26

Hallux rigidus

255

1691

1.53

9.27

2.1

2.5

3.03

3.06

g/l

0.16

192

1301

Drug-induced osteoporosis

122

3.24

9.23

1.7

2.5

3.44

3.14

g/l

0.61

Post-traumatic stress disorder

411

2.09

9.23

1.6

1.9

2.88

3.04

g/l

0.84

334

Xerosis cutis

172

2.84

9.17

1.6

2.5

2.93

3.15

g/l

0.73

136

Other follicular disorders

116

629

1.88

9.14

2.3

2.4

2.99

3.08

g/l

0.42

506

Vitamin deficiency

504

2.00

9.12

2.5

2.4

3.05

3.09

g/l

0.14

396

Vitamin deficiency, wide

504

2.00

9.12

2.5

2.4

3.05

3.09

g/l

0.14

396

Fall involving bed

344

2.24

9.12

2.4

2.3

3.28

3.22

g/l

0.17

268

Emphysema

152

896

1.74

9.10

2.5

3.28

3.08

g/l

1.89

126

698

Drug-induced cataract

237

2.51

9.08

2.6

2.5

3.18

3.11

g/l

0.20

188

Fall on same level involving ice and snow

996

8129

1.23

9.05

2.0

2.3

3.04

3.07

g/l

0.51

738

6300

Ulcerative colitis, NAS

226

1468

1.56

9.02

2.1

2.4

3.11

3.09

g/l

0.12

172

1158

Sacroiliitis, not elsewhere classified

311

2.26

9.00

2.0

1.8

3.15

3.16

g/l

0.00

247

Carcinoma in situ of skin

178

1099

1.66

8.99

2.0

2.4

3.16

3.13

g/l

0.12

147

856

Syphilis

238

2.48

8.97

2.4

3.10

3.08

g/l

0.04

190

Adhesive capsulitis of shoulder

301

2078

1.47

8.96

1.9

2.2

3.03

3.09

g/l

0.46

237

1622

Excessive, frequent and irregular menstruation

605

2562

1.32

8.95

1.9

2.1

3.02

3.14

g/l

1.65

425

2000

Other juvenile arthritis

201

2.58

8.93

1.9

1.7

3.15

3.07

g/l

0.21

157

Carcinoma in situ of skin of trunk

354

2.21

8.93

2.7

1.5

3.40

3.12

g/l

1.33

273

Other disorders of adrenal gland

412

2.09

8.92

2.7

2.5

3.03

3.14

g/l

0.41

335

Infection due to other mycobacteria

157

2.88

8.92

1.6

2.1

3.56

3.08

g/l

1.68

118

Other/unspecified enthesopathies of lower limb, excluding foot

120

663

1.84

8.92

1.9

2.2

3.03

3.12

g/l

0.38

102

532

Benign neoplasm: Rectosigmoid junction

503

2.00

8.91

2.1

2.8

2.91

3.16

g/l

1.75

398

Hypothyroidism, strict autoimmune, 3 medication purchases required

1530

8836

1.19

8.89

2.0

2.3

3.00

3.07

g/l

1.92

1186

6824

Abrasion of teeth

414

2207

1.39

8.89

2.5

2.0

2.88

3.02

g/l

1.95

305

1658

Other dermatomyositis

4.83

8.88

1.3

2.2

3.12

2.93

g/l

0.47

Certolizumab pegol

103

3.33

8.88

1.3

1.9

3.56

3.15

g/l

1.06

Superficial injury of abdomen, lower back and pelvis

239

1578

1.53

8.86

1.9

2.2

3.05

3.10

g/l

0.35

193

1250

Myocarditis

339

2.19

8.85

2.3

2.1

3.00

2.87

g/l

0.54

248

Malignant melanoma, excluding all cancers (controls excluding all cancers)

318

2225

1.45

8.85

2.3

1.5

3.10

3.05

g/l

0.39

239

1702

Other demyelinating diseases of the central nervous system

276

2.34

8.84

1.6

1.9

2.91

3.04

g/l

0.39

222

Benign neoplasm: Descending colon

137

792

1.77

8.84

2.1

1.4

3.27

3.02

g/l

1.48

100

618

Exfoliative dermatitis

3.43

8.83

1.5

2.6

3.39

3.24

g/l

0.24

Acute gastritis

152

905

1.71

8.76

1.6

2.6

3.07

3.13

g/l

0.29

112

727

Melanocytic naevi of lower limb, including hip

368

2.15

8.76

2.4

1.4

3.09

3.03

g/l

0.21

292

Algoneurodystrophy

265

2.37

8.75

1.2

1.9

2.89

3.00

g/l

0.43

215

Striking against or struck by other objects

486

3647

1.34

8.70

1.9

2.2

3.08

3.03

g/l

0.47

380

2876

Other diseases of jaws

118

654

1.84

8.70

4.7

1.9

2.85

3.04

g/l

1.28

523

Chronic laryngitis and laryngotracheitis

257

1732

1.51

8.69

1.8

2.2

2.94

3.10

g/l

1.64

187

1362

Other diseases of oesophagus

189

1192

1.61

8.66

2.0

2.6

2.97

3.10

g/l

0.89

146

947

Calculus of kidney and ureter

572

4403

1.31

8.65

2.0

2.4

3.06

3.07

g/l

0.07

465

3424

therapeutic use

352

2.19

8.63

1.6

2.4

3.06

3.15

g/l

0.23

270

Malignant neoplasm of bone and articular cartilage

3.55

8.59

7.7

2.2

3.24

3.15

g/l

0.16

Benign neoplasm of major salivary glands

179

1117

1.63

8.59

1.9

1.4

3.11

3.06

g/l

0.23

139

865

Rosacea

197

1257

1.59

8.58

1.9

2.3

3.02

3.09

g/l

0.45

152

992

Idiopathic pulmonary fibrosis

165

1013

1.67

8.53

2.1

2.5

3.25

3.10

g/l

1.17

125

805

Mouth breathing

697

5503

1.28

8.53

2.5

2.4

2.96

3.04

g/l

1.32

542

4351

Other disorders of ear

1766

10115

1.17

8.52

2.4

2.3

2.96

3.09

g/l

5.97

1270

7956

Other erythematous conditions

360

2.15

8.50

2.6

2.2

2.88

3.17

g/l

1.87

286

Other disorders of nervous system

133

771

1.77

8.49

2.6

2.4

2.85

3.10

g/l

2.62

616

Postmenopausal bleeding

529

2191

1.34

8.49

2.1

2.2

3.12

3.17

g/l

0.46

404

1698

Other nonthrombocytopenic purpura

3.51

8.46

2.3

2.0

2.87

3.14

g/l

0.97

Mental and behavioural disorders due to opioids

213

2.49

8.45

1.6

3.10

3.09

g/l

0.02

177

Other specified and unspecified personality disorders

133

770

1.75

8.43

1.9

2.1

3.07

3.06

g/l

0.06

107

610

Superficial injury of thorax

252

1702

1.50

8.42

1.5

2.4

3.13

3.11

g/l

0.09

184

1340

Mature T/NK-cell lymphomas, hilmo

157

2.84

8.41

1.5

2.6

3.29

3.19

g/l

0.21

123

Exposure to other and unspecified forces of nature

4.73

8.37

3.0

1.2

3.13

3.11

g/l

0.02

626

4335

1.29

8.35

2.2

2.3

3.13

g/l

0.01

448

3272

Psoriatic arthropathies, ICD10

189

1203

1.60

8.34

1.8

2.4

3.26

3.09

g/l

1.07

142

953

ILD-related respiratory insufficiency

398

2.09

8.32

2.1

2.7

3.40

3.18

g/l

1.22

310

Disorders of ocular muscles, binocular movement, accommodation and refraction

707

5565

1.27

8.29

2.1

2.2

2.99

3.04

g/l

0.70

546

4361

Arthropathic psoriasis

200

1292

1.57

8.27

1.7

2.4

3.29

3.10

g/l

1.33

154

1031

Melanocytic naevi of trunk

182

1150

1.61

8.26

2.2

1.4

2.91

3.03

g/l

1.03

146

898

Follicular cysts of skin and subcutaneous tissue

314

2220

1.43

8.25

2.5

2.2

3.10

3.07

g/l

0.16

256

1745

Other/unspecified crystal arthropathies

4.20

8.23

1.7

2.2

3.44

3.09

g/l

0.48

Somnolence, stupor and coma

432

2.02

8.22

1.5

2.9

3.16

3.17

g/l

0.04

345

Gonarthrosis, primary, with knee surgery

1147

7819

1.21

8.21

2.2

2.4

3.20

3.08

g/l

3.14

882

5991

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

419

3110

1.36

8.20

1.5

2.6

3.14

3.01

g/l

1.58

332

2452

Other sleep disorders

190

1218

1.58

8.12

1.7

2.4

3.04

3.13

g/l

0.47

119

975

Misadventures to patients during surgical and medical care

249

1692

1.49

8.12

1.9

2.3

3.20

3.09

g/l

0.98

181

1316

Disorders of magnesium metabolism

3.88

8.10

1.2

1.3

3.43

3.27

g/l

0.25

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

391

2873

1.37

8.09

1.9

2.1

3.05

3.03

g/l

0.18

294

2293

Benign neoplasm: Other and unspecified parts of mouth

347

2.14

8.09

3.0

1.4

3.19

3.04

g/l

0.47

275

Eating disorders

118

667

1.79

8.07

2.0

1.8

3.01

3.05

g/l

0.17

537

Cluster headache, strict

275

2.27

8.04

1.8

2.8

2.78

3.13

g/l

2.81

223

Coeliac disease

202

1317

1.56

8.01

2.5

2.3

2.88

3.08

g/l

2.35

148

1035

Hodgkin lymphoma

232

2.40

7.99

1.3

3.45

3.02

g/l

1.65

185

CR(E)ST syndrome

161

2.75

7.99

2.3

1.8

3.02

3.11

g/l

0.31

132

Cholangitis (primary sclerosing, PSC), with reimbursement 202

132

2.91

7.98

2.6

2.0

3.27

3.13

g/l

0.44

108

Alcohol abuse, main dg, excluding more controls

232

1559

1.51

7.95

1.2

2.5

3.06

3.03

g/l

0.20

183

1251

Monoplegia

144

2.84

7.95

2.0

2.6

2.93

3.11

g/l

0.67

112

D07AA Corticosteroids, weak (group I)

215

1420

1.53

7.95

1.8

2.3

3.08

3.09

g/l

0.05

164

1127

Other and unspecified glaucoma

150

917

1.67

7.91

1.8

2.6

3.18

3.16

g/l

0.08

118

704

N06DA Anticholinesterases

417

4490

0.74

7.88

1.9

2.3

3.04

3.14

g/l

1.09

291

3369

Use of anticholinesterases

417

4490

0.74

7.88

1.9

2.3

3.04

3.14

g/l

1.09

291

3369

Bullous pemphigoid

254

2.35

7.87

1.5

2.7

2.94

3.27

g/l

2.31

197

Sacrococcygeal disorders, not elsewhere classified

272

2.27

7.84

2.0

2.97

3.11

g/l

0.46

215

Portal vein thrombosis

151

2.78

7.83

1.8

2.1

3.15

3.21

g/l

0.11

119

Exposure to other and unspecified inanimate mechanical forces

110

618

1.81

7.80

2.4

3.10

3.08

g/l

0.07

487

Disorders of orbit

462

1.95

7.79

2.9

2.6

3.06

3.13

g/l

0.25

362

Leukaemia of unspecified cell type

3.38

7.76

2.3

2.2

3.50

3.13

g/l

1.08

Diseases of peritoneum

195

1273

1.56

7.75

2.0

2.4

3.25

3.11

g/l

0.98

143

999

Other/unspecified enthesopathies, not elsewhere classified

161

1005

1.63

7.75

1.7

2.1

2.98

3.11

g/l

0.90

126

791

6-mercaptopurine

151

2.70

7.70

1.3

2.6

3.30

3.02

g/l

0.86

124

Umbilical hernia

464

3530

1.33

7.69

2.0

2.3

3.10

3.05

g/l

0.37

386

2788

Chronic myeloproliferative disease

153

2.77

7.69

3.7

2.8

3.30

3.16

g/l

0.38

127

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

222

1489

1.51

7.68

1.9

2.3

3.12

3.04

g/l

0.61

174

1186

Other and unspecified injuries of lower leg

117

673

1.77

7.66

2.1

2.4

3.10

3.14

g/l

0.12

532

Fracture of neck

119

690

1.77

7.65

3.3

2.4

2.99

3.12

g/l

0.78

552

Carcinoma in situ of skin of trunk

377

2.07

7.63

2.7

2.4

3.40

3.19

g/l

0.88

295

Chronic conjunctivitis

276

2.24

7.60

2.3

2.2

2.97

3.15

g/l

0.80

211

Disorders of oesophagus in diseases classified elsewhere

220

2.42

7.57

3.7

2.6

3.42

3.19

g/l

0.63

173

Blepharochalasis

559

4372

1.29

7.57

2.0

2.4

3.07

3.12

g/l

0.51

423

3351

Superficial injury of shoulder and upper arm

183

1185

1.57

7.52

2.1

2.3

2.93

3.11

g/l

1.44

143

938

Disease of hard tissues of teeth, NOS

3.50

7.52

6.7

1.6

3.47

2.99

g/l

0.90

Disorders of optic nerve and visual pathways

154

958

1.63

7.52

2.2

2.5

3.25

3.08

g/l

1.19

117

760

Menorrhagia

574

2462

1.30

7.52

1.9

2.1

2.94

3.15

g/l

4.05

397

1917

Carcinoma in situ of other and unspecified digestive organs

272

2.26

7.50

2.2

1.4

3.22

3.08

g/l

0.49

214

Visual impairment including blindness (binocular or monocular)

129

769

1.71

7.48

2.2

2.1

3.10

3.17

g/l

0.24

594

Other congenital malformations

115

662

1.76

7.47

1.7

2.3

3.12

3.11

g/l

0.04

522

Other disorders of bladder

230

1568

1.49

7.45

2.1

2.4

3.14

3.03

g/l

0.83

171

1211

Chondrocostal junction syndrome [Tietze]

372

2.05

7.44

2.1

3.06

3.13

g/l

0.28

295

Listeriosis

4.72

7.44

3.2

1.6

3.56

3.24

g/l

0.47

Bacterial, viral and other infectious agents

131

785

1.69

7.40

3.0

2.2

3.13

3.07

g/l

0.26

108

633

Emotional disorders starting during childhood or adolecense, excluding more controls

3.09

7.39

1.1

1.5

2.95

3.12

g/l

0.61

Superficial injury of wrist and hand

278

1962

1.43

7.39

1.8

2.2

2.98

3.07

g/l

0.95

219

1558

Dermatopolymyositis, unspecified

4.28

7.38

6.3

2.6

3.07

2.94

g/l

0.27

Superficial injury of ankle and foot

155

969

1.62

7.38

1.8

2.2

2.98

3.10

g/l

0.76

118

770

Other/unspecified disorders of vestibular function

444

1.95

7.34

1.8

2.5

3.15

3.17

g/l

0.07

351

Acute peritonitis

123

728

1.73

7.34

2.3

2.5

3.36

3.09

g/l

1.88

582

Other and unspecified rosacea

151

942

1.63

7.33

1.9

2.5

3.02

3.07

g/l

0.22

115

749

Trigger finger

230

1571

1.48

7.33

1.6

2.2

2.97

3.10

g/l

1.24

186

1240

Benign neoplasm: Parathyroid gland

106

3.10

7.31

2.7

1.3

2.54

3.07

g/l

1.46

Benign neoplasm: Pancreas

315

2.15

7.31

2.5

2.7

2.92

3.14

g/l

1.00

249

Other disorders of patella

231

1578

1.48

7.31

2.0

2.4

3.03

3.00

g/l

0.14

180

1241

Thyrotoxicosis with toxic multinodular goitre

126

754

1.71

7.26

1.7

2.4

3.31

3.13

g/l

1.08

581

Crohn disease

192

1266

1.53

7.26

1.6

2.3

3.17

3.08

g/l

0.63

147

1004

Follicular lymphoma, hilmo

547

1.85

7.25

1.4

2.9

3.27

3.16

g/l

0.50

429

Monoamine oxidase A inhibitors

211

1421

1.51

7.24

2.0

2.5

2.93

3.09

g/l

1.96

172

1109

Carcinoma in situ of skin of lower limb, including hip

251

2.31

7.24

3.1

2.5

3.00

3.22

g/l

1.05

193

Other psoriatic arthropathies

180

1173

1.56

7.23

1.8

2.4

3.25

3.09

g/l

1.00

135

929

Astigmatism

508

1.86

7.23

2.3

2.5

2.85

3.14

g/l

2.74

404

Endometriosis

541

2495

1.30

7.22

1.9

2.1

2.94

3.14

g/l

4.90

414

1946

Supplementary factors related to causes of morbidity and mortality classified elsewhere

489

3781

1.30

7.21

1.9

2.2

3.00

3.07

g/l

0.76

307

2970

Dipeptidyl peptidase 4 (DPP-4) inhibitors

242

1679

1.47

7.20

1.7

2.4

3.18

3.06

g/l

1.04

193

1312

Sulfonylureas

778

5058

1.24

7.20

1.9

2.4

3.16

3.09

g/l

1.03

608

3831

Cholecystitis

268

1893

1.43

7.18

2.2

2.3

3.13

3.11

g/l

0.09

192

1453

Anosmia

121

2.84

7.15

2.8

1.3

2.93

3.02

g/l

0.22

Inguinal hernia

1087

6150

1.20

7.15

2.6

2.2

3.00

3.08

g/l

1.88

857

4761

Other specified/unspecified hearing loss

162

1035

1.59

7.15

2.6

2.3

3.00

3.13

g/l

1.03

111

826

Cerebral cysts

511

1.86

7.14

1.6

2.3

2.89

3.11

g/l

0.98

416

Primary coxarthrosis, bilateral

572

4526

1.28

7.10

2.2

2.4

3.02

3.10

g/l

1.11

414

3444

Speech and linguistic disorders

434

1.90

7.09

1.7

1.9

3.09

3.15

g/l

0.16

347

Cluster headache, wide

310

2.11

7.09

1.8

2.7

2.76

3.12

g/l

3.21

253

Hemiplegia

549

1.82

7.09

1.6

2.3

2.93

3.12

g/l

1.35

435

993

0.44

7.08

1.2

2.4

3.21

3.08

g/l

0.42

778

Carcinoma in situ of skin of ear and external auricular canal

154

2.68

7.06

1.6

1.5

3.07

3.17

g/l

0.31

112

Respiratory disorders in diseases classified elsewhere

142

2.74

7.06

1.5

2.2

2.95

3.21

g/l

0.87

112

Hepatic failure, not elsewhere classified

373

2.01

7.05

1.5

2.7

3.02

3.12

g/l

0.37

294

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

401

1.98

7.04

2.1

2.6

3.09

3.15

g/l

0.26

321

Hypopituitarism

101

571

1.80

7.04

2.7

2.4

3.00

3.10

g/l

0.35

472

ILD and respiratory illness in diseases classified elsewhere

4.14

7.04

1.5

2.6

3.07

3.11

g/l

0.05

Benign neoplasm: Parotid gland

142

884

1.64

6.99

2.0

1.4

3.09

3.03

g/l

0.23

110

683

Impingement syndrome of shoulder

418

3180

1.33

6.98

2.5

2.4

3.03

3.06

g/l

0.26

286

2501

Other and/or unspecified nontoxic goitre

161

1034

1.59

6.96

2.3

3.01

3.13

g/l

0.75

137

803

Suggestive for eosinophilic asthma

172

1121

1.56

6.95

2.3

2.4

3.02

3.07

g/l

0.32

142

885

Benign neoplasm: Skin of eyelid, including canthus

265

1881

1.43

6.93

3.1

1.4

2.94

3.07

g/l

1.32

201

1432

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.36

6.92

1.8

2.2

3.20

3.25

g/l

0.07

Urolithiasis

605

4832

1.26

6.91

2.0

2.3

3.06

3.07

g/l

0.03

490

3757

Unspecified lump in breast

266

1891

1.42

6.88

1.9

2.3

3.01

3.13

g/l

1.05

211

1448

Benign neoplasm: Small intestine

455

1.90

6.85

2.5

1.4

3.25

3.08

g/l

0.84

356

Monoarthritis, not elsewhere classified

390

1.96

6.85

1.6

2.4

3.09

3.03

g/l

0.19

296

Melanocytic naevi of lower limb, including hip

405

1.95

6.82

2.4

3.09

3.10

g/l

0.04

326

Mental and behavioural disorders due to use of other stimulants, including caffeine

132

2.70

6.78

1.1

1.5

3.13

2.95

g/l

0.45

110

Erythema multiforme

218

2.32

6.78

1.7

2.4

3.02

3.12

g/l

0.30

173

Fentanyl

172

1126

1.55

6.76

6.7

1.7

3.21

3.09

g/l

0.67

115

844

COPD, hospital admissions 1, only main diagnosis

701

4849

1.24

6.76

1.9

2.4

3.31

3.08

g/l

7.68

542

3735

Retinal detachment with retinal break

247

1741

1.44

6.75

2.5

2.4

3.08

3.06

g/l

0.11

192

1353

Hyperkinetic disorders, excluding more controls

332

2.01

6.74

1.4

1.7

2.75

3.00

g/l

1.34

266

Suicide or other Intentional self-harm

349

2599

1.35

6.74

2.0

2.2

3.07

3.05

g/l

0.21

267

2070

Other abnormal uterine and vaginal bleeding

398

2143

1.34

6.72

2.1

2.2

3.07

3.18

g/l

0.97

242

1655

Crohn's disease NAS

101

581

1.77

6.67

1.9

2.4

3.09

3.08

g/l

0.03

463

Seborrhoeic dermatitis

164

1068

1.56

6.65

2.3

2.5

2.88

3.10

g/l

2.29

125

849

Acute generalized exanthematous pustulosis

466

1.87

6.65

3.7

2.7

3.16

3.15

g/l

0.02

368

Follow-up examination after treatment for malignant neoplasms

178

1180

1.53

6.64

2.3

2.1

3.16

g/l

0.01

134

935

Panniculitis affecting regions of neck and back

360

1.99

6.62

1.8

2.0

2.99

3.12

g/l

0.54

287

Procreative management

409

2626

1.32

6.62

1.7

2.1

3.05

3.03

g/l

0.09

332

2104

Bronchitis, not specified as acute or chronic

152

974

1.58

6.61

1.9

2.4

3.05

3.07

g/l

0.05

112

749

Other disorders of optic [2nd] nerve and visual pathways

108

636

1.73

6.60

2.3

2.7

3.30

3.09

g/l

1.14

510

Crushed, pushed or stepped on by crowd or human stampede

524

1.80

6.57

2.7

2.2

3.04

3.12

g/l

0.32

422

Erythema nodosum

300

2.09

6.57

3.2

2.1

3.12

3.14

g/l

0.05

244

Myasthenia gravis

178

2.46

6.54

1.3

2.4

3.21

3.17

g/l

0.08

136

Disorders of synovium and tendon in diseases classified elsewhere

190

2.40

6.53

1.6

1.9

3.24

3.15

g/l

0.20

151

Melanoma in situ

463

1.87

6.51

2.4

1.4

3.14

g/l

0.01

362

Benign neoplasm: Duodenum

275

2.15

6.51

2.8

1.4

3.24

3.09

g/l

0.49

212

Any event in hilmo or specialist outpatient

11.91

6.50

3.2

1.8

3.17

3.15

g/l

—

Polycythaemia vera

378

1.96

6.47

2.8

1.4

3.25

3.09

g/l

0.55

287

Other bursitis of elbow

3.36

6.46

1.4

2.0

3.82

3.07

g/l

1.45

Disorders of psychological development

104

561

1.73

6.45

1.6

1.8

3.06

3.11

g/l

0.18

448

Other orthopaedic follow-up care

101

588

1.75

6.44

1.8

2.0

3.04

g/l

0.02

476

Parodontitis, under 40 years

369

1.94

6.42

1.3

1.4

3.26

3.00

g/l

1.11

292

Childhood asthma (age<16), excluding more controls

401

1.81

6.42

1.4

2.91

2.90

g/l

0.01

331

Postprocedural disorders of nervous system

528

1.78

6.42

2.2

2.0

2.77

3.13

g/l

2.94

430

Superficial injury of forearm

138

871

1.60

6.40

1.7

2.2

2.96

3.12

g/l

1.23

108

698

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

3.74

6.39

10.2

2.5

3.21

3.23

g/l

0.03

Abscess of anal and rectal regions

128

794

1.63

6.38

1.2

2.2

3.19

3.03

g/l

1.01

108

642

Parkinson's disease, strict definition, excluding more controls

235

1626

1.44

6.38

1.9

2.3

3.05

3.23

g/l

1.78

179

1273

Atypical facial pain

524

1.79

6.35

1.9

2.4

3.12

g/l

0.02

404

Squamous cell neoplasms and carcinomas of the skin

254

1822

1.42

6.34

2.5

2.4

3.14

3.13

g/l

0.06

200

1399

Parodontitis, under 40 years, or operation codes

371

1.93

6.33

1.3

1.4

3.26

2.99

g/l

1.12

294

Disorders of breast

743

5669

1.22

6.31

2.0

2.2

3.02

3.08

g/l

0.81

557

4350

Secondary thrombocytopenia

121

2.78

6.31

3.2

1.6

3.48

3.15

g/l

0.72

Benign neoplasm: Descending colon

137

870

1.61

6.30

2.1

2.5

3.27

3.12

g/l

0.72

100

698

Coronary revascularization (ANGIO or CABG)

953

5589

1.20

6.30

1.9

2.4

3.22

3.08

g/l

3.64

754

4270

Unspecified/other endometriosis

113

681

1.68

6.29

1.9

2.85

3.13

g/l

2.13

527

Melanocytic naevi

448

3492

1.29

6.28

2.3

2.2

2.99

3.05

g/l

0.74

366

2720

Acute bronchiolitis

223

2.16

6.27

6.3

1.9

3.10

3.11

g/l

0.04

184

Benign neoplasm: Parathyroid gland

116

2.83

6.26

2.7

1.9

2.54

3.19

g/l

1.91

Type of accident

451

3520

1.29

6.26

1.9

2.2

3.02

3.08

g/l

0.51

275

2751

Abscess of lung

139

2.62

6.24

1.4

2.4

3.51

3.11

g/l

1.06

110

IBD patients in KELA-register

334

2502

1.35

6.24

2.3

2.2

3.15

3.04

g/l

1.14

262

1986

Malignant neoplasm of kidney, except renal pelvis

181

1223

1.51

6.24

1.8

2.5

3.36

3.11

g/l

2.27

137

967

Melanoma in situ of other and unspecified parts of face

128

2.74

6.24

2.3

1.3

3.12

3.04

g/l

0.12

Other specified and unspecified retinal disorders

383

1.93

6.24

2.4

2.6

3.16

3.14

g/l

0.06

308

Injuries to the wrist and hand

1701

10834

1.14

6.23

2.1

2.3

3.02

3.05

g/l

0.59

1339

8415

Other chondrocalcinosis

146

2.61

6.23

1.6

2.3

3.64

3.22

g/l

1.18

114

Hidradenitis suppurativa

245

2.17

6.23

1.3

2.0

3.17

3.14

g/l

0.08

197

Chronic hepatitis, not elsewhere classified

341

1.99

6.21

1.5

2.7

3.08

g/l

0.01

276

Drug-induced adrenocortical insufficiency

176

2.43

6.21

3.3

2.1

2.86

3.17

g/l

0.88

142

Disorders of refraction and accommodation

358

2700

1.33

6.21

2.0

2.2

2.99

3.06

g/l

0.67

287

2116

Parkinson's disease, excluding more controls

251

1755

1.41

6.20

2.0

2.3

3.08

3.22

g/l

1.24

191

1376

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

507

1.80

6.19

1.6

1.4

3.42

3.06

g/l

1.93

406

Childhood asthma (age<16)

406

1.79

6.19

1.4

1.3

2.91

2.90

g/l

0.01

337

Arterial embolism and thrombosis

113

686

1.68

6.19

1.4

2.5

3.38

3.11

g/l

1.68

539

Other/unspecified synovitis and tenosynovitis

184

1247

1.49

6.18

1.9

2.2

3.08

3.10

g/l

0.07

138

978

Wet age-related macular degeneration

352

2618

1.34

6.18

2.4

2.2

3.19

3.14

g/l

0.34

262

1979

Liver disorders in diseases classified elsewhere

5.77

6.17

2.2

1.2

3.24

3.23

g/l

0.01

Other and unspecified disorders of vitreous body

757

6238

1.22

6.16

2.3

2.4

2.96

3.09

g/l

2.89

587

4810

Pneumothorax

128

804

1.62

6.13

2.5

2.3

3.07

3.06

g/l

0.06

105

640

Bell's palsy

195

1340

1.47

6.13

2.4

2.2

2.89

3.10

g/l

2.48

147

1058

Otalgia

125

781

1.63

6.10

2.1

2.4

2.89

3.15

g/l

2.48

615

Nontoxic goitre/thyroid nodule

533

4262

1.26

6.09

2.2

2.3

3.04

3.11

g/l

0.75

403

3251

Cardiac murmurs and other cardiac sounds

126

778

1.62

6.09

2.7

2.2

3.18

3.14

g/l

0.14

100

599

Coxarthrosis, primary, with hip surgery

924

7394

1.19

6.09

2.1

2.4

3.08

3.10

g/l

0.16

695

5679

Dermatophytosis

231

1641

1.43

6.09

2.4

2.3

3.09

3.07

g/l

0.10

173

1277

Somnolence

106

2.85

6.07

1.6

2.0

3.14

3.09

g/l

0.10

Benign neoplasm: Other and unspecified parts of mouth

387

1.91

6.06

3.0

2.7

3.19

3.13

g/l

0.16

302

Hodgkin lymphoma, hilmo

262

2.12

6.05

1.3

2.7

3.45

3.11

g/l

1.17

214

Tinnitus

410

3182

1.30

6.00

2.3

2.92

3.10

g/l

3.33

324

2518

Parodontitis, under 40 years and operation codes

343

1.94

6.00

1.3

1.4

3.24

3.01

g/l

0.91

277

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

154

2299

0.66

5.99

1.9

1.4

3.15

3.05

g/l

0.54

112

1763

Benign neoplasm of breast

189

1297

1.48

5.99

2.3

1.5

3.03

3.08

g/l

0.24

141

982

Bulimia nervosa (incl. atypical)

153

2.46

5.98

1.2

1.7

3.20

3.08

g/l

0.28

133

Oral leukoplakia and related diseases

111

679

1.67

5.96

1.9

2.5

3.19

3.14

g/l

0.19

540

Congenital malformations of the circulatory system

198

1327

1.46

5.96

1.7

2.3

3.01

3.09

g/l

0.52

155

1057

Parodontitis, operation under 40 years and operation codes

344

1.93

5.95

1.3

1.4

3.24

3.00

g/l

0.92

278

Drug-induced neutropenia

133

850

1.59

5.95

3.0

2.6

3.39

3.08

g/l

2.03

107

665

Testicular dysfunction

277

2.07

5.94

1.4

2.6

3.02

3.08

g/l

0.17

221

Intracranial and intraspinal abscess and granuloma

102

2.88

5.93

4.0

3.0

3.10

3.16

g/l

0.09

Malignant neoplasm of urinary organs

193

1336

1.47

5.91

1.8

2.4

3.33

3.10

g/l

2.10

147

1050

Benign paroxysmal vertigo

511

4084

1.26

5.89

2.0

2.3

2.95

3.11

g/l

2.94

375

3147

Vitamin D deficiency

143

2.53

5.88

1.3

2.1

3.00

3.03

g/l

0.07

114

Benign neoplasm: Oesophagus

114

2.76

5.87

1.2

1.3

3.14

3.11

g/l

0.05

Inflammatory disease of uterus

184

1260

1.47

5.87

1.7

2.2

3.11

3.07

g/l

0.26

139

989

Assault

155

1025

1.53

5.85

1.7

2.2

3.21

3.06

g/l

0.77

121

823

Carcinoma in situ of colon

138

2.59

5.85

2.7

1.3

3.59

3.14

g/l

1.52

103

Pustulosis palmaris et plantaris

464

1.81

5.84

2.0

2.5

3.26

3.11

g/l

0.64

368

Injury of eye and orbit

206

1443

1.44

5.84

1.8

2.2

3.07

3.06

g/l

0.05

154

1151

Pustular psoriasis

516

1.76

5.83

1.9

2.4

3.24

3.11

g/l

0.50

405

Other eating disorders

238

2.13

5.82

1.3

1.7

2.94

3.06

g/l

0.36

201

Adenomyosis (Endometriosis of uterus)

229

1638

1.41

5.80

2.2

2.97

3.19

g/l

3.07

185

1277

Carcinoma in situ of other and unspecified digestive organs

302

2.03

5.79

2.2

2.9

3.22

3.17

g/l

0.16

230

Carrier of infectious disease

207

2.24

5.79

1.2

1.8

2.80

3.14

g/l

1.54

168

Lichen ruber planus, wide definition including periferal and oral lichen planus

363

2788

1.32

5.78

2.4

2.3

2.94

3.09

g/l

2.25

283

2161

Pneumonia due to Streptococcus pneumoniae

385

1.88

5.78

5.3

2.0

3.20

3.02

g/l

0.62

298

Open wound of abdomen, lower back and pelvis

233

2.15

5.77

1.8

2.2

3.08

3.13

g/l

0.10

188

Other and unspecified haemorrhagic conditions

157

2.45

5.77

5.0

2.1

3.38

3.20

g/l

0.49

123

Plantar fascial fibromatosis

154

1023

1.52

5.75

2.5

2.2

2.87

3.12

g/l

2.81

120

805

Other obstetric conditions, not elsewhere classified

265

1247

1.39

5.75

1.5

1.7

2.88

2.91

g/l

0.23

214

999

Other and unspecified psoriasis

121

763

1.62

5.74

2.1

2.5

3.00

3.08

g/l

0.37

605

Unspecified visual impairment (binocular)

139

2.54

5.74

1.7

1.9

2.80

3.15

g/l

1.58

106

Disorders of speech understanding and production

242

2.10

5.71

1.9

2.3

3.31

3.25

g/l

0.13

189

Psychotic depression

563

1.71

5.70

1.7

2.8

3.00

3.10

g/l

0.32

445

Viral and other specified intestinal infections

228

1592

1.41

5.70

1.9

2.0

3.08

g/l

0.04

173

1259

Entropion and trichiasis of eyelid

173

1183

1.49

5.67

2.3

2.5

3.06

3.13

g/l

0.39

134

916

Right bundle-branch block

374

1.89

5.66

3.1

2.2

3.23

3.12

g/l

0.45

296

Other disorders of penis

158

1060

1.51

5.65

1.6

2.3

2.93

3.07

g/l

0.90

123

848

Other symptoms and signs involving the digestive system and abdomen

262

1925

1.37

5.64

1.9

2.3

3.01

3.13

g/l

0.74

142

1506

Other and unspecified nerve root and plexus disorders, also in other diseases

295

2208

1.35

5.63

2.6

2.2

2.93

3.07

g/l

1.68

195

1758

Other and unspecified vascular occlusions

184

1275

1.47

5.62

2.5

3.26

3.12

g/l

0.89

140

994

Palmar fascial fibromatosis [Dupuytren]

290

2167

1.35

5.62

2.4

2.3

2.99

3.09

g/l

1.11

220

1683

Lumbosacral root disorders, not elsewhere classified

117

2.68

5.59

2.5

2.1

3.00

3.05

g/l

0.07

Psoriasis (vulgaris), strict definition

291

2.01

5.58

1.4

2.5

2.99

3.06

g/l

0.19

237

Carcinoma in situ of skin of ear and external auricular canal

173

2.37

5.57

1.6

2.3

3.07

g/l

0.01

125

Other specified/unspecified spondylopathies

278

2.04

5.57

3.0

2.0

3.18

3.21

g/l

0.07

217

Specific development disorders of speech and language

312

1.94

5.56

1.9

2.1

3.22

g/l

0.01

244

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

111

2.69

5.55

4.9

1.6

2.81

3.06

g/l

1.02

Aspergillosis

2.92

5.54

2.5

1.5

3.48

3.18

g/l

0.65

Seborrhoeic keratosis

403

3158

1.29

5.53

2.5

2.3

3.06

3.07

g/l

0.06

306

2407

Use of donepezil

221

2928

0.72

5.52

1.9

2.3

2.93

3.17

g/l

2.38

146

2209

Triptan medication for migraine, min. 3 purchases

703

4597

1.21

5.52

2.2

2.1

2.88

3.02

g/l

3.41

560

3621

Amenorrhoea

434

1.79

5.49

2.0

1.9

3.01

3.13

g/l

0.54

347

Varicose veins

1177

7701

1.16

5.49

2.4

2.3

3.09

3.06

g/l

0.50

844

5938

Other and unspecified tonsillitis

383

2520

1.29

5.48

1.8

2.0

3.07

3.01

g/l

0.53

314

2053

Benign neoplasm: Pituitary gland, craniopharyngeal duct

466

1.77

5.45

2.9

1.4

2.81

3.00

g/l

1.19

370

Other benign neoplasms of skin

656

5431

1.22

5.43

3.0

2.3

2.97

3.09

g/l

2.15

491

4175

Event of undetermined intent

541

1.71

5.43

2.0

2.3

3.13

3.08

g/l

0.17

434

Congenital malformations of cardiac septa

515

1.71

5.42

1.7

2.3

3.09

3.08

g/l

0.03

408

Cardiac arrest

103

542

1.66

5.42

2.2

2.3

3.30

2.92

g/l

2.62

402

Inflammatory bowel disease, strict (require KELA)

334

2559

1.31

5.40

2.3

2.2

3.15

3.05

g/l

0.91

262

2038

Melanocytic naevi of trunk

182

1267

1.45

5.40

2.2

2.3

2.91

3.10

g/l

2.08

146

1012

Lactose intolerance

260

2.04

5.39

1.4

1.7

2.89

3.17

g/l

1.69

214

Unspecified urinary incontinence

158

1072

1.50

5.39

1.3

2.3

3.11

3.13

g/l

0.06

825

Benign neoplasm: salivary glands, exclude unknown (D119)

159

1081

1.49

5.37

1.9

2.5

3.11

3.09

g/l

0.08

122

859

Chondropathies

232

1686

1.39

5.37

2.0

2.2

3.10

3.08

g/l

0.08

173

1343

Other/unspecified soft tissue disorders related to use, overuse and pressure

247

2.07

5.37

2.2

2.0

2.85

3.22

g/l

2.21

188

Bursitis of shoulder

234

2.11

5.36

2.5

1.9

3.09

3.21

g/l

0.40

176

Complications of cardiac and vascular prosthetic devices, implants and grafts

235

2.12

5.34

1.8

2.7

3.46

3.13

g/l

1.37

178

Ganglion

294

2216

1.34

5.34

2.1

2.2

2.82

3.07

g/l

4.52

217

1739

Iridocyclitis in diseases classified elsewhere

169

2.32

5.34

1.9

2.4

3.19

3.23

g/l

0.08

135

Alcohol abuse, main dg

232

1689

1.39

5.31

1.2

2.3

3.06

3.07

g/l

0.01

183

1355

Thyroiditis

117

746

1.59

5.31

2.3

2.4

2.96

3.13

g/l

0.94

584

Other acute viral hepatitis

2.85

5.29

2.2

1.9

3.26

3.08

g/l

0.36

Thrombotic microangiopathy

3.68

5.29

4.8

1.4

3.06

3.10

g/l

0.06

Irregular menses

599

3984

1.22

5.28

2.2

2.1

3.00

3.02

g/l

0.20

455

3163

Operations for atrial fibrillation

177

2.31

5.28

1.3

3.2

3.47

3.20

g/l

0.72

143

Diseases of tongue

108

677

1.62

5.27

2.5

2.0

2.79

3.08

g/l

2.06

531

Vulvovaginal ulceration/inflammation in other diseases

411

1.80

5.27

1.7

2.0

2.96

3.13

g/l

0.91

330

Other and unspecified nonorganic psychotic disorders

244

1792

1.37

5.27

1.5

2.3

3.12

3.07

g/l

0.46

177

1425

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

252

1194

1.38

5.26

1.4

1.7

2.89

2.90

g/l

0.09

204

960

Shock, not elsewhere classified

3.07

5.24

3.5

2.1

3.12

3.08

g/l

0.04

Alcohol dependence

462

3703

1.26

5.24

1.5

2.5

3.14

3.03

g/l

1.57

360

2913

Other epidermal thickening

450

1.77

5.24

2.0

2.6

2.96

3.10

g/l

0.54

358

Enteropathic arthropathies

170

2.29

5.23

1.5

2.2

2.87

3.05

g/l

0.50

127

Fracture at wrist and hand level

514

4164

1.24

5.23

2.3

3.05

3.06

g/l

0.08

404

3267

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

248

1832

1.37

5.23

2.3

1.5

3.05

3.04

g/l

0.04

183

1407

Autoimmune hyperthyroidism

525

1.70

5.19

1.9

2.6

3.02

3.05

g/l

0.10

418

Benign neoplasm of major salivary glands

179

1254

1.45

5.19

1.9

2.4

3.11

3.10

g/l

0.04

139

982

Acne

516

1.70

5.18

2.0

1.6

3.16

3.06

g/l

0.35

413

Other and unspecified follicular disorders

356

1.86

5.18

3.1

2.5

2.92

3.09

g/l

0.65

295

Deficiency of other B group vitamins

231

2.10

5.17

3.7

2.0

3.16

3.07

g/l

0.26

187

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

452

1.76

5.17

4.1

1.4

3.41

3.09

g/l

1.34

361

Golimumab

237

2.07

5.16

1.3

1.7

3.40

3.07

g/l

1.18

201

Viral agents as the cause of diseases classified to other chapters

191

2.21

5.15

2.7

2.0

2.89

3.12

g/l

1.17

150

Otitis externa, unspecified

159

1089

1.48

5.15

1.9

2.4

3.01

3.09

g/l

0.36

117

862

Attention to artificial openings

423

1.79

5.15

2.3

2.1

3.45

3.00

g/l

3.85

349

Vascular diseases of the intestine

446

1.77

5.12

3.0

2.4

3.45

3.15

g/l

1.46

358

Type 1 diabetes, definitions combined

105

655

1.61

5.11

2.0

2.94

3.06

g/l

0.52

538

Generalized skin eruption due to drugs and medicaments

409

1.80

5.11

3.8

2.5

3.20

3.17

g/l

0.11

325

Testicular hypofunction

245

2.04

5.10

1.5

2.7

2.93

3.08

g/l

0.48

193

Benign neoplasm: Duodenum

302

1.95

5.10

2.8

2.7

3.24

3.15

g/l

0.27

238

Other bursitis of hip

192

2.20

5.10

2.0

1.7

3.08

3.17

g/l

0.23

145

Other keratitis

162

1117

1.47

5.07

2.0

2.3

3.01

3.10

g/l

0.51

127

884

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

589

1.65

5.07

1.9

2.3

3.10

3.07

g/l

0.09

459

Other and specified injuries of hip and thigh

226

2.10

5.07

1.4

2.2

3.06

3.31

g/l

0.63

180

Urethral stricture

110

701

1.60

5.05

2.1

2.5

3.09

3.02

g/l

0.28

547

Other noninflammatory disorders of vulva and perineum

131

866

1.53

5.05

1.5

2.1

3.05

3.17

g/l

0.72

669

Cachexia

3.90

5.04

2.3

1.5

3.06

3.29

g/l

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

2.79

5.04

1.2

1.3

2.70

3.09

g/l

1.48

Other maltreatment syndromes

219

2.09

5.03

1.5

3.50

3.07

g/l

1.37

171

Other deformities of toe(s)

360

1.85

5.02

1.8

2.2

3.13

3.08

g/l

0.10

273

Nail disorders

127

836

1.54

5.01

1.7

2.4

3.11

3.08

g/l

0.14

663

Atypical mycobacterium lung infection

124

2.53

5.01

1.7

2.0

3.52

3.26

g/l

0.70

Benign neoplasm: Oesophagus

124

2.53

5.01

1.2

2.3

3.14

3.17

g/l

0.05

Type 1 diabetes, strict (exclude DM2)

104

651

1.61

5.00

2.0

2.95

3.06

g/l

0.51

535

Visual field defects

152

1040

1.48

5.00

2.2

2.3

3.12

g/l

0.00

115

823

Pulmonary oedema

194

2.19

4.99

1.6

2.3

3.37

3.21

g/l

0.55

146

Alzheimer’s disease (undefined)

123

0.00

4.98

0.0

2.0

—

3.20

—

Benign neoplasm: Parotid gland

142

960

1.50

4.97

2.0

2.5

3.09

3.10

g/l

0.05

110

766

Type1 diabetes, definitions combined, early onset

301

1.90

4.96

1.4

1.5

2.92

3.05

g/l

0.39

247

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

167

2.25

4.95

1.7

1.8

3.28

3.06

g/l

0.69

138

Unspecific neurodegenerative disorder

603

5007

0.82

4.95

2.0

2.3

3.14

3.12

g/l

0.11

401

3808

Recurrent dislocation and subluxation of joint

494

1.70

4.94

2.0

2.3

3.17

3.05

g/l

0.42

387

Emergency coronary revascularization (for ACS)

1108

6924

1.16

4.91

1.9

2.4

3.20

3.08

g/l

3.08

867

5291

Biological medicines for asthma

107

2.61

4.88

1.7

1.8

2.86

3.05

g/l

0.44

Obsessive-compulsive disorder

333

1.85

4.87

2.1

3.05

3.10

g/l

0.18

279

Melanoma in situ

507

1.70

4.86

2.4

2.7

3.14

3.15

g/l

0.03

400

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

226

1664

1.37

4.86

2.5

2.3

3.11

3.07

g/l

0.18

181

1313

Other symptoms and signs involving general sensations and perceptions

364

1.82

4.85

2.5

2.7

2.94

3.17

g/l

1.23

295

Iron deficiency

119

2.49

4.84

2.3

2.1

3.00

3.05

g/l

0.10

103

Benign neoplasm: Spinal meninges

108

2.63

4.84

1.3

3.09

2.97

g/l

0.13

Benign neoplasm: Small intestine

508

1.70

4.82

2.5

2.7

3.25

3.17

g/l

0.30

397

Ulcerative colitis (strict definition, all Crohn cases excluded)

202

1463

1.39

4.82

2.8

2.3

3.12

3.09

g/l

0.16

159

1166

Other aneurysm

104

663

1.60

4.80

2.0

2.5

3.32

3.07

g/l

1.34

529

Nail dystrophy

3.20

4.80

1.4

2.4

3.38

3.21

g/l

0.22

Coronary artery bypass grafting

574

3611

1.22

4.77

1.6

2.4

3.32

3.08

g/l

6.60

453

2762

Chronic myeloid leukaemia

3.63

4.76

1.6

2.7

3.36

3.07

g/l

—

Benign neoplasm: Skin of ear and external auricular canal

426

1.75

4.75

2.2

1.4

2.98

3.08

g/l

0.49

336

Congenital malformations and deformations of the musculoskeletal system

604

1.61

4.75

1.4

2.0

3.02

3.09

g/l

0.27

487

Alzheimer disease

404

3797

0.80

4.74

1.9

2.2

3.21

3.15

g/l

0.49

265

2872

Benign neoplasm of urinary organs

510

1.68

4.72

2.1

1.4

3.00

3.09

g/l

0.38

396

Ulcerative colitis (strict definition, require KELA)

232

1724

1.36

4.71

2.6

2.2

3.10

3.08

g/l

0.11

186

1363

Cluster headache, strict, including avohilmo

404

1.76

4.70

1.7

2.3

2.77

3.06

g/l

2.62

325

Spontaneous abortion

429

3622

0.80

4.70

1.9

2.3

2.91

3.05

g/l

2.32

333

2788

Extreme obesity with alveolar hypoventilation

435

1.74

4.70

1.6

2.7

3.36

3.05

g/l

2.32

345

Perineal laceration during delivery

905

0.56

4.69

1.6

2.55

2.98

g/l

4.88

733

Ectropion of eyelid

497

1.69

4.67

1.5

2.4

3.11

3.20

g/l

0.37

369

Hyphaema and other vascular disorders of iris and ciliary body

186

2.16

4.67

2.2

2.9

3.28

3.14

g/l

0.29

148

Other otitis externa (chronic)

109

707

1.57

4.65

2.6

2.5

3.25

3.09

g/l

0.70

556

Acidosis

207

2.10

4.63

2.0

2.2

3.31

3.22

g/l

0.21

166

Abnormal findings on diagnostic imaging of central nervous system

415

1.74

4.59

2.5

2.7

3.08

3.13

g/l

0.16

335

Diffuse brain injury

276

1.91

4.58

2.5

2.0

3.20

g/l

0.02

224

Other superficial mycoses

174

2.18

4.57

1.9

2.4

2.74

3.08

g/l

1.44

142

Ankylosing spondylitis, strict definition

356

1.80

4.56

1.5

2.4

3.12

3.01

g/l

0.38

285

Disorders of optic nerve, not elsewhere classified

229

2.03

4.56

2.4

3.0

3.19

3.14

g/l

0.11

181

Other or ill-defined heart diseases

476

1.68

4.54

1.6

2.0

3.28

3.08

g/l

0.79

376

Focal brain injury

623

1.59

4.54

2.0

2.3

3.20

3.15

g/l

0.21

492

Third [oculomotor] nerve palsy

202

2.10

4.54

1.7

2.9

2.89

3.18

g/l

1.08

158

Exposure to other and unspecified animate mechanical forces

201

2.08

4.53

3.0

1.8

3.08

3.13

g/l

0.09

167

Pediculosis, acariasis and other infestations

492

1.67

4.53

1.9

2.2

3.03

3.10

g/l

0.24

399

Lichen planus, including avohilmo

308

2399

1.30

4.53

2.5

2.3

2.92

3.10

g/l

2.57

241

1863

Drug-induced hypoglycaemia without coma

149

2.29

4.52

1.3

2.9

3.34

3.16

g/l

0.33

121

Papilloedema, unspecified

175

2.17

4.51

1.2

2.4

3.48

3.08

g/l

0.90

141

Other disorders of cornea

155

1088

1.44

4.49

2.0

2.3

3.08

g/l

0.00

117

856

Other other unspecified disorders of the circulatory system

411

1.74

4.49

1.8

2.6

3.18

3.11

g/l

0.19

321

Localized scleroderma [morphea]

144

2.30

4.44

1.8

3.03

3.14

g/l

0.34

120

Leiomyoma of uterus

669

3166

1.20

4.43

2.2

1.4

3.03

3.01

g/l

0.12

496

2456

Duodenal ulcer

199

1464

1.37

4.39

1.7

2.5

3.24

3.10

g/l

1.10

160

1147

Other congenital malformations of skin

346

1.79

4.38

1.9

2.4

3.12

3.13

g/l

0.01

276

severe traumatic brain injury, does not include concussion

390

3138

1.25

4.37

2.4

2.2

3.18

3.09

g/l

1.03

287

2421

Clear cell adenocarcinoma of kidney

561

1.62

4.37

1.6

2.8

3.42

3.10

g/l

1.58

449

Open wound of hip and thigh

274

1.90

4.37

1.3

2.6

3.21

3.08

g/l

0.35

219

Cluster headache, wide,, including avohilmo

436

1.70

4.37

1.7

2.3

2.76

3.06

g/l

2.96

351

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

251

1911

1.32

4.35

2.5

2.2

3.09

3.08

g/l

0.05

202

1509

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.62

4.32

1.5

1.3

3.29

3.06

g/l

0.46

Post-traumatic wound infection, not elsewhere classified

226

1.99

4.32

1.7

2.4

3.12

3.04

g/l

0.19

181

Other salmonella infections

378

1.75

4.31

2.5

2.1

3.07

3.09

g/l

0.05

292

Other disorders of iris and ciliary body

276

1.89

4.31

2.3

2.7

3.25

3.11

g/l

0.37

216

Status epilepticus

341

1.79

4.30

1.7

2.6

2.96

3.25

g/l

1.20

276

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

384

3089

1.25

4.28

1.7

2.2

3.04

3.05

g/l

0.10

305

2439

Benign neoplasm: Kidney

357

1.78

4.28

2.2

1.5

3.07

g/l

0.01

273

Lung cancer and mesothelioma

326

2199

1.28

4.26

2.1

1.9

3.45

2.97

g/l

13.43

268

1687

Lactose intolerance, other/unspecified

234

1.96

4.26

1.4

1.7

2.92

3.14

g/l

1.03

189

Disorder of external ear, unspecified

328

1.81

4.25

2.5

3.13

3.14

g/l

0.03

262

Pure hyperglyceridaemia

214

2.01

4.24

1.9

2.3

3.03

3.19

g/l

0.45

179

Presence of other devices

424

3454

1.24

4.23

2.5

2.3

2.72

3.13

g/l

11.49

289

2666

Other condition

199

1472

1.36

4.23

2.2

2.3

3.06

3.11

g/l

0.25

136

1175

Other noninfective disorders of lymphatic vessels and lymph nodes

358

1.77

4.23

1.6

2.4

3.33

3.11

g/l

0.72

283

Carcinoma in situ of colon

161

2.21

4.22

2.7

2.1

3.59

3.17

g/l

1.44

123

Acne vulgaris

379

1.73

4.21

2.0

1.7

3.07

3.05

g/l

0.06

315

Melanoma in situ of other and unspecified parts of face

155

2.24

4.21

2.3

2.6

3.12

3.17

g/l

0.08

122

Crohn's disease of small intestine

596

1.58

4.20

1.7

2.3

3.22

3.09

g/l

0.58

475

Other secondary coxarthrosis

374

1.75

4.20

1.5

2.4

3.11

3.15

g/l

0.11

300

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

303

2349

1.28

4.19

2.1

2.0

2.97

3.03

g/l

0.44

238

1863

Scleritis and episcleritis

597

1.58

4.19

1.7

2.2

2.95

3.07

g/l

0.54

474

Congenital iodine-deficiency syndrome/hypothyroidism

352

1.77

4.19

3.1

2.2

2.96

3.18

g/l

1.10

276

Other specified disorders of muscle

264

1.90

4.18

1.3

2.3

2.93

3.16

g/l

0.93

200

Ulcerative enterocolitis

271

1.88

4.18

1.8

2.4

3.29

3.10

g/l

0.50

210

Other surgical follow-up care

271

1.88

4.18

2.6

2.0

3.15

3.03

g/l

0.31

230

Other Crohn's disease

573

1.59

4.18

1.4

2.2

3.35

3.06

g/l

1.72

456

Postprocedural disorders of digestive system, not elsewhere classified

345

1.78

4.16

1.8

2.7

3.26

3.15

g/l

0.48

274

Salpingitis and oophoritis

268

2074

1.30

4.16

1.8

2.4

3.07

g/l

0.01

213

1609

Dislocation, sprain and strain of joints and ligaments at neck level

189

1390

1.37

4.16

2.4

2.3

2.97

3.05

g/l

0.62

148

1107

Malignant neoplasm of bronchus and lung

222

2731

0.75

4.15

2.1

2.3

3.47

3.08

g/l

6.95

183

2090

Benign neoplasm of eye and adnexa

159

1139

1.41

4.15

1.7

1.4

3.04

g/l

0.00

122

862

Oesophagitis

615

1.57

4.15

2.1

2.7

3.32

3.10

g/l

1.13

498

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

331

1.80

4.15

2.3

1.4

3.36

3.06

g/l

1.07

260

All dysplastic lesions of the cervix uteri, vagina or vulva

309

2417

1.28

4.15

2.2

2.0

3.00

2.99

g/l

0.09

246

1897

Thyrotoxicosis with diffuse goitre

201

1494

1.36

4.14

2.0

2.3

3.08

3.09

g/l

0.08

165

1172

Other retinal artery occlusion

273

1.89

4.14

2.1

2.8

3.08

3.17

g/l

0.25

219

Ulcerative proctitis

559

1.60

4.14

1.4

2.1

3.01

3.06

g/l

0.14

440

Benign neoplasm of meninges

165

1190

1.40

4.14

1.9

1.4

3.07

3.09

g/l

0.10

123

903

Benign neoplasm: Spinal meninges

117

2.42

4.13

1.3

1.9

3.09

3.27

g/l

0.21

Bicipital tendinitis

514

1.62

4.11

2.2

2.4

2.96

3.07

g/l

0.49

404

Noninflammatory disorders of female genital tract

611

2576

1.20

4.10

2.2

2.1

3.10

3.14

g/l

0.33

471

2010

Dental caries 2, only avohilmo

1116

7765

1.14

4.08

2.6

2.2

2.94

3.04

g/l

2.73

871

6087

Alzheimer’s disease (undefined), excluding more controls

101

0.00

4.07

0.0

1.7

—

3.43

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

135

853

1.45

4.06

1.4

1.6

2.84

3.02

g/l

1.66

106

685

Postprocedural musculoskeletal disorders, not elsewhere classified

126

870

1.47

4.06

2.1

2.6

3.19

3.09

g/l

0.36

684

Acute suppurative otitis media

256

1840

1.30

4.06

2.7

2.0

3.05

3.03

g/l

0.09

199

1480

Other and unspecified iridocyclitis

416

1.69

4.03

3.1

2.3

3.21

3.09

g/l

0.46

328

Achilles tendinitis

156

1119

1.41

4.03

2.6

2.2

2.94

3.11

g/l

1.38

118

911

Benign neoplasm: Pituitary gland, craniopharyngeal duct

509

1.62

4.02

2.9

2.5

2.81

3.10

g/l

2.20

405

Use of antiglaucoma preparations and miotics

156

1122

1.41

4.01

2.2

2.5

3.10

3.16

g/l

0.28

116

860

Alzheimer disease, including avohilmo

502

4338

0.83

3.97

2.0

2.3

3.17

3.13

g/l

0.32

348

3266

Injury of muscle and tendon at hip and thigh level

146

1039

1.42

3.97

2.1

2.3

2.99

3.06

g/l

0.39

112

830

Nystagmus and other irregular eye movements

106

2.43

3.96

1.7

2.3

3.25

3.12

g/l

0.23

Sleep disorders, other/unspecified

240

1.91

3.96

1.4

1.9

3.14

3.13

g/l

0.01

197

Nontoxic multinodular goitre

346

2782

1.25

3.96

1.9

2.4

3.13

3.14

g/l

0.04

242

2133

Subacute thyroiditis

373

1.72

3.95

2.8

2.2

2.83

3.11

g/l

1.60

292

Postzoster neuralgia

145

2.21

3.95

3.4

2.1

3.09

3.21

g/l

0.28

112

!Aliquae complicationes praecoces traumatis

396

1.70

3.93

2.6

2.4

3.33

3.06

g/l

1.02

324

Early complications of trauma

396

1.70

3.93

2.6

2.4

3.33

3.06

g/l

1.02

324

Allergic contact dermatitis

184

1361

1.36

3.93

1.4

2.4

3.08

3.09

g/l

0.02

144

1059

Corneal scars and opacities

263

1.87

3.93

1.7

2.7

3.15

3.22

g/l

0.14

207

Viral conjunctivitis

165

2.11

3.92

2.3

1.7

3.03

3.09

g/l

0.15

136

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

753

5062

1.17

3.91

2.1

1.5

3.23

3.06

g/l

3.92

573

3902

Other and unspecified trigeminal disorders

126

2.28

3.89

1.4

2.0

2.81

2.99

g/l

0.40

Other obstructive and reflux uropathy

359

1.72

3.89

2.0

2.1

3.22

3.07

g/l

0.59

284

Viral infections of the central nervous system

107

721

1.50

3.88

2.3

3.22

3.14

g/l

0.26

567

Orchitis and epididymitis

147

1052

1.41

3.87

1.9

2.3

3.06

g/l

0.00

109

832

Emotional disorders and disorders of social functioning with onset specific to childhood

156

2.10

3.87

1.1

1.4

2.98

3.17

g/l

0.85

131

Triptan medication for migraine, single purchase ok

1124

6734

1.13

3.86

2.1

2.2

2.91

3.05

g/l

5.07

889

5264

Migraine, single triptan purchase ok & required. ICD-code if available is included

1124

6734

1.13

3.86

2.1

2.2

2.91

3.05

g/l

5.07

889

5264

Malignant neoplasm of other connective and soft tissue

265

1.86

3.86

3.4

2.6

3.60

3.16

g/l

1.23

206

Maternal care for other conditions predominantly related to pregnancy

201

1490

1.34

3.85

1.9

2.89

2.94

g/l

0.33

166

1191

Left hemicolectomy

280

1.84

3.85

2.5

2.7

3.53

3.16

g/l

1.20

225

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

160

2.13

3.85

1.5

1.4

3.09

3.12

g/l

0.04

120

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

211

1597

1.33

3.84

2.6

1.4

3.17

3.02

g/l

1.30

161

1238

Fasciculation

108

2.40

3.84

1.2

2.0

2.53

3.08

g/l

2.31

Exclusion endpoint for clefts

114

2.32

3.81

1.6

1.9

3.31

3.00

g/l

0.82

Viral warts

135

955

1.43

3.80

2.1

2.4

3.04

3.09

g/l

0.24

101

759

Other hearing loss

529

4380

1.19

3.79

2.4

2.3

3.02

3.15

g/l

2.09

377

3389

Atopic conjunctivitis

340

1.73

3.76

1.4

1.9

3.01

3.08

g/l

0.20

268

Other misadventures during surgical and medical care

217

1.94

3.75

1.6

2.6

3.50

3.13

g/l

1.05

169

Glucosamine medication

986

6939

1.14

3.75

2.4

2.3

3.11

3.09

g/l

0.19

775

5273

Corneal ulcer

261

2044

1.29

3.73

2.2

3.10

3.06

g/l

0.19

204

1607

Corns and callosities

112

769

1.48

3.73

1.8

2.4

2.97

3.10

g/l

0.69

605

Malignant melanoma

262

2056

1.29

3.73

2.1

2.4

3.08

3.09

g/l

0.05

197

1595

Hyperaldosteronism

290

1.80

3.72

2.4

2.6

3.15

3.22

g/l

0.18

232

410

3198

1.22

3.72

2.1

2.2

3.09

3.13

g/l

0.34

284

2409

Other disorders of central nervous system

2.45

3.72

1.2

1.8

2.87

3.12

g/l

0.51

Dissection of aorta

366

1.70

3.69

1.7

2.7

3.29

3.10

g/l

0.81

294

Arthropathy in ulcerative colitis

110

2.35

3.68

1.6

1.8

2.91

3.11

g/l

0.38

Alzheimer’s disease (Atypical or mixed)

1218

0.65

3.68

2.1

2.2

3.31

3.23

g/l

0.22

916

Use of memantine

331

3554

0.80

3.68

1.9

2.3

3.16

g/l

0.01

208

2679

Use of other anti-dementia drugs

331

3554

0.80

3.68

1.9

2.3

3.16

g/l

0.01

208

2679

Atrophic disorders of skin

216

1655

1.32

3.67

2.1

2.2

3.06

3.13

g/l

0.46

169

1275

Injury of muscle and tendon at lower leg level

236

1830

1.30

3.67

2.6

2.4

2.96

3.07

g/l

0.99

189

1458

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

439

3646

1.21

3.67

2.7

2.2

3.09

3.06

g/l

0.28

356

2873

Injury of other and unspecified intrathoracic organs

101

682

1.50

3.66

1.8

2.4

3.16

3.08

g/l

0.27

548

Perichondritis of external ear

198

1.98

3.66

2.7

2.4

3.37

3.21

g/l

0.28

157

Abdominal aortic aneurysm (AAA)

188

1402

1.34

3.66

1.9

2.3

3.38

3.05

g/l

3.79

140

1068

Septal defects

486

1.59

3.66

1.7

2.4

2.97

3.08

g/l

0.45

390

Ulcer of oesophagus

124

873

1.44

3.63

2.2

2.8

3.08

3.11

g/l

0.14

704

Personal history of medical treatment

2.54

3.63

1.4

1.9

3.41

3.13

g/l

0.36

Chronic myeloid leukaemia [CML], BCR/ABL-positive

105

2.39

3.62

1.5

2.8

3.29

3.18

g/l

0.19

Other secondary gonarthrosis

620

1.53

3.61

2.5

3.0

3.32

3.08

g/l

1.74

492

Benign neoplasm: Cerebral meninges

145

1050

1.40

3.61

2.0

1.4

3.09

3.10

g/l

0.05

109

801

Nasal polyp

319

2571

1.25

3.61

2.9

2.4

2.96

3.07

g/l

1.51

252

2033

Haemangioma, any site

119

832

1.45

3.60

2.8

1.4

3.09

3.03

g/l

0.21

655

Acute laryngitis and tracheitis

112

760

1.46

3.60

1.6

1.9

2.96

3.10

g/l

1.01

607

Benign neoplasm: Tongue

271

1.81

3.59

4.0

1.3

3.13

3.02

g/l

0.26

212

Focal epilepsy, strict definition

300

2402

1.26

3.58

2.2

2.3

3.20

3.09

g/l

0.98

212

1873

Benign neoplasm: Skin of eyelid, including canthus

265

2094

1.28

3.58

3.1

2.3

2.94

3.11

g/l

2.20

201

1627

Degenerative macular diseases

223

1725

1.31

3.58

1.9

2.4

3.08

3.11

g/l

0.14

165

1326

Benign neoplasm of middle ear and respiratory system

123

867

1.44

3.57

2.6

1.4

2.98

3.03

g/l

0.26

101

674

Coronary angioplasty

749

4995

1.16

3.57

2.0

2.4

3.11

3.08

g/l

0.33

590

3800

Parapsoriasis

186

1.99

3.55

1.7

2.4

3.08

3.15

g/l

0.18

148

Medical abortion

973

4658

1.14

3.54

1.8

2.3

3.06

3.08

g/l

0.20

754

3539

Benign lipomatous neoplasm

439

3661

1.21

3.54

2.6

1.4

3.05

3.04

g/l

0.12

319

2859

Other and unspecified corneal deformities and disorders

317

1.74

3.53

2.2

2.4

2.96

3.08

g/l

0.44

246

Non-small cell lung cancer, squamous

624

0.52

3.52

2.2

2.5

3.43

3.13

g/l

0.93

478

Non-small cell lung cancer, squamous, helper endpoint

624

0.52

3.52

2.2

2.5

3.43

3.13

g/l

0.93

478

Autonomic disorders

208

1.92

3.50

2.1

2.4

2.87

3.13

g/l

1.15

169

Benign neoplasm of urinary organs

552

1.55

3.50

2.1

2.7

3.00

3.15

g/l

0.73

438

Haemangioma and lymphangioma, any site

125

887

1.42

3.50

3.2

1.3

3.09

3.03

g/l

0.19

691

Status post-ami

983

0.65

3.49

1.5

2.4

3.22

3.11

g/l

0.54

740

Atrial septal defect

286

1.76

3.48

2.0

2.1

3.15

3.13

g/l

0.03

234

Other specified/unspecified disorders of bone/cartilage

274

1.79

3.47

2.4

2.0

2.72

3.07

g/l

2.27

215

Premature rupture of membranes

109

1146

0.70

3.45

1.9

1.8

2.76

2.97

g/l

2.09

926

Other and unspecified mononeuropathies of upper limb

267

1.79

3.45

1.3

2.2

3.05

3.08

g/l

0.07

214

Single delivery by forceps and vacuum extractor

652

0.63

3.44

1.3

1.6

2.89

2.98

g/l

0.30

543

Ill-defined and unknown causes of mortality

873

0.60

3.44

2.1

2.5

3.19

3.15

g/l

0.12

679

Brachial plexus disorders

115

806

1.44

3.44

2.5

2.3

2.81

3.08

g/l

2.52

642

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

192

1461

1.32

3.44

1.9

2.1

2.98

3.07

g/l

0.59

148

1139

Other disorders of binocular movement

160

2.04

3.43

1.6

1.8

2.91

3.16

g/l

1.36

130

Disseminated intravascular coagulation [defibrination syndrome]

3.71

3.43

1.7

1.6

3.18

3.03

g/l

—

Other acute disseminated demyelination

2.65

3.43

1.4

2.7

3.05

3.11

g/l

0.05

Other disorders of pigmentation

475

1.58

3.43

2.9

2.2

2.94

3.13

g/l

1.02

379

Unspecified misadventure during surgical and medical care

595

1.52

3.43

1.9

2.5

3.24

3.09

g/l

0.69

477

Encephalopathy

2.41

3.41

1.7

2.6

2.85

3.14

g/l

0.61

Lichen planus

216

1675

1.30

3.41

2.8

2.3

2.87

3.12

g/l

3.53

167

1316

Focal epilepsy

319

2588

1.24

3.40

2.2

2.3

3.21

3.09

g/l

1.01

222

2019

Sequelae of injuries of neck and trunk

276

1.77

3.39

2.5

2.8

3.12

g/l

0.01

220

Viral meningitis

283

1.76

3.39

1.8

2.0

3.20

3.08

g/l

0.23

227

Lichen simplex chronicus

344

1.69

3.39

2.9

2.8

3.23

3.10

g/l

0.32

274

Injury of nerves at lower leg level

2.44

3.38

1.2

2.0

2.93

3.13

g/l

0.39

Other neurotic disorders

540

1.54

3.38

1.5

2.6

3.10

3.12

g/l

0.09

429

Benign neoplasm: Anus and anal canal

299

1.74

3.38

2.9

1.5

3.02

3.13

g/l

0.26

232

Benign neoplasm: Kidney

383

1.65

3.38

2.2

2.7

3.07

3.08

g/l

0.03

303

Asthma mixed form (mode), excluding more controls

460

1.58

3.37

1.9

1.6

2.88

3.05

g/l

0.67

355

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

225

1.85

3.36

2.1

2.0

2.85

3.12

g/l

1.57

181

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

196

1.91

3.36

3.7

2.2

3.20

3.16

g/l

0.10

156

Contact with sharp object, undetermined intent

162

2.02

3.33

1.7

2.1

3.26

3.12

g/l

0.26

128

Gluteal tendinitis

361

1.66

3.33

2.0

2.2

2.94

3.15

g/l

0.89

287

Retinal breaks without detachment

265

2115

1.26

3.32

2.5

2.4

3.01

3.05

g/l

0.23

201

1648

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

109

2.27

3.32

2.8

2.3

3.05

3.06

g/l

0.01

Benign neoplasm: Skin of ear and external auricular canal

472

1.58

3.30

2.2

2.5

2.97

3.15

g/l

0.89

381

Assault by bodily force

526

1.53

3.30

1.6

2.1

3.17

3.07

g/l

0.35

423

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

575

1.51

3.29

1.9

2.3

2.93

3.14

g/l

1.39

461

Contusion of toe(s) without damage to nail

170

1.98

3.27

1.2

2.5

2.59

3.01

g/l

2.45

143

Cysts of oral region, not elsewhere classified

409

1.61

3.27

2.3

2.1

3.12

3.03

g/l

0.28

328

Other mental disorders due to brain damage and dysfunction and to physical disease

199

1537

1.31

3.27

2.7

2.4

2.94

3.11

g/l

2.00

132

1211

UC patients in KELA-register (code 208), prior to 1994

505

1.55

3.26

2.6

3.05

3.09

g/l

0.12

400

Impetigo

309

1.70

3.25

2.8

2.0

2.93

3.08

g/l

0.71

249

Dental caries 1 and operation codes, only avohilmo

456

1917

1.20

3.25

2.7

2.9

3.14

3.07

g/l

0.71

358

1445

Other and unspecified mononeuropathies, also in other diseases

310

1.71

3.25

1.8

2.3

2.98

3.17

g/l

0.52

241

Emotional disorders starting during childhood or adolescence

148

2.02

3.24

1.1

1.4

2.95

3.19

g/l

1.16

126

Personal history of malignant neoplasm

403

1.62

3.24

4.4

1.9

3.43

3.15

g/l

0.89

329

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

190

1459

1.31

3.23

2.6

1.4

3.09

3.03

g/l

0.36

140

1134

Hyperfunction of pituitary gland

379

1.63

3.23

3.0

2.0

3.00

3.11

g/l

0.41

309

Malignant neoplasm of respiratory system and intrathoracic organs

273

3112

0.80

3.22

2.3

3.42

3.08

g/l

6.16

222

2384

Complications of genitourinary prosthetic devices, implants and grafts

251

1.79

3.22

1.9

3.41

3.15

g/l

1.07

198

Malnutrition

193

1.91

3.21

1.7

2.2

3.36

3.09

g/l

0.43

149

Undefined dementia

115

1469

0.71

3.21

1.8

2.2

3.05

3.21

g/l

0.78

1086

Unstable angina pectoris

760

5531

1.14

3.18

2.3

2.4

3.16

3.09

g/l

1.18

575

4203

Moderate visual impairment, binocular

320

1.69

3.17

1.7

2.0

3.25

3.28

g/l

0.04

248

Burns and corrosions

183

1402

1.31

3.17

1.9

2.2

3.19

3.09

g/l

0.64

142

1121

Oesophageal obstruction

406

1.61

3.15

2.8

3.0

3.11

3.13

g/l

0.04

329

Blindness, monocular

2.42

3.15

4.8

2.0

3.07

3.14

g/l

—

Unspecified protein-energy malnutrition

2.83

3.14

1.7

2.8

3.86

3.10

g/l

—

Senility

2.59

3.14

1.6

1.5

3.19

3.37

g/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

540

2817

1.18

3.14

2.1

1.5

3.12

3.02

g/l

1.33

419

2230

Spontaneous rupture of synovium and tendon

128

932

1.39

3.13

1.9

2.3

3.01

3.11

g/l

0.54

729

Meralgia paraesthetica

321

1.68

3.13

1.5

2.3

3.13

3.12

g/l

0.04

253

Aortic valve malfunction, age under 60 years

134

983

1.38

3.13

1.8

2.3

3.30

3.04

g/l

1.83

108

785

Other ill-defined and unspecified causes of mortality

763

0.59

3.11

1.5

2.5

3.25

3.16

g/l

0.24

595

Disturbance of activity and attention

400

1.59

3.11

1.4

1.5

2.75

3.05

g/l

1.82

321

Type 1 diabetes, strict definition

413

1.58

3.09

1.4

1.5

2.92

3.03

g/l

0.40

337

Combinations of oral blood glucose lowering drugs

495

4230

1.18

3.09

1.8

2.5

3.05

g/l

0.04

398

3286

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

109

775

1.42

3.08

3.4

1.4

3.47

3.05

g/l

2.59

602

Left ventricular outflow tract obstruction (LVOTO), broad definition

140

1037

1.36

3.07

1.8

2.3

3.34

3.04

g/l

2.12

113

830

Contact with and exposure to communicable diseases

311

2535

1.23

3.07

2.2

2.0

2.92

3.01

g/l

0.81

152

2066

Hand

2.88

3.06

1.5

1.4

2.82

3.01

g/l

—

Malignant neoplasm of parotid gland

2.34

3.05

1.2

1.9

2.72

3.10

g/l

1.16

Flat foot [pes planus] (acquired)

129

945

1.38

3.04

1.8

2.6

2.99

3.03

g/l

0.14

737

Alzheimer’s disease, wide definition

319

3232

0.82

3.03

1.8

2.3

3.20

3.16

g/l

0.26

216

2448

Hyperkinetic disorders

435

1.55

3.00

1.4

1.5

2.75

3.04

g/l

1.78

353

Familial hypercholesterolemia, with ischemic heart disease

182

1408

1.31

3.00

2.0

2.4

3.15

3.09

g/l

0.28

128

1070

Herpesviral keratitis and keratoconjunctivitis

459

1.55

2.99

3.0

2.4

2.98

3.13

g/l

0.75

367

Organic, including symptomatic, mental disorders

961

6199

1.12

2.99

2.1

2.3

3.14

3.11

g/l

0.32

668

4782

Abnormal blood-pressure reading, without diagnosis

419

1.57

2.99

2.4

3.01

3.17

g/l

0.78

329

Injury of intra-abdominal organs

205

1.84

2.98

2.2

2.3

3.50

3.12

g/l

0.87

163

Other noninflammatory disorders of uterus, except cervix

374

2126

1.21

2.98

2.5

2.2

3.12

3.18

g/l

0.53

273

1637

Polyp of the female genital tract

483

2389

1.18

2.97

1.9

2.2

3.07

3.16

g/l

0.89

373

1856

Behavioural disorders, excluding more controls

2.43

2.97

1.3

2.6

3.30

3.03

g/l

0.37

Convergent concomitant strabismus

443

1.55

2.97

2.2

2.0

3.02

3.11

g/l

0.33

354

Other puerperal infections

411

1.57

2.96

1.2

1.6

2.69

3.06

g/l

2.54

333

Otorrhagia

2.55

2.96

2.4

2.6

2.99

3.15

g/l

0.39

Benign neoplasm: Prostate

2.55

2.96

1.2

1.3

2.82

3.25

g/l

—

Complications of labour and delivery

699

4446

0.87

2.95

2.4

2.2

2.95

3.07

g/l

2.35

546

3436

Additional codes for the location of defect, injury or illness

591

1.47

2.94

1.4

2.5

2.85

3.16

g/l

1.91

465

Unspecified dementia

115

1418

0.73

2.94

1.8

2.2

3.05

3.19

g/l

0.65

1081

Central retinal artery occlusion

259

1.74

2.93

3.9

2.4

3.23

g/l

0.01

207

Epiphora

244

1.76

2.93

2.7

2.4

3.07

3.20

g/l

0.43

188

Other diseases of spinal cord

289

1.69

2.92

3.5

2.8

3.13

3.10

g/l

0.06

233

Complications of other internal prosthetic devices, implants and grafts

438

1.56

2.92

2.0

2.4

3.09

3.18

g/l

0.32

345

Other bullous disorders

274

1.71

2.92

3.0

2.4

2.84

3.12

g/l

1.13

218

Other disorders of the genitourinary system

218

1732

1.27

2.90

2.1

2.4

3.18

3.11

g/l

0.40

171

1336

Benign neoplasm of breast

189

1476

1.29

2.89

2.3

2.2

3.03

3.12

g/l

0.56

141

1130

Degenerative diseases of the nervous system

491

4298

0.86

2.88

1.9

2.2

3.15

3.13

g/l

0.18

327

3252

Appendectomy

971

8392

1.12

2.88

2.2

3.04

3.03

g/l

0.11

768

6561

Tongue abnormality

104

744

1.42

2.88

2.6

2.5

2.77

3.12

g/l

2.66

584

Congenital malformations of heart and great arteries

158

1165

1.32

2.88

2.0

2.3

3.01

3.08

g/l

0.38

119

936

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

3.01

3.29

g/l

—

Strabismus

363

3037

1.20

2.85

2.2

2.97

3.08

g/l

1.24

274

2369

Other specified disorders of kidney and ureter

346

1.62

2.84

2.4

2.9

2.73

3.10

g/l

2.20

276

Other inflammation of vagina/vulva

246

1.73

2.81

1.2

2.1

2.95

3.14

g/l

0.56

204

Maternal care for known or suspected fetal abnormality and damage

132

872

1.35

2.81

1.7

2.83

2.93

g/l

0.77

116

701

Other congenital malformations of upper alimentary tract

0.00

2.81

0.0

2.7

—

3.16

—

Peroneal tendinitis

117

2.10

2.81

2.2

1.9

2.99

3.03

g/l

0.09

Granulomatous disorders of skin and subcutaneous tissue

232

1.76

2.80

3.1

1.9

2.72

3.13

g/l

2.42

191

Other specified disorders of external ear

427

1.55

2.80

1.9

2.7

3.13

3.10

g/l

0.07

347

Hydrocele

194

1527

1.28

2.79

2.6

2.4

3.00

3.09

g/l

0.53

152

1202

Leisure time condition

260

2116

1.24

2.78

1.7

2.3

2.96

3.12

g/l

1.38

145

1667

Focal epilepsy, mode (most common among epilepsy diagnosis)

274

2242

1.23

2.78

2.3

2.2

3.14

3.09

g/l

0.31

187

1748

Haemorrhagic disorder due to circulating anticoagulants

139

2.01

2.77

1.9

2.2

3.96

3.24

g/l

1.85

108

Tobacco use

476

1.51

2.76

1.8

2.6

3.20

3.08

g/l

0.61

388

Benign neoplasm: Liver/bile ducts

196

1.82

2.75

2.5

1.3

2.84

3.02

g/l

0.85

154

295

1.67

2.75

2.1

2.8

3.42

3.14

g/l

0.99

221

Redundant prepuce, phimosis and paraphimosis

273

2226

1.23

2.74

2.0

2.4

3.11

3.06

g/l

0.31

215

1769

Paralytic ileus

421

1.54

2.73

3.5

2.4

3.32

3.09

g/l

0.93

336

Cerebral amyloid angiopathy

2.98

2.73

5.4

2.2

2.63

3.05

g/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

309

2566

1.21

2.72

2.3

1.4

3.27

3.06

g/l

2.11

231

1948

Pre-eclampsia or eclampsia

254

2067

1.23

2.72

2.4

2.2

3.01

g/l

0.01

190

1627

Varicella [chickenpox]

334

1.60

2.70

5.4

2.0

2.98

3.03

g/l

0.15

269

Endocrine disorders, other/unspecified

185

0.32

2.70

1.7

2.2

2.72

3.15

g/l

—

152

Benign neoplasm: Lip

205

1.79

2.70

3.1

1.4

2.99

3.05

g/l

0.12

156

Later onset COPD

562

3846

1.15

2.69

1.6

2.4

3.30

3.09

g/l

5.97

450

2909

Myopia

137

1034

1.33

2.69

1.9

2.3

2.96

3.11

g/l

1.09

108

815

Single spontaneous delivery

509

3134

0.86

2.67

2.6

2.1

3.12

3.11

g/l

0.09

395

2423

Optic neuritis

359

1.58

2.67

1.5

2.2

3.08

3.12

g/l

0.09

286

Scabies

351

1.59

2.67

2.0

2.84

3.07

g/l

1.03

283

Infective dermatitis

169

1316

1.29

2.66

1.8

2.5

3.10

3.12

g/l

0.06

117

1051

Other disorders of choroid

148

1.94

2.66

1.7

3.3

3.42

3.24

g/l

0.26

118

Crohn's disease of large intestine

464

1.50

2.65

1.6

2.3

3.12

3.07

g/l

0.13

367

Other arterial embolism and thrombosis

329

1.61

2.65

1.3

2.6

3.42

3.13

g/l

0.98

257

Conduct disorder

2.18

2.62

1.3

2.0

3.25

3.05

g/l

0.27

Impotence

606

1.44

2.62

1.9

2.3

3.00

3.04

g/l

0.15

483

Use of disulfiram, acamprosate or naltrexone

118

876

1.36

2.62

1.5

2.3

3.07

3.05

g/l

0.07

699

Mental and behavioural disorders due to tobacco

122

911

1.35

2.61

1.8

2.5

3.32

3.05

g/l

2.01

733

Other specified/unspecified dorsopathies

346

1.58

2.60

4.2

2.1

2.83

3.18

g/l

2.37

273

Acute appendicitis

1080

9252

1.10

2.59

2.5

2.2

2.99

3.04

g/l

0.95

850

7261

Campylobacter enteritis

253

1.69

2.59

2.0

2.5

2.95

3.16

g/l

0.85

196

Other, unspecified and serous retinal detachments

331

1.60

2.59

2.0

2.7

3.08

3.16

g/l

0.21

267

All dysplastic lesions of the cervix uteri

246

2002

1.23

2.59

2.3

2.0

2.97

2.98

g/l

0.02

196

1582

Diseases of appendix

1175

9761

1.10

2.58

2.5

2.2

3.00

3.05

g/l

0.96

922

7635

Pigmented purpuric dermatosis

108

2.11

2.58

2.4

3.0

2.96

3.20

g/l

0.86

Benign neoplasm: Connective and other soft tissue, unspecified

101

2.14

2.57

1.3

1.5

2.77

2.99

g/l

0.83

Graves ophthalmopathy, strict

216

1.75

2.56

1.2

1.8

3.00

3.12

g/l

0.33

175

Melanocytic naevi of upper limb, including shoulder

201

1.77

2.56

2.0

1.3

2.88

3.07

g/l

0.61

158

Desensitization to allergens

315

1.60

2.56

1.5

1.7

2.96

3.13

g/l

0.54

256

Chronic hepatitis NAS

129

1.99

2.55

1.4

2.1

3.35

3.06

g/l

0.60

106

Secondary parkinsonism, excluding more controls

216

1.74

2.55

2.9

2.3

2.89

3.30

g/l

1.43

172

Viral encephalitis, not elsewhere classified/unspecified

194

1.79

2.55

3.9

2.5

3.37

3.13

g/l

0.45

156

Benign neoplasm of bone and articular cartilage

101

735

1.39

2.54

1.4

1.3

2.94

3.04

g/l

0.51

577

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

529

2758

1.16

2.53

2.1

1.5

3.12

3.02

g/l

1.37

408

2179

Muscle strain

232

1.70

2.51

2.4

2.2

2.96

3.14

g/l

0.69

182

Pre-eclampsia or poor fetal growth

316

2643

1.20

2.51

2.3

2.0

2.98

g/l

0.01

240

2091

Delivery

516

3137

0.87

2.50

2.5

2.1

3.14

3.11

g/l

0.22

400

2426

Other strabismus

272

2245

1.21

2.49

2.3

2.93

3.08

g/l

1.68

209

1774

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

295

1.62

2.49

3.2

1.4

3.08

3.14

g/l

0.19

223

Asthma mixed form (mode)

495

1.47

2.49

1.9

1.7

2.88

3.07

g/l

0.76

381

Unspecified threat to breathing

2.30

2.48

2.4

2.1

2.70

3.05

g/l

0.98

Orthopaedic devices associated with adverse incidents

204

1.76

2.47

1.1

2.5

2.69

3.16

g/l

0.57

159

Other and unspecified acute skin changes due to ultraviolet radiation

296

1.62

2.46

1.9

2.5

3.06

3.19

g/l

0.42

229

Hyperprolactinaemia

241

1.68

2.46

3.4

1.7

2.97

3.13

g/l

0.58

193

Prolonged pregnancy

865

0.68

2.45

1.5

1.7

2.90

2.94

g/l

0.11

694

Schizophrenia

135

1751

0.77

2.45

2.4

2.3

3.20

3.07

g/l

1.05

1398

Other acute skin changes due to ultraviolet radiation

392

1.53

2.44

1.7

2.3

3.05

3.14

g/l

0.31

310

Sixth [abducent] nerve palsy

360

1.55

2.44

2.6

2.7

3.23

3.17

g/l

0.13

278

Spinal osteochondrosis

2.22

2.44

1.5

2.0

2.67

2.99

g/l

0.85

Postpartum haemorrhage

150

1674

0.78

2.44

1.9

2.0

2.81

2.97

g/l

1.78

114

1339

Congenital malformations of trachea and bronchus

2.18

2.44

2.9

2.0

2.93

3.18

g/l

0.37

Smoking dependency

122

922

1.34

2.43

1.8

2.5

3.32

3.05

g/l

1.97

740

Manic episode

242

1.68

2.43

1.9

2.2

2.94

3.12

g/l

0.51

194

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

409

1.51

2.42

2.9

1.4

2.99

3.05

g/l

0.22

325

Delivery, wide proxy

426

2633

0.86

2.42

2.4

2.0

3.18

3.16

g/l

0.18

325

2019

Trigeminal neuralgia

633

1.41

2.41

2.8

2.4

3.09

3.13

g/l

0.12

500

Burns and corrosions of multiple and unspecified body regions

190

1.77

2.40

1.9

2.3

3.53

3.10

g/l

1.08

156

Vascular dementia (mixed)

176

1.81

2.39

2.4

2.2

3.11

3.27

g/l

0.33

134

Myocardial infarction, with ST-elevation

312

2630

1.19

2.39

1.7

2.3

3.28

3.08

g/l

3.15

245

2025

Ulcerative colitis (strict) with PSC

2.57

2.39

2.6

3.32

3.14

g/l

0.34

Disorder of the sleep-wake schedule

125

1.95

2.38

1.1

1.9

3.24

3.13

g/l

0.20

103

Systemic sclerosis,strict definition

2.16

2.38

1.2

1.8

3.18

g/l

0.00

Endometriosis of pelvic peritoneum

185

1460

1.26

2.36

1.5

2.2

2.88

3.10

g/l

2.08

133

1143

Other predominantly sexually transmitted diseases, not elsewhere classified

171

1355

1.27

2.36

1.9

2.0

2.93

3.06

g/l

0.84

129

1071

Other and unspecified mononeuropathies of lower limb

276

1.62

2.35

1.7

2.2

3.12

3.15

g/l

0.05

215

Schizophrenia or delusion, excluding more controls

380

3232

1.17

2.35

1.9

2.2

3.13

3.06

g/l

0.94

273

2560

Inflammatory disorders of male genital organs, not elsewhere classified

126

1.95

2.35

1.1

3.2

3.01

3.13

g/l

0.27

Suppurative and unspecified otitis media

403

3075

1.16

2.33

2.5

2.1

3.05

3.04

g/l

0.04

314

2441

Intentional self-harm by unspecified means

2.42

2.31

1.2

1.7

3.67

3.12

g/l

—

Lagophthalmos

127

1.94

2.31

2.2

2.1

3.02

3.11

g/l

0.21

101

Laparoscopic right hemicolectomy

716

1.37

2.31

2.0

2.7

3.07

3.12

g/l

0.21

568

HSIL lesion of the cervix uteri, vagina or vulva

195

1574

1.24

2.31

2.1

2.0

3.00

3.01

g/l

0.06

153

1238

Benign neoplasm of eye and adnexa

159

1256

1.28

2.30

1.7

2.5

3.04

3.08

g/l

0.18

122

990

Retinal haemorrhage

278

1.61

2.30

4.8

2.9

2.99

3.18

g/l

0.57

223

Melanocytic naevi of upper limb, including shoulder

208

1.71

2.30

2.0

2.6

2.88

3.13

g/l

0.87

166

Benign neoplasm: Tongue

310

1.58

2.29

4.0

2.4

3.13

3.12

g/l

0.02

243

Benign neoplasm of meninges

165

1311

1.27

2.28

1.9

2.4

3.07

3.13

g/l

0.29

123

1008

Paralytic strabismus

111

837

1.34

2.28

2.1

2.5

3.04

3.13

g/l

0.34

671

Burns and corrosions of external body surface, specified by site

139

1080

1.30

2.28

2.1

2.3

3.21

3.10

g/l

0.69

107

863

Surgical ablation of atrial fibrillation

2.45

2.28

1.1

1.4

3.37

3.05

g/l

—

Chronic iridocyclitis

514

1.44

2.27

2.1

2.4

2.98

3.08

g/l

0.37

402

Crohn disease (strict definition, require KELA)

522

1.43

2.27

1.8

2.1

3.22

3.08

g/l

0.52

416

Congenital malformations of the respiratory system

142

1.87

2.26

2.4

2.1

2.84

3.12

g/l

0.60

113

Other acquired deformities of musculoskeletal system and connective tissue

498

1.44

2.26

2.2

2.4

3.29

3.09

g/l

0.75

391

Arterial embolism and thrombosis of lower extremity artery

424

1.48

2.26

1.5

2.7

3.37

3.16

g/l

0.77

335

Sudden idiopathic hearing loss

164

1304

1.27

2.26

2.1

2.3

3.01

3.11

g/l

0.54

115

1044

Benign neoplasm: Anus and anal canal

335

1.55

2.26

2.9

2.5

3.02

3.18

g/l

0.45

262

Other diseases of appendix

121

1.95

2.25

1.9

2.0

3.37

3.17

g/l

0.33

Other sexually transmitted chlamydial diseases

286

1.58

2.25

1.4

3.03

3.05

g/l

0.04

231

Embedded teeth, including avohilmo

556

1.41

2.24

2.8

1.9

3.01

3.10

g/l

0.33

451

Episcleritis

507

1.44

2.24

1.5

2.2

2.89

3.08

g/l

0.90

398

Anorexia (incl.atypical)

407

1.48

2.24

2.7

1.7

3.12

3.11

g/l

0.01

330

Cholangitis (primary sclerosing, PSC)

659

1.38

2.24

2.0

2.4

3.31

3.14

g/l

0.82

518

Behavioural disorders

2.12

2.24

1.3

2.1

3.30

3.01

g/l

0.40

Asymptomatic human immunodeficiency virus [HIV] infection status

2.87

2.23

1.1

2.3

3.01

2.94

g/l

—

Prepatellar bursitis

450

1.46

2.22

1.8

2.2

3.06

3.11

g/l

0.13

350

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

114

1.96

2.22

2.8

1.9

2.62

3.10

g/l

1.59

Appendicitis, broad definition

1155

9700

1.09

2.21

2.5

2.2

2.99

3.05

g/l

1.14

907

7589

Colorectal cancer, excluding all cancers (controls excluding all cancers)

444

3746

1.15

2.21

2.3

1.5

3.20

3.06

g/l

1.60

332

2885

Otitis media, unspecified

108

748

1.34

2.21

2.9

2.1

3.06

3.12

g/l

0.25

596

Acute appendicitis, no complications

796

7171

1.11

2.20

2.5

2.2

2.96

3.03

g/l

1.44

624

5679

Benign neoplasm: Liver

173

1.76

2.20

2.7

1.4

2.77

3.03

g/l

1.36

133

Infectious mononucleosis

467

1.44

2.18

2.1

1.5

3.13

3.03

g/l

0.34

377

Injury of nerves and spinal cord at neck level

235

1.65

2.18

2.9

3.0

2.81

3.15

g/l

1.19

190

Benign neoplasm: Choroid

663

1.37

2.18

1.6

1.4

2.89

3.05

g/l

0.63

508

Conductive and sensorineural hearing loss

1461

9380

1.08

2.18

2.4

2.3

2.99

3.10

g/l

3.76

1020

7359

Disorders of lacrimal system and orbit in diseases classified elsewhere

243

1.63

2.16

1.2

1.9

2.98

3.10

g/l

0.35

198

Unspecified event, undetermined intent

212

1.68

2.16

2.6

2.8

3.02

3.10

g/l

0.18

173

Dysplasia of cervi uteri

271

1757

1.20

2.15

2.2

2.0

2.96

3.09

g/l

1.52

209

1376

Melanoma in situ of trunk

138

1.86

2.14

2.9

1.3

3.01

3.12

g/l

0.18

104

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

535

0.61

2.14

2.2

1.4

3.43

3.05

g/l

1.29

416

Foreign body in ear

145

1.82

2.13

1.8

2.6

3.20

3.09

g/l

0.15

119

Crohn disease (strict definition, require KELA, min 2 HDR)

512

1.42

2.13

1.8

2.1

3.28

3.08

g/l

0.87

411

Benign neoplasm: Prostate

2.16

2.13

1.2

3.0

2.82

3.09

g/l

—

Hordeolum and other deep inflammation of eyelid

522

1.41

2.11

2.8

2.6

3.00

3.10

g/l

0.52

420

Open wound of shoulder and upper arm

168

1.76

2.10

1.6

2.1

3.22

3.18

g/l

0.06

131

Contusion of other and unspecified parts of foot

348

1.51

2.10

2.4

2.2

2.91

3.12

g/l

0.88

281

Type 1 diabetes, strict definition, subgroup 1

371

1.49

2.10

1.3

1.5

2.91

3.04

g/l

0.41

301

Contusion of ankle

300

1.55

2.10

1.7

2.2

3.23

3.10

g/l

0.30

245

Ulcer of vagina/vulva

214

1.66

2.09

2.3

2.2

3.14

3.16

g/l

0.03

179

Scar conditions and fibrosis of skin

357

1.50

2.09

2.1

3.20

3.11

g/l

0.28

280

Other blood glucose lowering drugs, excl. Insulins

292

2482

1.18

2.09

1.8

2.4

3.22

3.08

g/l

1.25

226

1910

Oral lichen ruber planus, including avohilmo

694

1.36

2.08

2.2

2.6

2.96

3.12

g/l

0.91

533

Acute alcohol intoxication, ICD10

270

2279

1.19

2.08

1.3

2.3

3.04

3.06

g/l

0.10

220

1812

Contact with heat and hot substances

465

1.43

2.07

1.8

2.3

3.25

3.09

g/l

0.57

376

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

116

895

1.31

2.06

2.0

2.5

3.06

3.11

g/l

0.29

705

Ingrowing nail

474

1.43

2.06

1.8

2.5

3.10

3.07

g/l

0.12

383

Cerebral aneurysm, nonruptured

130

1019

1.29

2.04

1.8

2.4

3.05

3.08

g/l

0.12

104

797

Graves ophthalmopathy

247

1.61

2.04

1.2

1.9

2.98

3.08

g/l

0.29

203

Varicose veins of other sites

696

1.35

2.04

2.6

2.5

2.82

3.05

g/l

1.24

555

Pyoderma

185

1.71

2.04

2.1

2.4

3.16

3.15

g/l

0.02

147

Other lesions of median nerve

295

1.55

2.03

1.2

2.3

3.09

3.24

g/l

0.33

231

Other meningitis

140

1.82

2.03

1.5

2.1

3.10

3.15

g/l

0.10

112

HSIL lesion of the cervix uteri

168

1356

1.24

2.03

1.9

2.0

2.97

3.00

g/l

0.11

133

1069

Melanocytic naevi of scalp and neck

185

1.70

2.03

2.6

1.4

2.90

3.02

g/l

0.33

148

Alzheimer’s disease (Late onset)

298

2985

0.85

2.02

1.9

2.3

3.22

3.17

g/l

0.31

198

2260

Other abnormal findings in urine

163

1.76

2.02

6.4

2.4

3.24

3.17

g/l

0.11

124

Burn and corrosion of ankle and foot

126

1.87

2.01

1.3

2.3

3.32

3.14

g/l

0.34

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

569

1.38

2.01

1.7

2.2

3.26

3.09

g/l

0.67

453

Pedestrian injured in transport accident

724

1.34

2.01

1.4

2.3

3.18

3.14

g/l

0.13

576

Use of rivastigmine

167

2047

0.81

2.00

1.9

2.3

3.17

3.19

g/l

0.08

122

1530

Benign neoplasm: Liver/bile ducts

217

1.64

2.00

2.5

2.0

2.84

3.14

g/l

1.78

171

Benign neoplasm: Ill-defined sites within the digestive system

2.27

1.99

1.1

3.11

g/l

—

Lateral epicondylitis

170

1379

1.24

1.99

1.8

2.2

3.00

3.08

g/l

0.48

122

1092

Disorders of eyelid in diseases classified elsewhere

329

1.51

1.99

1.1

2.5

2.98

3.17

g/l

0.62

263

Abnormal findings in secretions and smears from cervix uteri vagina vulva

571

4002

1.12

1.97

2.2

2.1

3.03

3.02

g/l

0.08

451

3114

Open wound of wrist and hand

609

5408

1.12

1.97

2.3

2.2

3.02

3.05

g/l

0.26

489

4249

Dislocation, sprain and strain of joints and ligaments of thorax

289

1.54

1.97

1.2

2.4

2.96

3.13

g/l

0.61

227

IBD (strict) with PSC

2.24

1.97

2.5

2.3

3.36

3.11

g/l

0.55

Malignant neoplasm of small intestine

242

1.60

1.97

2.7

3.37

3.16

g/l

0.52

193

Other diseases of peritoneum

513

1.40

1.96

1.5

2.4

3.01

3.14

g/l

0.42

404

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

111

856

1.31

1.96

2.5

3.04

3.12

g/l

0.45

672

Recurrent dislocation of patella

257

1.57

1.95

1.5

1.8

3.00

3.06

g/l

0.20

195

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

306

1.52

1.95

1.6

2.4

2.65

3.14

g/l

4.45

250

Pre-eclampsia

223

1862

1.20

1.95

2.6

2.1

3.01

3.02

g/l

0.06

164

1465

Other drug-induced secondary parkinsonism

1.98

1.95

1.9

2.2

2.68

3.20

g/l

—

Tooth eruption problems

100

753

1.32

1.95

2.4

1.7

3.08

3.05

g/l

0.06

611

Other and unspecified injuries of wrist and hand

314

1.51

1.95

1.1

2.0

2.85

3.11

g/l

1.10

255

Other facial nerve disorders

258

1.57

1.95

2.1

2.3

3.06

3.10

g/l

0.06

204

Other and unspecified injuries of ankle and foot

314

1.51

1.94

1.3

2.1

3.00

3.07

g/l

0.23

256

Congenital malformations of genital organs

663

1.34

1.93

1.6

2.0

2.89

3.09

g/l

1.34

529

Lung diseases due to external agents

224

1875

1.20

1.93

2.6

2.2

3.29

3.08

g/l

2.36

156

1450

Viral haemorrhagic fevers, not elsewhere classified/unspecified

899

0.72

1.93

3.3

2.3

2.90

3.07

g/l

1.05

721

Volvulus

267

1.56

1.92

1.7

2.2

2.95

3.10

g/l

0.42

215

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

669

1.34

1.92

3.1

1.4

3.04

3.02

g/l

0.08

516

Burn and corrosion of wrist and hand

291

1.53

1.91

1.6

2.2

3.24

3.08

g/l

0.40

230

Dental pulpitis 3

277

1.46

1.91

1.1

1.2

3.13

3.03

g/l

0.32

235

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

113

880

1.29

1.89

2.9

1.4

3.03

3.07

g/l

0.13

672

Contracture of joint

107

1.91

1.89

1.4

1.7

3.01

2.98

g/l

0.04

Haemangioma, any site

119

934

1.28

1.88

2.8

2.4

3.09

3.08

g/l

0.03

737

Erythema intertrigo

229

1.60

1.87

2.2

3.2

3.06

3.14

g/l

0.18

182

Acute lymphadenitis

500

1.39

1.87

2.5

2.4

3.26

3.09

g/l

0.48

397

Rheumatic valve diseases

261

1.56

1.87

1.6

2.0

3.30

3.28

g/l

0.04

195

Alcohol withdrawal state with delirium

104

803

1.31

1.87

1.2

2.4

3.03

g/l

0.02

651

Tonsillectomy and adenotomy

517

4040

0.89

1.86

1.8

2.0

2.94

2.99

g/l

0.48

392

3244

Respiratory tuberculosis, confirmed

206

1.63

1.86

1.8

2.6

3.24

3.20

g/l

0.06

158

Polypectomy (DHB20)

103

795

1.31

1.86

2.7

2.4

2.99

3.10

g/l

0.71

642

Benign neoplasm of male genital organs

214

1.62

1.85

1.4

2.79

3.07

g/l

1.47

168

Crohn disease (strict definition, all UC cases excluded)

417

1.43

1.85

1.6

2.3

3.23

3.12

g/l

0.34

334

Sequelae of injuries of head

502

1.39

1.84

2.9

2.5

3.22

3.04

g/l

0.72

397

Procedures for purposes other than remedying health state

230

1.59

1.84

2.3

1.5

2.85

3.02

g/l

0.59

193

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

519

1.38

1.84

3.2

1.4

3.60

3.13

g/l

1.76

393

Glaucoma-related operations

736

1.32

1.84

2.8

2.6

3.17

g/l

0.00

581

Other and unspecified abdominal hernia

469

1.40

1.84

1.3

2.1

3.03

3.13

g/l

0.45

378

Medial epicondylitis

335

1.48

1.83

1.4

2.0

2.88

3.14

g/l

1.14

256

Haemangioma and lymphangioma, any site

125

991

1.27

1.83

3.2

2.4

3.09

g/l

0.02

783

Any dementia

599

4684

0.90

1.82

2.0

2.3

3.15

3.12

g/l

0.23

399

3554

Dental caries 3 and operation codes, only avohilmo

503

2242

1.13

1.82

2.5

2.8

3.15

3.06

g/l

1.07

399

1704

Aphakia

153

1.73

1.82

2.1

2.5

3.12

3.15

g/l

0.04

126

Other diseases of gallbladder

538

1.37

1.82

2.6

2.5

2.89

3.17

g/l

1.40

419

Pedal cyclist injured in noncollision transport accidents

142

1143

1.25

1.81

1.7

2.3

2.98

3.11

g/l

0.85

104

915

Graves disease, strict definition

121

956

1.27

1.81

2.3

2.2

2.97

3.12

g/l

1.07

750

Parkinson's disease, including avohilmo

273

2341

1.17

1.81

1.9

2.4

3.09

3.08

g/l

0.06

206

1802

Benign neoplasm: other/unspecified salivary gland

296

1.51

1.80

1.6

1.4

3.11

g/l

0.02

234

Oral lichen ruber planus

272

1.53

1.80

1.9

2.4

3.07

3.11

g/l

0.08

217

Benign neoplasm: Other and unspecified parts of small intestine

177

1.67

1.80

1.8

1.4

3.38

3.13

g/l

0.54

137

Benign neoplasm of brain and other parts of central nervous system

668

1.33

1.80

2.1

1.4

2.97

3.04

g/l

0.31

522

Malignant neoplasm of digestive organs

564

6163

0.90

1.79

2.1

2.3

3.23

3.09

g/l

2.16

427

4720

Hypersomnia

124

1.81

1.78

1.3

2.3

3.05

3.08

g/l

0.06

Outcome of delivery

141

698

1.26

1.78

1.7

1.9

2.93

2.97

g/l

0.17

112

580

Malignant neoplasm of ovary

569

0.66

1.78

2.2

2.3

3.14

3.16

g/l

0.03

447

Benign neoplasm: Connective and other soft tissue, unspecified

117

1.84

1.77

1.3

1.9

2.77

3.13

g/l

1.55

Embolic stroke with flimmer

289

1.51

1.77

2.5

1.8

3.23

3.27

g/l

0.10

224

Erectile dysfunction

143

1159

1.25

1.76

2.3

2.4

3.06

3.04

g/l

0.08

113

897

Benign neoplasm of middle ear and respiratory system

123

981

1.26

1.73

2.6

2.4

2.98

3.09

g/l

0.66

101

779

Anankastic personality disorder

290

1.50

1.73

2.1

2.4

2.86

2.99

g/l

0.53

240

Other female pelvic inflammatory diseases

222

1878

1.19

1.73

1.7

2.3

3.08

3.09

g/l

0.04

145

1440

Adult respiratory distress syndrome

133

1.77

1.73

4.3

2.2

3.31

3.21

g/l

0.15

103

Vascular dementia (subcortical)

382

1.44

1.73

2.3

3.27

3.26

g/l

0.01

290

Use of galantamine

971

0.74

1.72

1.2

2.3

3.19

3.18

g/l

0.02

739

Corneal degeneration

156

1.70

1.72

1.2

2.0

3.32

3.11

g/l

0.33

125

Dislocation of lens

156

1.70

1.72

3.0

2.8

2.97

3.23

g/l

0.83

129

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

107

1352

0.79

1.71

2.8

2.4

3.05

3.09

g/l

0.18

1059

Benign leiomyoma with endometriosis

220

1863

1.19

1.70

2.2

1.5

3.09

3.10

g/l

0.06

162

1416

Other renal tubulo-interstitial diseases

195

1.61

1.70

1.9

3.33

3.01

g/l

0.65

158

Use of glatiramer acetate

111

1.83

1.70

1.5

1.8

2.89

3.03

g/l

0.23

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

463

3349

1.13

1.70

1.9

1.4

3.21

3.06

g/l

2.03

347

2538

Acquired absence of limb

1.91

1.69

1.7

2.1

3.32

3.29

g/l

0.03

Pedestrian injured in collision with pedal cycle

317

1.47

1.68

1.8

2.5

3.15

3.17

g/l

0.05

249

Congenital deformities of feet

172

1.65

1.68

1.5

1.8

3.20

3.12

g/l

0.15

143

Preparation and fitting of bite rail to mouth

165

1362

1.22

1.68

2.9

2.5

2.92

3.08

g/l

1.35

131

1086

Thyroiditis, unspecified

157

1.69

1.68

1.3

1.6

3.22

3.09

g/l

0.15

130

Use of rotigotine

127

1.78

1.68

1.9

1.6

2.82

3.20

g/l

1.24

104

Other and unspecified disease of Bartholin gland

326

1.46

1.67

1.3

2.5

3.04

3.11

g/l

0.19

269

Melanocytic naevi of lip

2.02

1.67

1.2

3.07

2.98

g/l

—

Benign neoplasm: Larynx

318

1.46

1.66

2.8

1.4

2.78

3.06

g/l

1.19

252

Bitten or struck by other mammals

123

986

1.25

1.66

2.6

2.5

3.03

3.08

g/l

0.28

108

777

Malignant neoplasm of rectum

103

1301

0.79

1.65

2.5

2.4

2.97

3.09

g/l

0.73

1016

Ménière disease

152

1249

1.23

1.65

1.7

2.5

3.01

3.12

g/l

0.66

111

978

Endometriosis of ovary

215

1819

1.18

1.64

1.7

2.1

2.93

3.14

g/l

2.56

158

1424

Malignant neoplasm of breast, HER-negative

246

2856

0.86

1.63

1.9

2.4

3.13

3.12

g/l

0.04

189

2161

Hereditary ataxia

128

1.76

1.63

1.3

2.5

2.69

3.15

g/l

0.97

105

Benign neoplasm: Ill-defined sites within the digestive system

2.07

1.63

1.1

2.3

3.11

3.16

g/l

—

Pilonidal cyst

661

1.31

1.62

1.9

2.1

3.25

3.07

g/l

0.88

539

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.82

1.61

1.9

1.4

2.93

2.90

g/l

—

Allergic contact dermatitis due to drugs in contact with skin

231

1.54

1.59

1.6

2.0

3.35

3.12

g/l

0.45

185

conjunctival haemorrhage

117

939

1.26

1.59

2.5

2.4

2.90

3.08

g/l

1.32

743

Benign neoplasm: Liver

191

1.59

2.7

2.0

2.77

3.11

g/l

2.07

149

Other disorders of breast

164

1363

1.21

1.59

2.2

2.95

3.11

g/l

1.22

124

1054

Palindromic rheumatism

1.89

1.58

1.4

1.6

2.85

3.00

g/l

0.24

Benign neoplasm: Cerebral meninges

145

1192

1.23

1.58

2.0

2.5

3.09

3.14

g/l

0.21

109

922

Arthropod-borne viral fevers and viral haemorrhagic fevers

1138

0.78

1.58

3.4

2.4

3.02

3.10

g/l

0.36

910

Adenocarcinoma and papilloma adenocarcinoma of rectum

103

1292

0.79

1.57

2.9

2.4

3.04

3.09

g/l

0.22

1015

Other disorders of prostate

407

1.39

1.56

2.7

2.5

3.05

3.07

g/l

0.04

325

Meningitis

484

1.35

1.55

2.8

2.4

2.95

3.08

g/l

0.55

387

Malignant neoplasm of mesothelium and soft tissue

511

1.35

1.54

3.0

2.8

3.68

3.13

g/l

2.27

410

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

101

800

1.27

1.54

2.9

1.4

3.06

3.04

g/l

0.08

611

Spinal enthesopathy

306

1.45

1.54

2.8

2.0

3.32

3.28

g/l

0.07

221

Respiratory tuberculosis, bacteriologically and histologically confirmed

217

1.54

1.8

2.6

3.24

3.19

g/l

0.07

167

Benign lipomatous neoplasm of other sites/unspecified

128

1042

1.24

1.54

3.2

1.4

3.12

3.05

g/l

0.29

794

Benign neoplasm: Skin of scalp and neck

225

1.53

3.1

1.4

3.09

3.08

g/l

0.02

182

Melanocytic naevi of scalp and neck

201

1.56

1.53

2.6

2.90

3.12

g/l

0.67

161

Pneumonitis due to solids and liquids

121

980

1.24

1.53

1.5

2.2

3.34

3.09

g/l

1.90

773

Other benign neoplasms of connective and other soft tissue

127

1034

1.24

1.52

2.7

1.4

2.91

3.05

g/l

0.81

802

Presbyopia

625

1.31

1.52

1.4

2.3

2.98

3.11

g/l

0.44

494

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

452

1.36

1.52

2.9

2.5

2.99

3.11

g/l

0.48

358

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

621

3695

1.10

1.51

1.9

1.4

3.16

3.04

g/l

1.96

479

2828

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

621

3695

1.10

1.51

1.9

1.4

3.16

3.04

g/l

1.87

478

2828

Leiomyoma of uterus

946

4987

1.08

1.50

2.2

3.11

3.07

g/l

0.40

700

3832

Benign neoplasm: Skin of other and unspecified parts of face

152

1263

1.21

1.50

3.8

1.4

2.96

3.07

g/l

0.51

102

963

Acute alcohol intoxication

377

3356

1.13

1.49

1.4

2.4

3.08

3.04

g/l

0.32

299

2645

Maternal care for other known or suspected fetal problems

126

992

0.81

1.49

1.5

1.8

2.88

2.93

g/l

0.26

806

Glaucoma

1014

8295

1.08

1.49

2.3

3.02

3.10

g/l

1.70

730

6377

malignant neoplasm of female genital organs

174

2059

0.84

1.49

1.8

2.2

3.25

3.15

g/l

0.54

135

1554

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

391

0.63

1.48

3.5

2.4

2.80

3.20

g/l

2.99

305

Combined immunodeficiencies

117

1.75

1.48

3.3

2.0

3.05

3.03

g/l

0.02

Acute nasopharyngitis (common cold)

143

1175

1.22

1.48

1.7

2.1

2.87

3.06

g/l

1.88

113

946

L01XE Protein kinase inhibitors

726

1.28

1.47

3.1

2.7

3.62

3.11

g/l

2.92

583

Specific development disorders of scholastic skills

153

1.62

1.47

1.3

1.6

2.69

3.15

g/l

1.31

133

Use of levodopa decarboxylase inhibitor

226

1949

1.17

1.46

2.0

2.3

3.01

3.09

g/l

0.50

173

1507

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

370

1.39

1.45

1.9

1.5

3.39

3.16

g/l

0.62

282

Benign neoplasm: Lip

245

1.49

1.45

3.1

2.3

2.99

3.10

g/l

0.24

193

Lichen sclerosus et atrophicus

144

1196

1.21

1.44

2.1

3.00

3.15

g/l

1.09

108

910

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.86

1.44

6.7

1.3

3.15

3.21

g/l

0.11

Cauda equina syndrome

118

1.73

1.43

2.2

1.7

3.25

3.04

g/l

0.42

Antepartum haemorrhage, not elsewhere classified

551

1.31

1.43

2.2

1.8

2.87

2.98

g/l

0.51

443

Flatulence and related conditions

103

1.78

1.43

1.5

2.3

3.06

3.11

g/l

0.06

Conductive hearing loss, unspecified

116

943

1.24

1.43

2.1

2.3

3.08

g/l

0.02

757

Perforation of tympanic membrane

137

1133

1.22

1.43

2.0

2.4

2.92

3.11

g/l

1.66

892

Aneurysms, operations, SAH

252

2194

1.15

1.43

2.0

2.3

3.10

3.07

g/l

0.18

195

1702

Benign neoplasm: Conjunctiva

312

1.43

1.3

3.05

3.11

g/l

0.13

239

Loose body in joint

221

1.51

1.42

2.0

2.4

3.03

g/l

0.00

171

Congenital malformations of ovaries, fallopian tubes and broad ligaments

422

1.36

1.42

1.7

2.86

3.10

g/l

1.24

337

Striae atrophicae

1.89

1.42

1.7

2.4

3.13

3.06

g/l

0.09

Drug-induced myopathy

2.51

1.42

1.3

1.8

2.50

3.14

g/l

—

Postpartum hemorraghe, all women as controls

150

1784

0.84

1.42

1.9

2.81

2.95

g/l

1.38

114

1432

Other maternal disorders predominantly related to pregnancy

596

4102

0.91

1.41

2.2

3.00

3.02

g/l

0.22

455

3212

Carcinoma in situ of skin of lip

2.31

1.41

1.1

3.80

3.21

g/l

—

Carcinoma in situ of skin of lip

2.31

1.41

1.1

1.6

3.80

3.14

g/l

—

Unspecified contracted kidney

2.14

1.41

1.5

2.6

3.75

3.18

g/l

0.64

Occupational exposure to risk-factors

361

0.63

1.40

4.5

2.6

2.88

3.08

g/l

—

286

Nontoxic single thyroid nodule

106

856

1.25

1.40

2.5

2.4

2.89

3.13

g/l

1.63

673

Other peripheral vertigo

140

1164

1.21

1.40

1.8

2.5

2.98

3.09

g/l

0.73

100

920

Separation of retinal layers (serosa)

407

1.36

1.40

1.8

2.5

3.12

3.10

g/l

0.06

328

Ulcerative rectosigmoiditis

101

811

1.25

1.39

2.0

2.3

3.04

3.07

g/l

0.13

648

Nonsuppurative otitis media

228

1703

1.16

1.39

1.9

2.0

3.16

3.07

g/l

0.67

177

1346

Burn and corrosion of head and neck

166

1.59

1.39

4.8

2.6

3.12

3.05

g/l

0.13

127

Pregnancy, childbirth and the puerperium

387

2265

0.89

1.39

1.8

2.1

3.21

3.17

g/l

0.34

299

1707

Postpartum hemorraghe, parous women as controls

150

1566

0.84

1.38

1.9

2.0

2.81

2.91

g/l

0.81

114

1236

Other ulcerative colitis

520

1.32

1.38

1.3

2.4

3.13

3.06

g/l

0.19

412

Benign neoplasm: Skin of lip

135

1.66

1.38

2.2

1.3

2.97

3.06

g/l

0.10

Melanocytic naevi of lip

1.87

1.38

1.2

2.1

3.07

3.26

g/l

—

Melanoma in situ of trunk

159

1.61

1.38

2.9

3.0

3.01

3.20

g/l

0.39

125

Other acquired deformities of ankle and foot

1.91

1.36

1.4

1.9

3.23

3.05

g/l

—

Dementia

690

5165

0.92

1.36

2.0

2.3

3.11

3.12

g/l

0.16

467

3960

Amputation of thigh

341

1.40

1.36

1.3

2.4

3.52

3.25

g/l

1.12

258

Malignant melanoma of skin

178

1517

1.18

1.36

2.1

2.4

3.02

3.10

g/l

0.53

131

1189

Degeneration of nervous system due to alcohol

249

1.47

1.35

1.3

2.9

2.88

3.11

g/l

0.68

195

Other or unspecified paralytic strabismus

2.01

1.35

1.0

2.6

2.85

3.04

g/l

0.33

Benign neoplasm of male genital organs

233

1.48

1.34

1.4

2.7

2.79

3.10

g/l

1.67

177

Hereditary corneal dystrophies

385

1.37

1.34

1.4

2.7

3.26

3.19

g/l

0.17

302

Dronedarone medication

334

1.40

1.33

2.0

2.5

3.27

3.14

g/l

0.30

262

Vascular dementia

142

1149

1.20

1.32

2.3

2.2

3.18

3.21

g/l

0.11

874

Varus deformity, not elsewhere classified

106

1.73

1.31

1.4

2.1

2.50

3.03

g/l

—

Disorders of iron metabolism

137

1.63

1.31

1.3

2.0

2.84

3.17

g/l

0.81

112

Tetraplegia

1.93

1.31

1.8

2.86

3.09

g/l

—

Other benign neoplasm of uterus: Corpus uteri

1.93

1.31

4.8

1.2

2.92

3.02

g/l

—

Degeneration of the brain due to alcohol

251

1.46

1.31

1.3

2.9

2.88

3.11

g/l

0.68

197

Other disorders of conjunctiva

218

1894

1.16

1.30

2.6

2.4

2.88

3.11

g/l

2.76

165

1459

Dislocation, sprain and strain of joints and ligaments of knee

823

7112

1.08

1.30

1.9

2.3

2.99

3.03

g/l

0.53

640

5611

Contact with blunt object, undetermined intent

2.14

1.30

1.5

3.0

2.79

3.09

g/l

—

Hypertrophic disorders of skin

482

1.32

1.29

2.7

2.3

3.05

3.14

g/l

0.33

383

Injuries involving multiple body regions

327

1.39

1.29

2.5

2.4

3.17

3.13

g/l

0.12

259

Other benign neoplasm of uterus: Other parts/unspecified

545

1.30

1.28

2.8

1.5

3.25

3.23

g/l

0.03

402

Diseases of middle ear and mastoid

748

5680

1.08

1.28

2.4

2.1

3.02

3.03

g/l

0.04

577

4450

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

650

1.27

1.28

2.3

2.83

3.05

g/l

1.57

495

Obstructed labour due to malposition and malpresentation of fetus

145

1619

0.84

1.28

1.5

2.0

2.92

2.98

g/l

0.32

120

1298

Macular cyst

320

1.40

1.28

1.7

3.0

3.17

3.13

g/l

0.10

265

Foreign body or object entering through skin

571

1.29

1.28

2.9

2.3

2.87

3.07

g/l

1.09

462

Benign neoplasm: other/unspecified salivary gland

320

1.39

1.27

1.6

2.6

3.11

3.15

g/l

0.09

253

Inguinal hernia, bilateral

168

1435

1.18

1.27

2.6

2.2

2.95

3.03

g/l

0.56

135

1122

Malignant neoplasm, without specification of site

363

1.37

1.26

3.1

2.5

3.46

3.23

g/l

0.49

275

Juvenile osteochondrosis

219

1.47

1.26

1.4

2.1

3.07

3.09

g/l

0.02

181

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

146

1232

1.19

1.26

2.9

1.4

2.99

3.02

g/l

0.15

111

949

Postmenopausal atrophic vaginitis

399

2163

1.11

1.26

2.4

2.2

2.84

3.16

g/l

9.29

317

1678

Acute epiglottitis

123

1.65

1.25

3.6

1.9

2.95

3.04

g/l

0.29

Benign neoplasm: Brain, supratentorial

123

1.65

1.25

1.3

1.4

2.85

3.12

g/l

0.95

Pathological resorption of teeth

253

1.44

1.25

1.1

1.9

2.93

2.99

g/l

0.12

206

Other vitreous opacities

433

1.33

1.25

3.5

2.8

2.85

3.10

g/l

1.29

336

Other intracranial haemorrhages

364

1.36

1.25

1.8

2.4

3.27

3.16

g/l

0.26

282

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1000

0.79

1.24

2.2

1.4

3.26

3.04

g/l

1.28

767

Other disorders of bone density and structure

212

1.48

1.24

1.5

2.2

2.76

3.12

g/l

1.32

171

Other noninflammatory disorders of vagina

798

1.23

2.8

2.1

3.01

3.18

g/l

1.06

618

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

735

1.25

1.23

2.0

1.4

3.05

g/l

0.01

572

Foreign body in alimentary tract

566

1.28

1.23

1.5

2.6

3.10

3.11

g/l

0.01

452

Certain zoonotic bacterial diseases

180

1.52

1.23

2.7

2.4

2.82

3.14

g/l

0.92

142

Benign neoplasm: Spinal cord

132

1.62

1.22

1.1

1.3

2.84

2.96

g/l

0.26

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

190

1644

1.16

1.22

2.6

2.3

3.09

3.07

g/l

0.10

140

1304

Other benign neoplasms of uterus

692

1.25

1.22

3.0

1.5

3.23

3.16

g/l

0.17

516

Convalescence

540

1.29

1.22

2.1

3.05

3.07

g/l

0.09

440

Oral leukoplakia

197

1.50

1.21

1.2

2.1

3.44

3.14

g/l

0.74

158

Other and unspecified degenerative diseases of nervous system

281

1.41

1.20

1.6

2.4

3.07

3.23

g/l

0.33

219

Peritonsillar abscess

242

2131

1.14

1.20

2.7

2.2

3.00

3.04

g/l

0.24

197

1702

Dystonia

604

1.27

1.19

1.2

2.4

2.78

3.11

g/l

2.86

478

Ovarian dysfunction

418

1.32

1.19

1.4

1.7

3.08

g/l

0.01

346

Pregnancy with abortive outcome

962

4712

1.07

1.19

1.8

2.3

3.05

3.08

g/l

0.36

746

3573

Hypertrophic scar

436

1.32

1.19

2.8

2.0

3.07

3.12

g/l

0.17

349

Benign neoplasm: Spinal cord

133

1.60

1.19

1.1

2.4

2.84

3.09

g/l

0.70

108

Benign neoplasm: Choroid

731

1.24

1.18

1.6

2.5

2.89

3.14

g/l

1.16

575

Acute drug-induced interstitial lung disorder

1.77

1.18

9.7

2.0

3.21

g/l

0.00

Rheumatic fever incl heart disease

377

1.34

1.17

1.5

2.5

3.29

3.21

g/l

0.20

292

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

723

1.24

1.16

2.3

1.4

3.07

3.08

g/l

0.05

558

Acute otitis externa, noninfective

158

1.54

1.16

1.2

2.2

3.19

3.11

g/l

0.08

128

Inguinal or femoral hernia, bilateral

170

1466

1.17

1.16

2.5

2.2

2.94

3.02

g/l

0.63

137

1148

Reiter disease

1.90

1.16

5.1

1.9

3.19

3.04

g/l

0.26

Other infective spondylopathies

2.46

1.16

1.4

1.1

3.77

2.81

g/l

—

Alopecia areata

224

1.44

1.15

1.9

3.09

3.06

g/l

0.07

185

Dementia in other diseases classified elsewhere

572

1.27

1.15

1.7

2.5

3.05

3.17

g/l

0.42

453

Chalazion

147

1255

1.18

1.14

2.9

2.4

2.92

3.12

g/l

1.59

105

990

Residual foreign body in soft tissue

422

1.31

1.14

2.1

2.0

3.03

3.13

g/l

0.21

329

LSIL lesion of the cervix uteri, vagina or vulva

136

1153

1.18

1.14

2.6

2.1

3.01

3.05

g/l

0.20

112

906

Contraceptive management

410

3167

0.91

1.13

2.1

3.00

g/l

0.00

312

2540

Urethritis and urethral syndrome

192

1.47

1.12

1.2

2.2

3.09

g/l

0.00

155

Achalasia of cardia

184

1.49

1.12

2.2

3.1

3.19

3.17

g/l

0.03

150

Right hemicolectomy

763

1.23

1.12

3.2

2.5

3.19

3.16

g/l

0.10

607

Vertigo of central origin

176

1.50

1.12

1.7

2.6

2.76

3.18

g/l

1.03

135

Other and unspecified nail disorders

201

1.46

1.11

2.2

2.4

2.88

3.11

g/l

0.57

164

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

682

1.24

1.11

1.2

1.4

3.38

3.11

g/l

1.29

527

Laparoscopic left hemicolectomy

193

1.47

1.11

2.6

2.5

3.24

3.21

g/l

0.05

151

Gonococcal infection

311

1.36

1.11

2.2

1.9

3.04

3.07

g/l

0.06

253

Alzheimer’s disease (Atypical or mixed), excluding more controls

824

0.80

1.11

2.2

2.3

3.25

3.32

g/l

0.15

628

Examination and encounter for administrative purposes

372

1.33

1.10

3.1

2.5

3.24

3.15

g/l

0.28

310

Dysplastic lesion of unknown severity of the cervix uteri

1.85

1.10

1.5

3.11

3.03

g/l

0.10

Unspecified jaundice

567

1.26

1.09

1.6

2.3

3.29

3.14

g/l

0.61

457

Macular hole

766

1.23

1.09

2.0

2.7

3.15

3.11

g/l

0.12

598

Lesion of radial nerve

364

1.33

1.09

2.2

3.20

3.16

g/l

0.07

284

Nonspecific lymphadenitis

558

1.26

1.09

1.8

2.2

3.00

3.06

g/l

0.18

443

Parkinson's disease, strict definition

235

2085

1.13

1.08

1.9

2.4

3.05

3.06

g/l

0.07

179

1611

TMD related pain

278

1.38

1.08

1.8

2.2

3.15

3.12

g/l

0.05

229

Respiratory tuberculosis, clinically confirmed

153

1.53

1.08

1.2

2.7

2.76

3.17

g/l

0.86

119

Inflammation of lacrimal passages (acute and unspecified)

161

1.51

1.08

2.9

1.8

2.93

3.13

g/l

0.35

125

Benign mammary dysplasia

210

1850

1.14

1.08

2.5

2.3

3.06

3.14

g/l

0.51

158

1420

Other and unspecified injuries of thorax

153

1.52

1.07

1.5

2.2

3.59

3.04

g/l

1.17

117

Benign neoplasm: Other and unspecified parts of small intestine

203

1.45

1.07

1.8

2.2

3.38

3.22

g/l

0.32

163

Chondromalacia

296

1.36

1.07

1.4

2.1

3.24

3.06

g/l

0.31

241

Neovascular glaucoma

462

1.29

1.07

2.5

3.28

3.15

g/l

0.41

361

Tularaemia

129

1.58

1.07

3.3

2.2

2.73

3.08

g/l

0.77

104

Endometriosis diagnosis and infertility diagnosis occurring together

100

830

1.21

1.07

1.6

2.2

2.85

3.03

g/l

0.93

655

Pleural plaque

168

1460

1.16

1.06

2.3

3.04

3.05

g/l

0.08

123

1113

Foreign body entering into or through eye or natural orifice

813

1.21

1.06

2.7

2.3

3.13

3.08

g/l

0.21

656

Injury of muscle and tendon at forearm level

170

1.49

1.06

1.5

2.0

3.14

3.07

g/l

0.13

135

Glaucoma secondary to other eye disorders

463

1.29

1.06

2.5

2.7

3.28

3.15

g/l

0.42

358

Car occupant injured in other and unspecified transport accidents

218

1928

1.13

1.05

2.1

2.2

2.96

3.09

g/l

1.59

166

1516

Effects of foreign body entering through natural orifice

321

2903

1.11

1.05

2.3

2.91

3.06

g/l

1.86

250

2304

Carcinoma in situ of breast, intraductal

109

915

1.20

1.05

1.8

1.4

3.22

3.04

g/l

0.79

699

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

114

1.61

1.04

1.3

1.2

3.35

3.16

g/l

0.20

Tuberculosis, IBD comorbidity

114

962

1.19

1.04

2.0

2.3

3.10

3.13

g/l

0.10

750

Superficial injury of neck

138

1.54

1.04

1.2

1.7

2.84

3.07

g/l

0.46

110

Endometriosis ASRM stages 1,2

190

1668

1.14

1.03

1.4

2.0

2.88

3.06

g/l

1.57

136

1306

Benign neoplasm of bone and articular cartilage

101

844

1.20

1.02

1.4

2.4

2.94

3.09

g/l

0.97

663

Maternal care related to the fetus and amniotic cavity and possible delivery problems

402

2589

0.91

1.02

2.5

2.0

2.95

3.00

g/l

0.46

304

2059

Abnormal findings on antenatal screening of mother

370

0.70

1.02

1.0

1.5

3.00

g/l

0.00

288

Colorectal adenocarcinoma

268

2980

0.90

1.02

2.4

2.3

3.16

3.09

g/l

0.50

190

2281

Other diseases of biliary tract

126

1075

1.18

1.02

2.3

2.4

3.17

3.13

g/l

0.22

103

833

Serous carcinoma of ovary

437

0.72

1.01

2.6

2.5

3.23

3.16

g/l

0.13

351

Unspecified mental disorder

542

5028

1.08

1.01

1.9

2.2

3.05

3.04

g/l

0.13

409

3950

Inflammatory disorders of breast

511

1.26

1.00

1.5

2.3

3.03

3.07

g/l

0.16

409

Amblyopia ex anopsia

317

1.33

1.00

1.3

2.1

2.96

3.14

g/l

0.47

251

Parkinson's disease

251

2251

1.12

0.99

2.0

2.4

3.08

g/l

0.01

191

1740

Melanocytic naevi of other and unspecified parts of face

539

1.25

0.99

2.8

1.4

3.06

3.04

g/l

0.06

422

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

165

1.48

0.99

2.1

1.7

2.84

3.21

g/l

0.99

128

Labour and delivery complicated by fetal stress [distress]

131

1019

0.86

0.98

1.6

1.7

2.92

g/l

0.01

113

826

Peripheral retinal degeneration

336

1.32

0.98

3.4

2.7

2.87

3.11

g/l

1.06

271

1.77

0.98

1.7

3.1

3.36

3.15

g/l

—

Alzheimer’s disease, wide definition, excluding more controls

262

1598

1.12

0.97

2.0

2.3

3.20

3.23

g/l

0.11

178

1239

Benign neoplasm of brain and other parts of central nervous system

732

1.21

0.96

2.1

2.5

2.97

3.11

g/l

0.80

582

Brain meningioma, excluding all cancers (controls excluding all cancers)

587

1.24

0.96

2.3

1.4

3.22

3.05

g/l

0.61

441

Tuberculosis, wide

118

1008

1.18

0.96

2.0

2.5

3.11

3.15

g/l

0.15

786

Benign neoplasm: Central nervous system, other parts/unspecified

1.94

0.95

2.6

1.2

2.84

3.12

g/l

—

Sequelae of injuries of upper limb

122

1045

1.17

0.95

2.6

2.5

2.99

3.08

g/l

0.40

829

Frontotemporal dementia

1.77

0.95

2.4

2.2

2.90

3.27

g/l

—

Benign neoplasm: Skin of scalp and neck

251

1.37

0.95

3.1

2.8

3.09

3.15

g/l

0.14

202

Benign neoplasm: Short bones of upper limb

125

1.54

0.95

1.4

2.70

2.99

g/l

0.66

All dysplastic lesions of the vulva

435

1.27

0.95

1.3

2.3

3.21

3.14

g/l

0.20

349

LeFortI or BSSRO operation

305

0.68

0.94

1.0

1.7

2.62

3.02

g/l

1.98

249

Other disorders of Eustachian tube

286

1.34

0.94

1.5

2.2

3.16

3.17

g/l

0.01

226

Benign neoplasm of ovary

226

2022

1.12

0.94

2.4

1.5

3.21

3.08

g/l

1.00

179

1528

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

384

2956

1.09

0.94

2.3

1.5

3.39

3.04

g/l

8.82

315

2277

Contact with machinery

113

1320

0.85

0.93

2.3

2.91

3.04

g/l

0.73

1055

Alzheimer’s disease (Late onset), excluding more controls

250

1497

1.12

0.93

2.0

2.2

3.22

g/l

0.02

165

1162

Motorcycle rider injured in noncollision transport accidents

209

1.40

0.93

1.8

2.63

3.00

g/l

1.70

173

Abnormalities of forces of labour

808

1.19

0.92

1.4

2.0

2.71

3.03

g/l

4.66

647

Tuberculosis of other organs, strict

305

1.33

0.92

2.2

2.6

3.33

3.25

g/l

0.14

241

Calcaneal spur

110

1.57

0.92

1.2

1.7

3.17

3.05

g/l

—

LSIL lesion of the vulva

270

1.34

0.91

1.3

2.0

3.20

3.07

g/l

0.30

221

Migraine without aura, drug-induced

1.62

0.91

5.7

2.4

3.60

3.16

g/l

—

Other bursitis of knee

110

1.56

0.91

2.1

2.5

3.50

3.16

g/l

0.76

All dysplastic lesions of the vagina

236

1.37

0.91

2.8

1.9

2.90

3.11

g/l

0.69

195

Benign neoplasm of other and unspecified sites

323

1.31

0.90

2.8

1.4

3.03

3.05

g/l

0.05

254

Schizoaffective disorder

691

1.21

0.90

1.8

2.3

3.18

3.08

g/l

0.51

547

Benign neoplasm: Lower jaw bone

1.96

0.90

1.6

1.1

2.88

2.97

g/l

—

Benign neoplasm: Conjunctiva

341

1.30

0.90

1.3

2.9

3.05

3.16

g/l

0.29

276

Other benign neoplasm of uterus: Corpus uteri

1.68

0.89

4.8

2.1

2.92

3.25

g/l

—

Benign neoplasm: Skin of lip

152

1.47

0.89

2.2

1.9

2.97

3.23

g/l

0.33

119

Benign neoplasm of other and unspecified female genital organs

517

0.77

0.89

2.0

2.4

3.03

3.15

g/l

0.22

406

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

229

1.37

0.88

1.7

1.4

2.97

3.16

g/l

0.47

176

Vertical strabismus

316

1.31

0.87

1.9

2.6

3.21

3.17

g/l

0.06

250

Respiratory conditions due to other external agents

238

1.36

0.87

7.3

2.0

3.24

3.12

g/l

0.23

189

Other problems related to primary support group, including family circumstances

774

1.19

0.87

1.9

2.1

2.98

3.09

g/l

0.50

608

Sensorineural hearing loss

1362

9128

1.05

0.87

2.4

2.3

3.00

3.11

g/l

3.24

947

7145

Benign neoplasm: Skin of trunk

405

1.27

0.87

3.1

1.4

2.90

3.03

g/l

0.48

322

Injury of muscle and tendon at shoulder and upper arm level

569

5330

1.07

0.86

2.2

2.3

2.98

3.06

g/l

1.16

447

4172

Disturbances of smell and taste

460

1.25

0.85

2.9

3.0

2.99

3.13

g/l

0.56

362

Acute inflammation of orbit

1.80

0.85

10.6

1.2

3.20

3.18

g/l

—

Right ventricular outflow tract obstruction

1.95

0.85

1.0

2.0

3.07

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

101

863

1.18

0.84

2.1

1.4

2.93

3.03

g/l

0.52

671

Deep bite

103

770

1.17

0.84

2.0

2.3

3.12

3.10

g/l

0.07

617

Use of interferon beta-1a

171

1.41

0.83

1.3

1.8

2.54

3.03

g/l

2.88

145

Childhood allergy (age < 16)

393

1.24

0.83

1.1

1.2

3.00

3.03

g/l

0.08

329

Small plaque parapsoriasis

1.93

0.83

1.7

2.4

3.32

3.31

g/l

—

Maternal care for cervical incompetence

399

0.75

0.83

7.1

2.4

3.05

3.12

g/l

0.09

321

Injury of blood vessels at hip and thigh level

1.93

0.83

2.3

2.0

3.07

3.25

g/l

—

Radial styloid tenosynovitis [de Quervain]

489

1.23

0.82

2.1

2.2

3.08

3.12

g/l

0.09

386

Oligomenorrhoea

275

1.32

0.82

1.6

2.3

2.90

3.23

g/l

1.77

217

Contact with other hot fluids

223

1.35

0.82

1.1

2.4

3.18

3.07

g/l

0.19

185

Other obstetric trauma

330

0.72

0.82

2.0

2.1

2.81

2.98

g/l

0.85

269

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

233

1.34

0.80

4.2

1.4

3.36

3.07

g/l

0.71

192

Discharge from other and unspecified firearms

0.00

0.80

0.0

2.5

—

3.03

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

216

1.36

0.80

2.7

1.3

3.28

3.12

g/l

0.47

168

Vasomotor rhinitis (mode)

822

1.17

0.79

2.1

2.6

2.93

3.08

g/l

0.74

647

TMD related operations

193

1733

1.12

0.79

2.9

2.3

2.98

3.06

g/l

0.55

155

1379

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

693

1.19

0.79

2.3

2.2

2.83

3.09

g/l

1.97

546

Convergence insufficiency and excess

1.57

0.79

1.4

1.9

2.89

3.04

g/l

—

Maternal care for known or suspected malpresentation of fetus

851

0.86

0.78

1.9

1.7

2.94

2.92

g/l

0.07

685

Hyperosmolality and hypernatraemia

140

1.45

0.78

2.1

2.2

3.23

3.22

g/l

0.01

110

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

737

0.82

0.78

3.0

1.4

3.19

3.10

g/l

0.25

548

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

416

0.76

0.77

2.6

1.4

3.23

3.04

g/l

0.47

318

Acquired absence of organs, not elsewhere classified

124

1.47

0.76

4.5

2.3

4.03

3.16

g/l

1.58

101

Rubella [German measles]

315

1.28

0.75

2.3

1.9

2.89

2.98

g/l

0.31

253

Occlusion and stenosis of arteries, not leading to stroke

141

1.43

0.75

3.9

2.3

3.75

3.28

g/l

0.56

108

Transient global amnesia

113

1292

0.87

0.75

2.5

2.79

3.12

g/l

3.89

1027

Chorioretinal scars

1.89

0.75

1.9

2.3

3.04

3.16

g/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

1.89

0.75

2.6

2.4

2.84

3.17

g/l

—

Fall on and from ladder

107

930

1.16

0.75

3.7

2.6

2.82

3.06

g/l

2.12

753

Benign neoplasm: Scrotum

1.88

0.75

1.3

2.89

3.12

g/l

—

Acute appendicitis, with complications

284

2610

1.09

0.74

2.4

2.3

3.09

3.07

g/l

0.13

226

2049

Defect, injury or illness of neck

1.87

0.74

1.1

1.3

3.31

3.00

g/l

—

Carcinoma in situ, bladder

361

1.26

0.74

3.5

1.4

3.15

3.09

g/l

0.12

288

Dementia, including avohilmo

761

5523

0.95

0.74

1.9

2.3

3.07

3.13

g/l

0.72

518

4230

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

336

3112

1.08

0.73

3.3

1.5

3.56

3.04

g/l

10.65

256

2410

Use of rasagiline

317

1.27

0.73

1.4

3.0

2.93

3.14

g/l

0.74

253

Other contact dermatitis

829

1.16

0.73

1.7

2.5

2.84

3.13

g/l

2.52

654

Crystalline deposits in vitreous body

109

1.49

0.72

3.9

2.8

2.72

3.12

g/l

—

Carcinoma in situ of middle ear and respiratory system

1.61

0.72

1.9

1.3

2.86

3.18

g/l

—

Blood alcohol or alcohol intoxication level

185

1.36

0.72

1.2

2.2

2.67

3.12

g/l

1.80

147

Benign neoplasm: Scrotum

1.79

0.72

1.3

1.4

2.89

3.12

g/l

—

Benign neoplasm: Larynx

372

1.25

0.71

2.8

2.5

2.78

3.12

g/l

1.57

295

Benign lipomatous neoplasm

439

4113

1.07

0.71

2.6

2.3

3.05

3.06

g/l

0.06

319

3198

Benign neoplasm: Long bones of lower limb

247

1.30

0.71

1.1

1.3

2.87

3.01

g/l

0.41

194

Other benign neoplasms of uterus

740

1.17

0.70

3.0

2.2

3.23

3.21

g/l

0.05

575

Other corneal oedema

1.56

0.70

2.7

2.0

3.34

3.12

g/l

—

Malignant neoplasm of bladder

111

973

1.15

0.70

2.1

2.5

3.21

3.12

g/l

0.40

760

Carcinoma in situ of other and unspecified sites

400

1.23

0.70

3.3

1.4

3.21

3.06

g/l

0.33

321

Heterophoria

730

1.17

0.70

3.0

2.4

2.78

3.15

g/l

3.72

578

Embolic stroke

573

1.19

0.70

2.0

2.6

3.33

3.16

g/l

0.57

440

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

169

1521

1.12

0.70

2.3

1.4

3.25

3.05

g/l

1.36

121

1139

Divergent concomitant strabismus

740

1.17

0.69

1.9

2.3

2.88

3.13

g/l

1.87

577

Presbycusis

235

2141

1.10

0.69

2.5

2.2

3.04

3.20

g/l

1.70

173

1664

Persistent delusional disorders

866

0.85

0.68

2.2

2.4

3.29

3.09

g/l

1.06

679

Car occupant injured in noncollision transport accident

284

1.27

0.68

3.7

2.5

3.16

3.14

g/l

0.04

225

Carcinoma in situ of larynx

1.86

0.68

2.4

3.0

2.58

3.06

g/l

—

Inflammatory diseases of prostate (prostatitis)

184

1667

1.11

0.68

2.1

2.5

2.96

3.06

g/l

0.75

133

1323

Oral leukoplakia, including avohilmo

303

1.26

0.67

1.3

2.0

3.40

3.13

g/l

0.76

247

Alzheimer disease, excluding more controls

285

1756

1.09

0.67

2.2

2.3

3.20

3.23

g/l

0.17

184

1366

Tuberculosis of other organs

259

1.29

0.66

2.0

2.5

3.43

3.28

g/l

0.23

202

Bilateral sagittal split ramus osteotomy operation

248

0.72

0.65

1.0

1.7

2.62

2.98

g/l

1.72

204

Colorectal cancer

335

3593

0.93

0.65

2.4

2.3

3.16

3.09

g/l

0.56

250

2756

Mixed conductive and sensorineural hearing loss

187

1700

1.10

0.65

2.6

2.3

3.07

3.15

g/l

0.42

128

1337

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.49

0.64

1.2

2.3

3.52

3.01

g/l

—

Bacterial meningitis

350

1.24

0.64

3.5

2.6

2.81

3.05

g/l

0.91

279

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

113

1274

0.88

0.64

2.7

1.4

3.07

3.03

g/l

0.20

977

Placenta praevia

258

0.73

0.63

1.1

1.8

2.80

2.99

g/l

0.52

206

Secondary parkinsonism+Parkinsonism in other disease

306

1.25

0.63

2.9

2.5

2.89

3.18

g/l

1.03

243

Carcinoma in situ of larynx

1.73

0.63

2.4

1.1

2.58

3.10

g/l

—

Hypertrophy of breast in women and men

225

2068

1.09

0.62

1.9

2.3

3.02

3.06

g/l

0.22

175

1608

Gastrointestinal stromal tumor and sarcoma

130

1.40

0.62

1.3

2.4

3.35

3.20

g/l

0.15

101

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.62

0.0

1.1

—

2.63

—

Communicating hydrocephalus

235

1.29

0.62

1.6

2.8

2.99

3.12

g/l

0.30

186

Other fall from one level to another

276

2558

1.08

0.62

2.1

2.3

3.01

3.08

g/l

0.53

214

2020

Uterine polyps

121

1078

1.13

0.62

2.0

2.2

3.08

3.16

g/l

0.35

844

Spermatocele

111

984

1.13

0.62

2.4

2.3

2.97

3.04

g/l

0.42

779

Traumatic amputation of hip and thigh

0.00

0.62

0.0

2.1

—

3.02

—

Use of dimethyl fumarate

1.61

0.61

1.0

2.3

2.51

2.85

g/l

—

Hypermetropia

637

1.17

0.61

2.6

2.3

3.19

3.15

g/l

0.10

505

Other benign neoplasm of uterus: Other parts/unspecified

601

1.17

0.61

2.8

2.3

3.25

3.24

g/l

0.00

463

Adenocarcinoma and papillary adenocarcinoma of stomach

334

0.77

0.61

1.2

2.6

3.09

3.13

g/l

0.05

261

Benign neoplasm: Brain, supratentorial

148

1.36

0.60

1.3

2.9

2.85

3.17

g/l

1.23

118

Congenital malformations of uterus and cervix

122

1.40

0.60

1.2

2.0

2.60

3.23

g/l

1.82

105

Infections of genitourinary tract in pregnancy

887

0.87

0.60

2.2

3.03

3.10

g/l

0.24

703

Other congenital malformations of the digestive system

324

1.23

0.60

1.5

2.5

3.17

3.14

g/l

0.07

256

malignant neoplasm of male genital organs

731

4435

1.05

0.59

2.2

2.4

3.17

3.05

g/l

2.43

546

3479

Unspecified chronic bronchitis

427

1.20

0.59

1.9

2.9

2.84

3.14

g/l

1.39

326

Female infertility, tubal origin

381

1.21

0.59

1.3

1.8

3.07

3.10

g/l

0.06

301

Injury of nerves at wrist and hand level

354

1.22

0.59

2.5

2.7

3.01

3.09

g/l

0.26

275

Abscess of Bartholin gland

210

1.29

0.59

3.5

2.2

3.06

3.10

g/l

0.09

177

Benign neoplasm: Short bones of upper limb

140

1.37

0.59

1.4

2.2

2.70

3.15

g/l

1.15

113

Other melanin hyperpigmentation

255

1.27

0.59

3.0

2.2

2.80

3.17

g/l

1.54

199

Struck by thrown, projected or falling objec

409

1.20

0.59

1.2

2.6

2.76

3.09

g/l

1.59

328

Benign neoplasm: Vulva

242

0.74

0.58

2.3

3.15

3.10

g/l

0.05

198

Other and unspecified water transport accidents

1.75

0.58

1.0

1.2

3.07

2.86

g/l

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

1.50

0.58

1.2

1.3

2.63

3.07

g/l

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

229

1994

1.09

0.58

2.1

1.4

3.43

3.03

g/l

7.14

189

1515

Supervision of high-risk pregnancy

169

929

1.10

0.57

1.7

1.8

2.89

2.98

g/l

0.66

126

767

Use of ropinirole

448

1.19

0.57

2.3

3.0

3.26

3.13

g/l

0.29

356

Myocardial infarction, unclassifiable

343

3257

0.94

0.57

1.7

2.2

3.26

3.11

g/l

1.71

258

2467

Dermatitis herpetiformis

185

1.31

0.57

3.7

2.2

2.46

3.15

g/l

3.78

147

Brain meningioma

625

1.16

0.56

2.3

2.6

3.22

3.14

g/l

0.22

489

Medicines for HER+ breast cancer

478

4907

0.95

0.56

2.0

2.3

3.19

3.09

g/l

1.07

359

3720

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

476

1.18

0.56

2.5

1.4

3.17

3.06

g/l

0.52

378

Benign neoplasm: Tonsil

107

1.42

0.56

2.7

1.2

3.06

3.00

g/l

—

conjunctival degenerations and deposits

230

1.27

0.56

3.1

2.0

2.85

3.10

g/l

0.80

181

Maternal care for known or suspected abnormality of pelvic organs

182

1371

0.91

0.56

2.6

2.0

2.90

2.98

g/l

0.45

143

1101

Twin gestation

606

1.16

0.56

1.2

1.9

2.82

2.97

g/l

1.03

484

Frontotemporal dementia, wide, incl. Pick's disease

1.49

0.55

2.4

2.0

2.90

3.27

g/l

—

Other abnormal products of conception

270

1673

1.08

0.55

1.8

2.1

2.90

2.97

g/l

0.65

224

1329

Female infertility

324

1873

1.07

0.55

1.9

2.1

2.98

3.08

g/l

0.97

254

1474

Pedal cyclist injured in transport accident

271

2527

1.07

0.55

2.0

2.2

2.97

3.09

g/l

1.20

205

2007

Single delivery by caesarean section

134

859

0.90

0.55

2.0

1.6

2.96

3.00

g/l

0.17

102

726

Secondary parkinsonism

303

1.23

0.55

2.9

2.6

2.89

3.19

g/l

0.99

239

Carcinoma in situ of middle ear and respiratory system

1.50

0.55

1.9

3.1

2.86

3.15

g/l

—

Disorders of puberty, all

1.58

0.54

1.2

2.0

2.97

3.13

g/l

—

Other deformity of hallux (acquired)

1.45

0.54

1.2

1.9

3.44

2.95

g/l

—

Phakomatoses, not elsewhere classified

1.50

0.54

2.4

2.2

2.63

3.12

g/l

—

Vestibular neuronitis

122

1100

1.11

0.53

2.2

2.5

3.06

3.09

g/l

0.09

864

Pregnancy hypertension

439

3750

1.06

0.53

2.4

2.1

2.98

3.01

g/l

0.21

345

2931

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

110

1224

0.90

0.53

2.8

1.4

3.07

3.04

g/l

0.13

935

Benign neoplasm of other and unspecified sites

350

1.21

0.53

2.8

2.3

3.03

3.09

g/l

0.14

278

Malignant neoplasm of breast, HER-positive

459

4764

0.95

0.53

1.9

2.4

3.19

3.10

g/l

1.04

343

3603

Oral lichen ruber planus wide, hypothyreosis or thyroxin

657

1.15

0.53

1.6

2.6

2.95

3.13

g/l

0.93

508

Acute and transient psychotic disorders

132

1196

1.11

0.53

2.1

2.3

3.10

g/l

0.02

947

Other complications of labour and delivery, not elsewhere classified

535

0.84

0.52

1.3

1.5

2.79

2.94

g/l

0.73

434

Renal cell carcinoma of kidney

434

1.18

0.52

1.9

2.7

3.39

3.18

g/l

0.55

335

Normal-pressure hydrocephalus

682

0.86

0.52

2.6

2.5

2.93

3.18

g/l

1.54

534

Burn and corrosion of trunk

269

1.23

0.51

1.3

2.6

2.98

3.14

g/l

0.50

215

Malignant neoplasm of corpus uteri

100

1116

0.89

0.51

1.6

2.2

3.33

3.17

g/l

0.60

847

Urticaria due to cold and heat

1.40

0.51

1.7

1.6

2.99

3.11

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

102

1137

0.89

0.51

1.7

2.4

2.88

3.11

g/l

1.52

906

Obstructed labour due to maternal pelvic abnormality

156

1701

0.92

0.50

2.4

2.3

2.85

3.08

g/l

2.35

116

1312

Complications predominantly related to the puerperium

254

2373

1.07

0.50

1.9

2.1

2.88

3.01

g/l

1.36

196

1867

Malignant neoplasm of prostate

722

4377

1.04

0.50

2.2

2.5

3.17

3.05

g/l

2.36

537

3433

Schizotypal disorder

171

1.29

0.50

1.8

1.9

2.89

3.03

g/l

0.34

142

Multiple gestation

622

1.14

0.50

1.2

1.9

2.82

2.98

g/l

1.13

498

Dementia due to Parkinsons disease, excluding more controls

216

1.26

0.50

1.3

2.3

3.28

g/l

0.01

171

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

417

1.18

0.50

2.7

1.9

2.72

3.02

g/l

1.83

309

Other benign neoplasms of connective and other soft tissue

127

1154

1.10

0.49

2.7

2.4

2.91

3.11

g/l

1.35

909

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

1.55

0.49

1.1

1.2

3.24

3.10

g/l

—

Crushing injury of wrist and hand

154

1.31

0.49

1.7

2.7

3.02

3.17

g/l

0.31

124

Hepatocellular carcinoma

235

1.24

0.49

2.3

2.8

3.04

3.17

g/l

0.36

184

Kyphosis

128

1.34

0.48

1.4

1.6

3.00

3.12

g/l

0.26

104

Long labour

180

1699

0.92

0.48

2.3

2.0

2.91

2.98

g/l

0.37

144

1359

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

263

1.22

0.47

3.1

1.3

3.24

3.10

g/l

0.47

208

Universal erythroderma, KELA reimbursement

146

1.31

0.47

1.3

2.3

2.68

3.24

g/l

2.32

114

Generalized epilepsy

327

1.20

0.47

1.7

2.3

2.95

3.06

g/l

0.16

265

Open bite

272

1.22

0.47

1.1

1.5

2.98

3.10

g/l

0.31

226

Other menopausal disorders

381

2080

1.06

0.47

2.0

2.2

2.89

3.14

g/l

5.96

299

1621

Benign lipomatous neoplasm of other sites/unspecified

128

1168

1.10

0.47

3.2

2.4

3.12

3.09

g/l

0.10

923

Other obstructed labour

707

0.87

0.46

2.0

2.2

2.96

3.10

g/l

0.43

563

Other disorders of breast and lactation associated with childbirth

0.61

0.46

1.0

1.9

2.54

3.26

g/l

—

Papillary adenocarcinoma of thyroid gland

571

1.14

0.46

2.1

2.6

3.05

3.11

g/l

0.20

444

Dental caries 2 and operation codes, only avohilmo

1053

6333

1.03

0.46

2.6

2.3

2.94

3.04

g/l

2.73

819

4871

Malignant neoplasm of head and neck

117

1065

1.10

0.45

2.4

2.5

3.00

3.12

g/l

0.70

846

L02BB Anti-androgens

122

1335

0.91

0.45

1.9

2.4

3.29

3.05

g/l

1.55

1020

Malignant neoplasm of brain

319

0.81

0.45

1.5

2.4

3.00

3.09

g/l

0.24

257

Gestational diabetes (for exclusion)

253

1904

0.94

0.43

1.8

3.02

2.91

g/l

1.12

203

1525

Other specified and unspecified disorders of lens

122

1.33

0.43

1.8

2.7

2.89

3.28

g/l

—

Sequelae of inflammatory diseases of the central nervous system

1.59

0.43

1.8

4.1

3.08

3.29

g/l

—

Lesion of sciatic nerve

585

0.87

0.43

1.3

2.5

2.96

3.15

g/l

0.81

450

Intermittent heterotropia

396

1.16

0.43

2.1

2.0

2.79

3.19

g/l

1.80

317

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

102

926

1.10

0.42

1.8

2.2

3.13

3.07

g/l

0.25

720

Carcinoma in situ of cervix uteri

584

1.13

0.42

2.3

1.3

3.01

2.98

g/l

0.06

461

Other and unspecified injuries of shoulder and upper arm

267

1.20

0.42

1.4

2.4

3.20

3.22

g/l

0.02

209

Embedded and impacted teeth

177

1399

1.08

0.42

2.0

1.9

2.95

3.02

g/l

0.47

126

1141

Obstetric embolism

0.00

0.42

0.0

1.1

—

3.58

—

Family history of malignant neoplasm

1016

0.90

0.42

2.9

2.1

3.05

g/l

0.00

804

Drowning to ice

0.00

0.41

0.0

1.2

—

3.45

—

LSIL lesion of the cervix uteri

832

1.11

0.41

3.3

2.1

2.96

3.05

g/l

0.55

659

FESS (DNB20)

129

1401

0.92

0.41

2.4

2.3

2.86

3.09

g/l

2.10

1115

Benign neoplasm of other and unspecified female genital organs

466

0.85

0.41

2.0

1.3

3.03

3.02

g/l

0.03

357

Poor fetal growth

680

1.12

0.41

1.7

1.8

2.86

2.97

g/l

0.61

534

Dislocation, sprain and strain of joints and ligaments of head

314

1.18

0.41

1.3

1.9

2.86

3.05

g/l

0.63

249

Dependent personality disorder

195

1.24

0.41

1.9

2.0

2.96

3.09

g/l

0.39

161

Malignant neoplasm of oral cavity

380

1.16

0.40

2.4

2.9

3.23

3.17

g/l

0.18

298

Hydrocephalus

982

0.90

0.40

2.3

2.5

2.94

3.14

g/l

1.25

777

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

497

0.86

0.40

2.6

2.5

2.98

3.09

g/l

0.22

394

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

793

0.89

0.40

3.2

2.4

3.11

3.07

g/l

0.11

632

Other specified/unspecified diseases of inner ear

1.33

0.40

1.8

2.0

2.58

3.19

g/l

—

L02BG Aromatase inhibitors

392

4101

0.95

0.40

2.1

2.3

3.21

3.10

g/l

1.19

297

3122

Venous complications and haemorrhoids in the puerperium

101

0.69

0.40

1.3

1.7

2.87

3.19

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

223

1.22

0.40

4.3

1.3

2.78

3.08

g/l

0.93

169

Malignant neoplasm of other and unspecified urinary organs

1.45

0.40

1.0

1.3

2.58

3.18

g/l

—

Sequelae of infectious and parasitic diseases

826

1.10

0.39

2.8

2.2

3.11

3.13

g/l

0.06

648

Hypersensitivity pneumonitis due to organic dust

169

1.25

0.39

3.4

2.9

3.35

3.11

g/l

0.29

137

HSIL lesion of the vulva

169

1.25

0.39

1.4

2.2

3.17

3.19

g/l

0.03

143

Chorioretinal inflammation

279

1.19

0.39

1.5

2.4

2.98

3.13

g/l

0.32

224

Erosion and ectropion of cervix uteri

335

1.17

0.39

3.6

2.1

3.16

3.27

g/l

0.25

266

L02BA Anti-estrogens

215

2023

1.06

0.39

1.9

2.3

3.23

3.10

g/l

1.04

170

1545

Non-allergic asthma

108

991

1.09

0.38

2.0

2.5

3.14

3.10

g/l

0.24

774

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

524

1.13

0.37

1.6

1.9

2.99

3.01

g/l

0.09

413

Maltreatment syndromes

336

1.16

0.37

2.1

1.8

2.93

3.03

g/l

0.35

270

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

279

2820

0.95

0.37

1.9

1.4

3.10

3.08

g/l

0.10

214

2135

Bicuspidal aortic valve syndrome

318

1.17

0.37

2.1

2.4

3.17

3.06

g/l

0.35

257

Benign neoplasm: Long bones of lower limb

272

1.18

0.36

1.1

2.1

2.87

3.07

g/l

0.65

219

Other disorders of male genital organs

328

1.16

0.36

1.5

2.6

2.79

3.03

g/l

0.72

257

Female genital prolapse

421

2330

1.04

0.36

2.4

2.2

3.06

3.17

g/l

1.24

313

1808

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.45

0.36

1.8

1.3

3.47

3.04

g/l

—

Hypertrophy of breast

184

1729

1.07

0.36

1.5

2.3

3.02

3.05

g/l

0.14

141

1344

Excessive vomiting in pregnancy

631

1.11

0.35

2.3

2.2

2.90

3.08

g/l

0.77

506

Open wound of thorax

126

1.28

0.35

2.1

2.2

3.37

3.07

g/l

0.57

102

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

1.41

0.35

3.7

1.1

2.43

3.13

g/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

287

1828

1.05

0.35

2.0

2.1

2.99

3.08

g/l

0.73

225

1439

Melanocytic naevi of other and unspecified parts of face

604

1.11

0.34

2.8

2.4

3.06

3.12

g/l

0.21

476

Respiratory tuberculosis, not confirmed

542

0.88

0.34

2.4

2.6

2.78

3.17

g/l

2.19

419

Pterygium

349

1.15

0.34

2.2

2.6

2.88

3.08

g/l

0.45

276

Other and unspecified intracranial injuries

293

1.17

0.34

1.7

2.7

3.06

3.11

g/l

0.12

229

Other appendicitis

912

1.09

0.33

3.0

2.5

2.96

3.11

g/l

0.99

725

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.32

0.33

5.7

1.3

2.97

2.98

g/l

—

Anomalies of dental arch relationship, including avohilmo

177

1496

1.06

0.33

1.9

2.3

3.00

3.07

g/l

0.38

119

1192

Use of selegiline

587

1.11

0.33

2.2

2.5

2.95

3.14

g/l

0.68

468

Abnormal reflex

1.29

0.32

1.8

2.5

3.18

3.06

g/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

407

1.13

0.32

1.2

2.3

3.02

3.15

g/l

0.36

318

Benign neoplasm: Skin of other and unspecified parts of face

152

1428

1.07

0.31

3.8

2.4

2.96

3.11

g/l

0.81

102

1121

Cyst of Bartholin Gland

342

1.14

0.31

2.6

2.1

2.92

3.10

g/l

0.45

282

Mandibular retrognathia

463

0.88

0.31

1.2

1.8

2.85

3.07

g/l

0.88

373

Any dementia, excluding more controls

581

4158

0.97

0.31

2.0

2.3

3.15

3.14

g/l

0.07

388

3177

Bruxism

147

1.23

0.31

1.2

2.1

2.95

3.00

g/l

0.09

119

Follow-up care involving plastic surgery

381

1.13

0.30

1.5

1.9

3.04

3.00

g/l

0.08

306

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

509

4310

1.03

0.30

2.3

2.1

2.99

3.01

g/l

0.22

398

3360

Pedestrian injured in collision with car, pick-up truck or van

240

1.17

0.30

1.1

2.4

3.32

3.17

g/l

0.22

193

Multiple delivery

808

0.91

0.30

2.0

1.9

2.98

3.02

g/l

0.12

657

Melanocytic naevi, other sites/unspecified

725

1.09

0.30

2.0

1.4

3.13

3.05

g/l

0.23

575

Congenital malformations of aortic and mitral valves

353

1.14

0.30

2.0

2.3

3.25

3.06

g/l

0.69

284

Pedal cyclist injured in collision with motor vehicle

271

0.85

0.29

1.3

2.2

3.09

3.14

g/l

0.07

221

Labour and delivery complicated by umbilical cord complications

409

0.88

0.29

3.1

2.1

2.91

3.10

g/l

0.85

334

Caught, crushed, jammed or pinched in or between objects

401

1.13

0.29

1.3

2.3

2.83

3.12

g/l

1.13

319

Diabetes mellitus in pregnancy

219

1492

0.95

0.29

1.5

1.8

3.01

2.94

g/l

0.55

176

1202

Benign neoplasm: Skin of trunk

459

1.11

0.29

3.1

2.5

2.90

3.08

g/l

0.72

369

Failed induction of labour

281

0.85

0.29

1.3

1.6

3.12

2.98

g/l

0.23

228

Malignant neoplasm of stomach

641

1.10

0.29

1.2

2.5

3.39

3.17

g/l

0.77

498

Other and unspecified injuries of abdomen, lower back and pelvis

121

1.25

0.28

2.2

3.07

3.03

g/l

—

101

Antenatal screening

184

981

1.06

0.28

1.9

1.8

2.97

2.99

g/l

0.11

154

809

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

317

1.14

0.28

2.8

1.4

3.30

3.13

g/l

0.38

246

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

710

5944

0.97

0.28

2.3

2.2

3.00

3.02

g/l

0.28

562

4637

Postpartum haemorrhage due to retained placenta

772

0.92

0.27

2.0

1.8

2.87

2.93

g/l

0.28

593

Non-small cell lung cancer

229

2394

0.96

0.27

2.1

2.3

3.43

3.07

g/l

6.01

189

1842

Sequelae of other and unspecified infectious and parasitic diseases

500

1.10

0.26

2.6

2.1

3.10

3.09

g/l

0.02

400

Disorders of globe

291

1.14

0.26

1.9

2.5

3.12

3.11

g/l

0.03

225

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

299

0.87

0.26

1.2

1.5

3.09

3.14

g/l

0.07

227

Benign neoplasm: Skin of lower limb, including hip

263

1.15

0.26

1.7

1.3

2.60

3.01

g/l

1.97

208

Other and unspecified disorders of skin and subcutaneous tissue

742

1.08

0.25

1.7

2.5

2.98

3.12

g/l

0.34

586

Male infertility

288

0.87

0.25

1.6

2.2

2.68

3.03

g/l

0.85

233

Early lumbar disc prolapse, operated

636

1.09

0.25

2.0

1.9

2.81

3.00

g/l

1.14

521

Simple and mucopurulent chronic bronchitis

508

0.90

0.25

1.7

2.5

3.59

3.11

g/l

1.94

391

Benign neoplasm: Vulva

213

0.84

0.25

2.3

1.4

3.15

2.99

g/l

0.21

174

Motorcycle rider injured in other and unspecified transport accidents

403

0.89

0.25

1.3

2.1

2.97

3.08

g/l

0.30

326

Other disorders affecting eyelid function

1.27

0.24

2.7

1.6

2.26

3.07

g/l

—

Benign neoplasm: Cranial nerves

293

1.13

0.24

3.1

1.3

3.16

3.05

g/l

0.25

231

Benign neoplasm: Tonsil

124

1.22

0.24

2.7

2.0

3.06

3.16

g/l

—

Inflammatory disease of cervix uteri

786

0.93

0.24

1.4

2.3

2.84

3.13

g/l

2.09

616

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.36

0.24

1.8

1.2

2.56

3.02

g/l

—

Schizophrenia or delusion

380

3685

1.03

0.23

1.9

2.2

3.13

3.05

g/l

1.03

273

2910

Left ventricular outflow tract obstruction, narrow definition

408

1.11

0.23

1.9

2.4

3.39

3.07

g/l

1.14

328

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.33

0.23

1.8

3.0

2.56

3.17

g/l

—

Keratoconus

218

1.15

0.23

1.9

2.2

3.29

3.15

g/l

0.34

175

Unspecified transport accident

1.33

0.23

1.4

2.0

2.92

3.06

g/l

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

775

1.07

0.23

1.9

1.4

3.38

3.02

g/l

3.20

609

Malignant neoplasm of larynx

190

1.16

0.23

1.6

2.7

2.91

3.16

g/l

0.44

149

Intrahepatic Cholestasis of Pregnancy (ICP)

447

1.10

0.23

2.7

1.9

2.72

3.05

g/l

2.17

351

Haemorrhage in early pregnancy

280

2637

1.04

0.23

2.2

2.1

2.87

3.00

g/l

1.76

210

2076

Benign leiomyoma with endometriosis

220

2114

1.04

0.23

2.2

2.3

3.09

3.13

g/l

0.21

162

1626

Helminthiases

162

1.18

0.23

2.7

2.0

3.14

3.06

g/l

0.18

127

Melanoma in situ, other sites/unspecified

1.26

0.23

1.2

1.1

3.58

3.20

g/l

—

Hypothermia

181

1.17

0.22

1.0

3.1

2.95

3.12

g/l

0.32

143

Injury of urinary and pelvic organs

181

1.16

0.22

5.2

2.6

3.21

3.11

g/l

0.15

142

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.23

0.22

5.6

2.6

3.24

3.09

g/l

—

Carcinoma in situ, bladder

410

1.10

0.22

3.5

2.7

3.15

3.14

g/l

0.02

323

Retained placenta and membranes, without haemorrhage

116

1225

0.95

0.22

2.0

2.1

2.93

3.07

g/l

0.77

954

Impacted maxillary molar

219

1.14

0.22

2.2

1.7

2.96

3.13

g/l

0.53

184

Polycystic ovarian syndrome

257

1.13

0.22

1.2

1.6

3.17

3.10

g/l

0.08

212

Injury of muscle and tendon at wrist and hand level

168

1607

1.05

0.22

2.0

2.4

3.14

3.09

g/l

0.25

129

1276

Toxic effect of ethanol

324

1.11

0.22

1.1

2.2

2.80

3.08

g/l

0.84

261

Toxic effect of pesticides

0.00

0.22

0.0

1.0

—

3.02

—

Postpartum care and examination

546

0.93

0.21

1.6

2.92

2.97

g/l

0.14

458

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

2.82

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.21

0.0

1.4

—

2.37

—

Deep endometriosis

1028

0.94

0.21

1.5

2.2

2.79

3.15

g/l

2.91

803

Other congenital malformations of face and neck

220

1.14

0.21

3.0

2.0

2.93

3.07

g/l

0.48

182

Mumps

251

0.87

0.21

1.4

2.3

2.99

3.06

g/l

0.10

198

Suppurative otitis media, unspecified

219

0.86

0.20

1.5

2.2

3.60

3.15

g/l

0.83

171

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.20

0.0

1.2

—

2.98

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

318

2573

1.03

0.20

2.2

1.4

3.42

3.05

g/l

9.02

261

1978

Normotensive glaucoma

127

1210

1.05

0.20

2.1

2.5

2.87

3.12

g/l

2.24

944

Benign neoplasm: Rectum/anal canal icd-9

108

1.21

0.20

1.0

1.3

3.16

3.19

g/l

—

Cholesteatoma of middle ear

655

0.93

0.20

1.8

2.6

3.10

3.14

g/l

0.13

527

Dislocation, sprain and strain of joints and ligaments of elbow

519

1.08

0.20

1.8

2.98

3.07

g/l

0.26

411

Benign neoplasm of thyroid gland

375

0.90

0.19

2.5

2.3

2.70

3.10

g/l

1.69

301

Chronic diseases of tonsils and adenoids

1115

6948

1.02

0.19

1.9

2.3

3.02

3.05

g/l

0.48

875

5461

Benign neoplasm: Bronchus and lung

154

0.84

0.19

1.5

2.1

3.36

3.18

g/l

0.27

121

Fourth [trochlear] nerve palsy

228

0.87

0.19

1.5

2.7

3.02

3.18

g/l

0.26

179

Primary angle-closure glaucoma

571

0.93

0.19

2.7

3.28

3.17

g/l

0.31

441

Hypertrichosis

118

1.19

0.19

1.3

1.9

2.88

3.17

g/l

—

100

Carcinoma in situ of vulva

1.24

0.19

1.4

1.3

2.68

2.95

g/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

395

1.09

0.19

2.0

2.7

2.97

3.15

g/l

0.64

310

Carcinoma in situ of other and unspecified sites

453

1.09

0.19

3.3

2.7

3.21

3.13

g/l

0.15

356

Eustachian salpingitis and obstruction

579

1.07

0.18

1.9

2.0

2.99

3.06

g/l

0.28

457

Infections of breast associated with childbirth

232

1.12

0.18

1.1

1.6

2.63

3.16

g/l

3.54

192

Other noninflammatory disorders of cervix uteri

599

1.07

0.18

2.8

2.2

3.12

3.22

g/l

0.33

461

Schizophrenia, schizotypal and delusional disorders

381

3716

1.03

0.18

2.0

2.2

3.13

3.05

g/l

0.93

274

2933

Glaucoma, exfoliation

170

1636

1.04

0.18

2.3

2.4

2.87

3.15

g/l

2.46

124

1241

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS